Munster Technological University

SWORD - South West Open Research
Deposit
PhDs

Science

2014

Investigation of Pyrrolizidine Alkaloids in Foods using Liquid
Chromatography Mass Spectrometry
Caroline Griffin
Cork Institute of Technology

Follow this and additional works at: https://sword.cit.ie/scidiss
Part of the Analytical Chemistry Commons, and the Food Chemistry Commons

Recommended Citation
Griffin, Caroline, "Investigation of Pyrrolizidine Alkaloids in Foods using Liquid Chromatography Mass
Spectrometry" (2014). PhDs [online].
Available at: https://sword.cit.ie/scidiss/1

This Dissertation is brought to you for free and open access by the Science at SWORD - South West Open Research
Deposit. It has been accepted for inclusion in PhDs by an authorized administrator of SWORD - South West Open
Research Deposit. For more information, please contact sword@cit.ie.

Title

Investigation of Pyrrolizidine Alkaloids in Foods using
Liquid Chromatography Mass Spectrometry
Author

Caroline Griffin, B.Sc.(Hons.)

Department of Chemistry
Cork Institute of Technology
Cork, Ireland

Under the supervision of
Dr. Ambrose Furey (CIT) and
Dr Martin Danaher (Teagasc Food Research Centre)

A thesis submitted to Cork Institute of Technology
for consideration for the degree of Doctor of Philosophy

November 2014

“Learn from yesterday, live for today, hope for tomorrow.
The important thing is not to stop questioning.” Albert Einstein

Declaration
I hereby declare that the work submitted herein, for the degree of Doctor of Philosophy, is
entirely my own work and as a result of my own investigation except where reference is made to
published literature. I certify that this thesis has not been previously submitted for any other
award or degree at this institution or any other.

Signed: ________________________
Caroline Griffin

Date: __________________
13 November 2014

iii

Acknowledgements
I wholeheartedly thank my partner Ken for his neverending support throughout my studies.
Words cannot express how grateful I am. It was through his continuous encouragement, advice
and belief in me that I successfully completed my postgraduate studies. I am indebted to him.

A special thanks to my family and friends who provided support and solace when it was required.

I would like to thank the Chemistry department at CIT and my collaborators at Teagasc Food
Research Centre in Ashtown, Dublin. This research was funded by the Food for Health Research
Initiative (FHRI) administered by the Irish Department of Agriculture, Fisheries and Food
(DAFF) and the Health research Board (HRB) under the project ‘Safe and Healthy Foods’.

iv

Abstract
Pyrrolizidine Alkaloids (PAs) are known plant toxins which can cause hepatic veno-occlusive
disease (HVOD) in both humans and livestock when ingested. Although PAs are primarily
known for their hepatotoxicity they also induce genotoxicity, carcinogenicity and
pneumotoxicity.

PAs are consumed through plants as food, for medicinal purposes, or as

contaminants of agricultural crops. Aside from ingesting the plants directly PA exposure may
occur through the consumption of honey produced by bees that visit PA-containing plants or by
drinking milk produced by animals that have consumed PA-containing plants. Possible PA
contamination in our food chain is a potential health risk.

To assess the presence of PAs in the food chain 369 retail honeys from Ireland, 59 honeys from
Australia, 48 milk samples, 72 cheese samples, 18 herbal teas and 54 Traditional Chinese
Medicines (TCMs) were analysed using liquid chromatography coupled to mass spectrometry.
The sample extraction and clean-up protocol was optimised to be robust, sensitive and applicable
to a range of food matrices providing significant advantages over pre-existing protocols. LC-MS
methods were optimised, developed and validated for both ion trap and triple quadrupole mass
spectrometers whilst utilising software functionalities for data acquisition, integration and
spectral library matching. The analytical methods were targeted but the most comprehensive to
date, including all commercially available PA and PA N-oxide (PANO) reference standards.

The results were utilised in a dietary exposure assessment conducted for the Irish population
based on the consumption of PAs in honey. The mean PA concentration in positive honey from
Irish markets was 81 µg kg-1 (or 20 µg kg-1 for all 369 samples). The data was positively skewed
meaning that the majority of results fell to the left of the mean. The mean results from the
deterministic approach were exposure values of 0.0016, 0.0024 and 0.0022 µg kg-1 bw day-1 for
children, teenagers and adults, respectively.

This is based upon the overall mean PA

concentration (20 µg kg-1) detected and utilising the mean honey consumption data. The results
for the probabilistic mean exposure values were 0.0037, 0.0046 and 0.0046 µg kg-1 bw day-1 for
children, teenagers and adults, respectively.

However, using the 95th percentile exposure

estimates resulted in values which far exceeded the recommended maximum daily intake of
0.007 µg kg-1 bw day-1 at 0.0157, 0.0213 and 0.0196 µg kg-1 bw day-1 for children, teenagers and
adults, respectively.
v
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1.0

Literature Review

1.1

Introduction

1.1.1

Chemistry of PAs

Some of the first scientific research on PAs dates back to the early 1900’s by Watt (FSANZ,
2001). Significant chemical and structural work was carried out by Bull, Culvenor and Dick
(1968) and Mattocks (1986). PAs are alkaline compounds, colourless and chemically stable,
containing two fused five-membered rings, pyrroles, with a common nitrogen heteroatom at
position 4. Not all PAs are toxic but those which contain a 1,2-unsaturated necine base are.
According to Prakash, Pereira, Reilly and Seawright (1999) the requirements for toxicity are; (1)
one unsaturated pyrrole, (2) hydroxyl groups attached to positions C1 and C7 to facilitate
esterification, (3) one or preferably two of these hydroxyl groups esterified, and (4) branching of
the acid moiety. The PA structure is an ester of an amino-alcohol and termed a necine base to
which carboxylic acids or necic acids are attached. There are numerous necic acids but many are
stereoisomers (Mattocks, 1986). PAs are classified as monoesters (e.g. lycopsamine), non-cyclic
(open) diesters (e.g. echimidine) or macrocyclic (closed) diesters (e.g. senecionine) (Bull et al.,
1968).

Figure 1.0 (a) illustrates the 1,2-unsaturated pyrrolizidine nucleus and (b) the necine base and
necic acid of senecionine. The majority of naturally occurring toxic PAs are derived from
retronecine, retronecine N-oxide, heliotridine, and otonecine as per Figure 1.1, whilst the nontoxic PAs are generally derived from platynecine (Mattocks, 1986). Platynecine structures have
a saturated necine base and generally tend to be non-toxic (Lin, Cui and Hawes, 1998), as per
Figure 1.2.
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PAs naturally occur as both the tertiary (free base) PA and the N-oxide (PANO). The PANOs
are also toxic being reduced to the tertiary or free base form in the gastrointestinal tract and as
such have a similar toxicity when ingested orally (IPCS, 1988). To date, it is estimated that 600
PAs and PANOs are known (EFSA, 2011) with many more still to be identified. Tertiary PAs
are soluble in polar solvents, such as methanol, and at low pH the nitrogen heteroatom is
protonated becoming more water-soluble. The PANO, a charged molecule, is also soluble in
methanol or acetonitrile.
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Figure 1.0: (a) 1,2-unsaturated pyrrolizidine nucleus and (b) necine base and necic acid of
senecionine.
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1.1.2

PA-containing Plants

Pyrrolizidine alkaloids (PAs) are secondary plant metabolites found primarily within the plant
families Boraginaceae, Compositae (or Asteraceae) and Leguminosae (or Fabaceae). More than
95% of PA-containing plants belong to these families (Hartmann, 1999) covering an estimated
6,000 plant species or 3% of all flowering plants (Smith and Culvenor, 1981). Thus, PAcontaining plants have widespread distribution making it possible for them to be found in any
number of environments.

Table 1.0 lists the four PA-containing plant families with

corresponding genera, species, common name and PA-content. PAs play an important role in the
chemical defence mechanism of plants. They have adapted to cope with these toxins by
sequestering them for their own protection (Hartmann, 1999) against certain insect herbivores,
such as the cinnabar moth.
Family

Genera

Species

Common Name

PA-content*†

Reference

Boraginaceae

Cynoglossum
Echium

C. officinale
E. plantagineum

Hound's tongue
Paterson’s curse or

1.5-2%

Roeder, 2000

E. vulgare

Salvation Jane
Viper’s bugloss

0.95 mg kg-1
0.2%a

Rizk, 1990
El-Shazly et al., 1996

Heliotropium

H. europaeum
H. indicum

European heliotrope
Indian heliotrope

0.5-2.2%
0.4%

O’Dowd & Edgar, 1989
Roeder, 2000

Symphytum

S. asperum

Rough (prickly) comfrey

0.37%

Roeder, 1995

S. officinale
S. × uplandicum

Comfrey (true comfrey)
Russian comfrey

0.29%
0.2%

Roeder, 1995
Roeder, 1995

Petasites

P. hybridus
P. japonicus

Common butterbur
Giant butterbur

1.5 mg kg-1b
N.R.

Aydin et al., 2013
-

Senecio

S. aureus

Golden ragwort

0.02%

Dharmananda, 2001

S. jacobaea
S. longilobus

Ragwort
Threadleaf groundsel

0.3%
3.46%

Roeder, 1995
Johnson et al., 1985

Tussilago

S. vulgaris
T. farfara

Common groundsel
Coltsfoot

0.16%c
2 mg kg-1

Roeder, 1995
Roeder, 2000

Crotalaria

C. juncea

Sunn hemp

0.15%

Colegate et al., 2012

C. retusa

Rattleweed

6.84%

Anjos et al., 2010

Compositae
(Asteraceae)

Leguminosae
(Fabaceae)
*

Content given as either percentage (%) of dry weight or as mass (mg kg-1) of PA-content detected.
†
Content based on known PAs and PANOs hence possibly undervalued due to presence of unknown PAs.
a
Content given as % weight in fresh plant material
b
Highest content determined in leaves
c
Content determined in aerial system

Table 1.0: PA-containing plant families; example genera, species, common name and PAcontent.
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The biosynthesis of PAs occurs in both the root and shoot of the plant. Certain plants only
synthesise PAs in the roots (S. officinale) whereas others exclusively use the shoots (H. indicum)
(Frölich, Ober and Hartmann, 2007). PA-plants from the Compositae family begin synthesis of
PAs in the roots with final modifications to the chemical structures occurring in the leaves and
inflorescences. It has been demonstrated that inflorescences exhibit the highest PA content and
that the concentration can be 5 to 10-fold that of the levels found in leaves or roots (Hartmann
and Zimmer, 1986). In the same publication the authors state that the tertiary PA concentration
remained consistent over the developmental stages of the plant but the PANO concentration
increased significantly during the flowering stage. The percentage composition for tertiary PAs
and PANOs can vary depending upon the species. Johnson, Molyneux and Merrill (1985)
determined that the percentage composition for tertiary PAs was higher than the PANO
percentage in S. jacobaea but the reverse was true for both S. longilobus and S. riddellii. The PA
content was determined over a three year period and expressed as percentage of dry weight
demonstrating that S. riddellii content was 6.40%, S. longilobus 2.19% and S. jacobaea 0.31%.
In a publication by Roeder (1995), the PA content of certain medicinal plants used in Europe was
reported and the content given as a percentage of dry weight for Cynoglossum officinale (0.70 to
1.50%), Symphytum officinale (0.29%), Tussilago farfara (up to 0.02%), Senecio aureus
(0.02%), S. vulgaris (0.16%) and S. jacobaea (0.30%) with the latter (S. jacobaea) correlating
with the findings of Johnson et al. (1985). Further research is needed on the PA-content of plant
material as it is dependent upon a large number of factors such as species, plant organ, seasonal,
storage and extraction procedures (EFSA, 2011).

Several PA-containing species, including Symphytum, Petasites and Tussilago, are readily
consumed as vegetables, used for medicinal purposes or consumed as traditional remedies such
as ‘bush-teas’ (Wiedenfeld, 2011). Other species, such as Senecio, Heliotropium and Crotalaria
5

have been accidentally consumed by both humans and animals through contamination of grains
and cereals. In the Senecio genera alone one tenth of the species have been associated with PApoisonings (Stewart and Steenkamp, 2001).

The initial stages of biosynthesis focus on the decarboxylation of ornithine and arginine which
results in the formation of putriscine (Hartmann, 1994). Putriscine and spermidine are then acted
upon by homospermidine synthase which catalyses the transfer of the aminobutyl group from
spermidine to putriscine to form homospermidine (Ober and Hartmann, 1999). The reaction is
dependent on NAD+ which acts in the first part of the reaction as a hydride donor and a hydride
acceptor during the second part (Böttcher, Ober and Hartmann, 1994). Homospermidine is
converted to a necine base, trachelanthamidine, via 1-(4-aminobutyl)-3,4-dihydro-2H-pyrrolium
salt (Ober and Kaltenegger, 2009). The complete biosynthesis process for all PA types and the
steps involved have yet to be fully elucidated (Frölich et al., 2007). Esterification of the necine
base occurs to produce retronecine and heliotridine with further esterification forming a diverse
range of pyrrolizidine alkaloids (Frölich et al., 2007). Research on the biosynthesis of the necic
acids is lacking.

One investigation using labelled precursors in Senecio vulgaris and

S.pleistocephalus demonstrated that senecic acid formed two equivalents of 2-aminobutyric acid
(Stirling et al., 1997). Figure 1.3 illustrates the known stages of the biosynthesis of retronecine
and helotridine pyrrolizidine alkaloids.
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1.2

Toxicity of PAs

Toxicity of PA-containing plants to livestock is long recognised with reports of ragwort
(S.jacobaea) consumption causing deaths in cattle in the U.K. as early as 1787 (Molyneux,
Gardner, Colegate and Edgar, 2011). The toxic effect of PAs to humans was first recorded in
1920 by Wilmot and Robertson. Since then PAs have been classified primarily as hepatotoxic
causing veno-occlusive disease (VOD). In the 1960’s it was discovered that these compounds
can cause chronic toxicity in the lung (McLean, 1970). Mattocks (1986) reported that animal
studies confirmed that several hepatotoxic PAs were also potential carcinogens. Roeder (1995)
tested the mutagenic capacity of PAs and summarised 16 common PAs in decreasing mutagenic
order, noting that senkirkine had the highest mutagenic potential. Therefore, PAs are not only
hepatotoxic but also cytotoxic, genotoxic, pneumotoxic and carcinogenic (IPCS, 1988;
Stegelmeier, Edgar, Colegate, Gardner, Schoch, Coulombe and Molyneux, 1999; Fu, Xia, Lin
and Chou, 2004).

LD50 values for hepatotoxic PAs according to W.H.O. range from 34 to 547 mg kg-1 (IPCS,
1988). These values were determined by using a single intraperitoneal dose on rats. The acute
toxicity of PAs can vary widely. Schoental (1968) summarised that depending on the structure
toxicity could vary by a factor of 10 or more. Highly toxic PAs are generally macrocyclic
diesters of retronecine with LD50 values <100 mg per kg of body weight. PAs with monoester
structures are less toxic (Mattocks, 1986). Table 1.1 lists some of the known LD50 values for
hepatotoxic PAs. The extent of toxicity depends not only upon the molecular structure of the
alkaloid but also upon the mechanism of exposure. It has been shown that PANOs are as toxic as
their free bases when given orally but less so when administered intravenously or through
intraperitoneal doses (Mattocks, 1972). This was illustrated using retrorsine (LD50 34 mg kg-1)
and retrorsine N-oxide (LD50 250 mg kg-1). When retrorsine N-oxide was taken orally its LD50
8

value was found to be 48 mg kg-1, increasing its toxicity factor 5 times. In another study it was
shown that riddelliine N-oxide converted to the tertiary structure riddelliine and thus has the
potential to be as toxic (Chou, Wang, Yan, Yang, Beger, Williams, Doerge and Fu, 2003). The
results from a study by Wang, Yan, Fu and Chou (2005) confirm this finding on riddelliine Noxide but also show that this is a general phenomenon in retronecine-based PANOs.

PA

LD50

Observation

Test subject,

(mg kg-1)

Time (days)

gender and dose

109

4

rat, male, i.p.

Mattocks, 1972

230

4

rat, female, i.p.

Mattocks, 1972

Echimidine

200

N.R.

rat, male, i.p.

Culvenor et al., 1969

Heliotrine

296

3

rat, male, i.p.

Bull et al., 1958

478

3

rat, female, i.p.

Bull et al., 1958

274

7

rat, N.R., i.v.

Mattocks, 1986

138

3

rat, female, i.p.

Bull et al., 1958

77

7

mouse, N.R., i.v.

Mattocks, 1986

Lycopsamine

1500

N.R.

rat, male, i.p.

Cheeke and Shull, 1985

Retrorsine

34-38

7

rat, male, i.p.

Mattocks, 1971

153

7

rat, female, i.p.

Mattocks, 1972

59

7

mouse, N.R., i.v.

Mattocks, 1986

250

7

rat, male, i.p.

Mattocks, 1971

834

7

mouse, N.R., i.v.

Mattocks, 1986

50

7

rat, male, i.p.

Mattocks, 1972

85

N.R.

rat, male, i.p.

Culvenor et al., 1969

61

7

hamster, N.R., i.v.

Mattocks, 1986

64

7

mouse, N.R., i.v.

Mattocks, 1986

77

3

rat, male, i.p.

Bull et al., 1968

83

3

rat, female, i.p.

Bull et al., 1968

90

7

mouse, N.R., i.v.

Mattocks, 1986

220

N.R.

rat, male, i.p.

Hirono et al., 1979

Monocrotaline

Jacobine

Retrorsine-N-oxide

Senecionine

Seneciphylline

Senkirkine

Reference

N.R. = not reported

Table 1.1: LD50 values for PAs and PANOs determined after a single (i) intraperitoneal dose, i.p.
or (ii) intravenous dose, i.v.
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On the basis that oral doses of PAs and PANOs could potentially be 5 times more toxic than the
intraperitoneal dose (Mattocks, 1972), the oral LD50 values of retronecine-type PAs
(monocrotaline, retrorsine, senecionine and seneciphylline) from Table 1.1 could range from 5 to
20 mg kg-1.

This value is comparable to the mycotoxin patulin, produced by the fungus

Penicillium expansum causing apples and pears to rot, with an oral (rat) LD50 of 27 mg kg-1 and
an EU maximum residue limit (MRL) of 50 µg kg-1 for juices and 10 µg kg-1 for baby and infant
foods (Shaw, 2013).

1.2.1

Toxicity studies in animals

The route of administration, species, sex, age and diet all affect the toxicity exerted by PAs
(Mattocks, 1986; Stegelmeier et al., 1999).

A similar publication (Mattocks, 1972) found

Japanese quail to be resistant to PA toxicity from Senecio jacobaea through dietary intake (10%
of diet consisted of S. jacobaea) but susceptible to acute toxicity when injected with an
equivalent amount (Buckmaster, Cheeke, Arscott, Dickinson, Pierson and Shull, 1977).
Different animal species have varying susceptibility to PAs. Huan, Miranda, Buhler and Cheeke
(1998) found that there was no strong association between the production of pyrrolic metabolites
and the vulnerability of animals to PA toxicity among a range of species tested; sheep, cattle,
gerbils, rabbits, hamsters, Japanese quail, chickens, and rats. Instead, toxicity was dependent on
the individual species hepatic microsomal enzyme catalytic capability. Mori, Sugie, Yoshimi,
Asada, Furuya and Williams (1985) also found that there was a difference in liver bioactivation
of PAs among rat, mouse and hamster. Rats are highly susceptible and develop acute and
chronic lesions even after a single dose of PAs (Schoental, 1968). Sheep are up to 10 times more
resistant than cattle and horses (Hooper, 1978; Elliott, 2005) due to the capacity of their liver
enzymes or ruminal microbes to detoxify PAs (Cheeke, 1994; Chojkier, 2003) whereas pigs and
10

chickens are the species most at risk. Thus, toxicity information gained from one species may be
of little use when predicting toxicity in another species (Stegelmeier et al., 1999). The difference
in toxicity resulting from alternative routes of administration, species, sex, age and diet is not
exclusive to PAs. Similar findings are evident with mycotoxins. Deoxynivalenol, a Fusarium
species which frequently infects corn, wheat, oat, rice and barley in field or during storage,
differs in toxicity depending upon species, age, gender, route and duration of exposure in animals
(Sobrova, Adam, Vasatkova, Beklova, Zeman and Kizek, 2010). Poultry, especially turkeys, are
extremely sensitive to the toxic and carcinogenic action of aflatoxin B1 (Rawal, Kim and
Coulombe, 2010).

In a study administering the PA monocrotaline to sheep (Anjos, Nobre, Dantas, Medeiros,
Oliveira Neto, Molyneux and Riet-Correa, 2010) it was found that single doses of 205 to 274 mg
per kg of body weight resulted in mortalities for all test subjects (n = 5) from either acute (n = 3)
or chronic (n = 2) toxicity. If the dose was decreased to 137 mg per kg of body weight daily for
70 days the sheep exhibited a resistance to monocrotaline. In a similar study involving seeds of
Crotalaria retusa the authors concluded that sheep can be affected by acute monocrotaline
toxicity when consuming 5 to 40 g per kg of body weight over 5 days (Nobre, Dantas, RietCorrea, Barbosa Filho, Tabosa and Vasconcelos, 2005).

Gender and age influence PA

intoxication with males being more susceptible than females and young more so than adults
(Stegelmeier et al., 1999).

Maternal ingestion can cause foetal toxicity or PAs and their

metabolites can be secreted in the milk of lactating animals (Cheeke, 1988). Diet also affects PA
intoxication with hepatic bioactivation being promoted or inhibited. Pre-treatment over three
days with glycyrrhizin and glycyrrhetinic acid which are active ingredients of liquorice, were
found to be protective against retrorsine-induced liver damage in rats (Lin, Nnane and Chen,
1999).
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The antibacterial agents rifampin and erythromycin were found to be effective against jacobine
biotransformation (Wachenheim, Blythe and Craig, 1992). Diets of rats supplemented with
amino acids or phenobarbital which alters liver microsomal enzyme activity did not alter their
susceptibility to chronic poisoning by Senecio jacobaea (ragwort).

However, in the same study a combination of butylated hydroxyanisole and cysteine did increase
the survival time of rats fed ragwort (Garrett and Cheeke, 1984). It should also be remembered
that toxicity depends greatly upon the PA ingested. For example, rats fed groundsel (Senecio
vulgaris) had a much shorter survival time than those who were fed ragwort (Senecio jacobaea)
(Buckmaster et al., 1976). The results from this study are presented in the two graphs below.

Figure 1.4: Graphical representation of data to illustrate survival rates for rats fed ragwort and
groundsel (from results given in Buckmaster et al., 1976).

Common signs of PA toxicosis in livestock are weight loss, jaundice from elevated levels of
bilirubin in the blood, depression, diarrhoea, abdominal pain, circling and blindness. Horses are
particularly sensitive to neurological effects and may walk blind into objects or fences, walk
aimlessly in circles or straight lines, and/or display head pressing and ataxia (lack of coordination
and balance). Death can occur 2 to 3 days after the onset of clinical signs (Elliott, 2005).
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1.2.2

Metabolism of PAs

PAs require hepatic metabolic activation and thus the liver is the main organ of PA metabolism
(Prakash et al., 1999). Studies of the metabolism of PAs have shown that three main pathways
occur; hydrolysis, N-oxidation, and dehydrogenation and these pathways are dependent upon the
PA structure or type (as per Figure 1.1). All PA structures can undergo hydrolysis which is an
important detoxification pathway. Esterase acts upon the PA molecule causing a cleavage in the
structure into necine and necic acid fragments. These are non-toxic water soluble products and
as no further metabolism occurs they are excreted through the kidneys (Chen et al., 2010). Noxidation, catalysed by microsomal monooxygenases and cytochrome P450, of retronecine and
heliotridine type PAs can produce highly water soluble N-oxides which can be excreted in urine.
Although metabolism to the PANO is seen as a detoxification pathway it has also been shown to
form the corresponding parent PA upon ingestion, thereby producing pyrrolic esters, resulting in
toxicity. Otonecine type PAs cannot undergo N-oxidation due to the methylation of the nitrogen
in their necine base (Jiang, Fu and Lin, 2006). Figure 1.4 illustrates the metabolic pathways of
hydrolysis and N-oxidation.

Dehydrogenation, referred to as the activation pathway (COT, 2008), is catalysed by cytochrome
P450 and results in the formation of toxic pyrrolic derivatives. Retronecine and heliotridine type
PAs undergo hydroxylation at C3 and C8 positions on the necine base. Dehydration follows
yielding a pyrrolic ester; dehydropyrrolizidine (Fu, Yang, Xia, Chou, Cui and Lin, 2002). The
conversion of otonecine type PAs into pyrrolic derivatives occurs following oxidative Ndemethylation and dehydration of the necine base (Jiang et al., 2006). With appropriate leaving
groups from positions C7 and C9 of the dehydropyrrolizidine, the pyrrolic esters become strong
electrophiles and undergo nucleophilic substitution reactions (Stegelmeier et al., 1999).
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The pyrrolic esters bind to liver macromolecules causing hepatotoxicity and cross-links with
DNA forming DNA adducts causing tumorigenicity (Chojkier et al., 2003; Jiang et al., 2006).

Pyrrolic esters can also be hydrolysed into secondary metabolites which are less reactive but still
have mutagenic and carcinogenic effects (Prakash et al., 1999; Chen et al., 2010). Figure 1.5
illustrates the oxidative dehydrogenation or activation pathway.

Dehydropyrrolizidine has four further reaction pathways (Stewart and Steenkamp, 2001) which
are; (i) dehydrogenation to a less toxic pyrrole, (ii) conjugation with glutathione allowing for
excretion in bile, (iii) alkylation of macromolecules such as proteins or nucleic acids and/or (iv)
excretion into the circulatory system damaging vascular endothelial cells.
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1.2.3

Excretion

PA metabolites are generally excreted within 24 hours with an estimated 10 to 15% of the total
dose remaining in urine after 48 hours (Stewart and Steenkamp, 2001). PAs absorbed into the
liver or lung tissue can undergo cleavage into the necine and necic acid. These fragments are
non-toxic and can be further conjugated to allow excretion via the kidneys (Roeder, 1995; Chen,
Mei and Fu, 2010). PAs excreted into urine can be auto-oxidized into the PANO form, an
occurrence which Stewart and Steenkamp (2001) highlighted as being overlooked, which has
given rise to misinterpretation in metabolic pathways.

1.2.4

Diagnosis

Many signs of PA toxicosis do not develop until many weeks or months after the initial exposure.
As a result, Stegelmeier et al. (1999) state that most diagnoses are made using histological
changes alone. Except for PA epidemic situations, which have been seen for both animals and
humans, chronic toxicity from the ingestion of smaller quantities of PAs can be difficult to
identify unequivocally (Molyneux et al. 2011; Wiedenfeld 2011).

1.2.5

Symptoms of Toxicity

Pyrrolic metabolites are the principal cause of liver toxicity which is characterised by
megalocytosis (enlargement) of parenchymal cells (hepatocytes), followed by necrosis and
ultimately cirrhosis (EFSA, 2007). Acute hepatotoxicity in rodents presents with a loss of central
venous and sinusoidal endothelial cells, dilated and congested sinusoids with the final stages of
toxicity resulting in centrilobular parenchymal cell necrosis (Hanumegowda, Copple, Shibuya,
Malle, Ganey and Roth, 2003). Chronic intoxications result in megalocytosis of hepatocytes,
17

liver cirrhosis, bile-duct proliferation, fibrosis, vascular damage, loss of metabolic function and
tumour formation (Mattocks, 1986; IPCS, 1988; EFSA, 2007).

Along with hepatotoxicity, pneumotoxicity and neurotoxicity can ensue.

It has been

demonstrated that 30 to 60 mg kg-1 of monocrotaline provoked right ventricular hypertrophy in
rats (Orlinska, Olson, Gebb and Gillespie, 1989) whilst certain PAs can bind to neuroreceptors
causing interference with signal transduction (Schmeller, El-Shazly and Wink, 1997). The PAs
monocrotaline and fulvine (Crotalaria spp.) are most commonly used experimentally to
demonstrate pulmonary hypertension. By-products of hepatic metabolism are transported in the
blood to the lung (Chojkier, 2003). Renal alteration and teratogenicity have been noted in
experimental cases of high PA exposure or in fatal acute intoxications (Hooper, 1974; Mattocks,
1986). PAs are mutagenic in vivo and in vitro and their mutagenicity appears to be responsible
for carcinogenesis of PAs (Chen, Mei and Fu, 2010) and has been studied in different biological
systems, including Drosophila melanogaster, Salmonella typhimurium, and Escherichia coli (Fu,
Xia, Lin and Chou, 2004). There are no reports of cancer concerning domestic animals exposed
to PAs but laboratory studies have been able to produce PA-induced cancer in rodents (Prakash
et al., 1999).

Individual PAs such as monocrotaline, heliotrine, lasiocarpine, clivorine and riddelline and PAcontaining plants Senecio longilobus and Tussilago farfara L. and their major PA constituents
have shown to be carcinogenic (Prakash et al., 1999; Harris and Chen, 1970; Hirono, Mori and
Culvenor, 1976). Pyrrolic metabolites bind to form DNA-adducts, DNA cross-links and DNAprotein cross-links giving rise to mutagenicity and carcinogenicity (Prakash et al., 1999).
Macrocyclic PAs including senecionine, retrorsine and riddelliine are potent DNA cross-links
leading to cell death, mutations and/or carcinomas (Stewart and Steenkamp, 2001).
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It has also been shown that damage to DNA from PA pyrrolic metabolites was transmissible to
the next generation of cells in vitro (Martin, Thorburn, Hutchinson, Bras and Miller, 1972).

Dehydropyrrolizidine alkaloids are the primary metabolites of PAs but due to their instability,
biological and chemical reactivity it has been impossible to isolate these compounds from
biological systems (Zhao et al., 2012). In 2001, a genotoxic mechanism was proposed via (±)6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine (DHP)-derived DNA adduct formation
(Yang et al., 2001). Structures resulting in adducts were not elucidated until 2012 when Zhao et
al. (2012) proposed four DNA adduct structures as (i) a pair of epimers of 7-hydroxy-9(deoxyguanosin-N2-yl)dehydrosupinidine termed as DHP-dG-3 and DHP-dG-4 and (ii) a pair of
epimers of 7-hydroxy-9-(deoxyadenosin-N6-yl)dehydrosupinidine termed as DHP-dA-3 and
DHP-dA-4 adducts. It has also been shown that the most reactive site for dehydropyrrizidine
alkaloid metabolites binding with cellular DNA is the C7 position of the necine base (Yang et al.,
2001).

19

1.3

Regulation of PAs

Currently there are no EU regulatory limits for PAs and their N-oxides. The European Food
Safety Authority (EFSA, 2011) has recently conducted a safety assessment of PAs in food and
feed. It is recommended not to exceed an intake of 0.007 μg kg-1 body weight (bw) day-1 of 1,2unsaturated PAs as doses at this level are unlikely to pose a risk of cancer. Prior to this
assessment some countries proposed recommendations and tolerable levels of exposure.

In 1992 the German Federal Health Bureau, Bundesanzeiger, restricted PAs on the basis of their
potential to be genotoxic and carcinogenic. The use of herbal medicine containing unsaturated
PAs and PANOs was controlled. Regulations limited exposure to a maximum of 1 μg day-1 for a
total of 6 weeks per year or 0.1 μg day-1 if the exposure was to exceed a 6 week period/duration
and a zero tolerance for pregnant or lactating women (Bundesanzeiger, 1992). In Belgium
medicinal products for internal use containing PAs are prohibited (EMA, 2012) and in Austria it
has to be proven that the medicinal product which contains PA-containing plants has no PAs or
PANOs in the final product (Bundesgesetzblatt, 1994). On the probability of PAs causing
HVOD the Foods Standards Australia New Zealand (formerly Australia New Zealand Food
Authority) set an exposure level of 1 μg of PAs kg-1 bw day-1 (FSANZ, 2001).

In the

Netherlands a recommendation of 0.1 μg of PAs per 100g of food was introduced in 2001
(Edgar, Colegate, Boppré and Molyneux, 2011). In 2005 the Dutch National Institute for Public
Health and the Environment (Rijksinstituut voor Volksgezondheid en Milieu, RIVM) proposed a
virtual safe dose (VSD) for PAs at a level of 0.43 ng kg-1 bw day-1 (equivalent to 0.00043 µg kg-1
bw day-1) which signifies a greater risk of developing cancer in at most one person in a million.

The American Herb Products Association (AHPA, 1996) issued a recommendation that all
products with botanical ingredients containing toxic pyrrolizidine alkaloids carry a cautionary
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statement on the label “For external use only. Do not apply to broken or abraded skin. Do not
use when nursing”. The Consumer Healthcare Products Association established a voluntary
program for manufacturers with the same recommendation in 2001 (Dharmananda, 2001).

A report from EFSA in 2007 concluded that carry-over of PAs from animal feed into the food
chain is negligible. However, they recommended further investigations into honey, milk and
feed, and quantitative analysis of the same due to the possibility of high risk to infants (EFSA,
2007). The U.K. Committee on Toxicology (COT, 2008) issued a statement suggesting that
levels of 0.007 μg kg-1 bw day-1 were improbable to be a cancer risk. They determined this from
long-term experimental feeding studies on rats. It should be noted this is 16 times greater than
the VSD advised by RIVM.

Most recently the EFSA Panel on Contaminants in the Food Chain (CONTAM Panel) concluded
that there is a health concern for children and adults who are high consumers of PA-containing
honey. Assessment of the risk was based on three representative age groups and the effects of
both acute and chronic exposure levels. The report highlighted the need for on-going analytical
research into the PA content of food and feed (EFSA, 2007). To date EFSA (2011), COT (2008),
and the German Federal Institute of Risk Assessment (Bundesinstitut für Risikobewertung - BfR,
2011) all recommend not to exceed an intake of 0.007 μg kg-1 bw day-1 of 1,2-unsaturated PAs.
This level is based upon a BMDL10 (benchmark dose lower confidence limit 10%; an estimate of
the lowest dose which is 95% certain to cause no more than a 10% cancer incidence in rodents.)
of 0.073 mg kg-1 bw day-1 derived from the study on lasiocarpine in male rats. A margin of
exposure (MOE) of 10,000 and above would thus correspond to doses of up to 0.007 μg kg-1 bw
day-1 of 1,2-unsaturated PAs and would be unlikely to be of concern. A summary of the current
PA regulations are given in Table 1.5.
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Proposed Regulation

Regulatory Authority/Reference

0.007 µg kg-1 bw day-1 a

European Food Safety Authority (EFSA), 2011
Bundesinstitut für Risikobewertung (BfR), 2011
Committee on Toxicity (COT), 2008

0.1 µg kg-1 bw day-1 b

Rijksinstituut voor Volksgezondheid en Milieu (RIVM), 2007

1.0 µg kg-1 bw day-1 c

Food Standards Australia New Zealand (FSANZ), 2001

1.0 µg day-1 d, f

Bundesanzeiger, 1992

0.1 µg day-1 e, f
a

Cancer unlikely
Non-cancer effects unlikely
c
HVOD unlikely
d
Intake for maximum of 6 weeks per year
e
Intake if exceeding 6 weeks per year
f
Zero exposure for pregnant and lactating women
b

Table 1.2: Current regulations on PAs and PANOs exposure limits (modified from Edgar et al.,
2011).
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1.4

Human PA Intoxications

There are many documented cases of human poisoning due to consumption of pyrrolizidine
alkaloids (PAs), the earliest dating back to 1920. Wilmot and Robertson (1920) are acclaimed as
being the first researchers to report that an outbreak of hepatic veno-occlusive disease (HVOD)
in South Africa was due to the contamination of flour grain with seeds from PA-containing
plants, those from the Senecio genera. The term “bread poisoning” originates from around this
time when bread was prepared from imperfectly winnowed wheat (Selzer, 1951) contaminated
primarily with Senecio seeds, hence the alternative term “Senecio disease”.

Budd-Chiari

syndrome, most prevalent in Southern Africa and Asia, has been linked to bread poisoning from
Senecio (Selzer, 1951). Budd-Chiari syndrome occurs due to occlusion of the hepatic vein,
leading to accumulation of fluid in the abdomen (ascites) and scarring of the liver (cirrhosis).
Both Stein (1957) and Schoental (1968) recognised that the elevated levels of HVOD in South
Africa at that time were most likely due to "Senecio disease". Although Budd-Chiari syndrome
has been compared with HVOD it is wise to note that however similar these conditions are they
are distinct from each other (Janssen, 2004).

HVOD results from microscopic blockages of veins in the liver leading to an accumulation of
blood. This congestion reduces the amount of blood entering the liver and so cells become
damaged as they do not receive sufficient blood (ischemia). The congestion causes the liver to
become enlarged and increases the pressure of the portal vein (portal hypertension).

The

elevated pressure in the portal vein and the liver congestion leads to fluid accumulating in the
abdomen which is referred to as ascites. The spleen may also enlarge. The skin and whites of
the eyes can turn yellow. Bilirubin levels in the blood are elevated. The damage within the liver
eventually leads to severe scarring which is referred to as cirrhosis (Culvenor, 1983).

23

1.4.1

Grain

Human PA poisoning due to contamination of grain has occurred most often in areas that
experienced drought conditions, poverty or famine, especially Africa, Central and Southern Asia.
Mass intoxication was observed in these areas due to man’s susceptibility during times of
deprivation. PA-containing weeds of the genera Senecio, Heliotropium and Crotalaria can thrive
during arid periods.

In the 1970's both Afghanistan and India experienced such mass

intoxications resulting in an estimated 1,667 cases of HVOD, of which there where many
casualties (Huxtable, 1980).

As with large-scale disasters this figure varies widely and

symptoms of PA poisoning can take time to present leading to a late diagnosis in patients. In
later reports it is stated that the food supply was affected for 35,000 people in Afghanistan alone,
of which up to 2,000 developed HVOD (Rizk, 1990). Seeds from Heliotropium popovii were the
cause of the Afghanistan epidemic (Stickel, Patsenker and Schuppan, 2005).

Mohabbat,

Srivastava, Younos, Sediq, Menzad and Aram (1976) suggested that 0.03% of the flour grain was
contaminated and that the alkaloid consumption was 2 mg per person per day with a total
ingestion of approximately 1.46 g per person. In India the contamination of millet grain known
as 'Gondli' with Crotalaria seed was much higher equating to 40 mg per person per day
(Culvenor, 1983). It has also been reported that the mean daily intake of PAs would have been
lower if the level of exposure was estimated (Huxtable, 1989).

Outbreaks of PA poisoning have occurred sporadically in Uzbekistan (formerly part of the Soviet
Union) from 1935 through to the 1950’s.

One of the first reported incidents involved

contamination from Heliotropium lasiocarpum seeds with approximately 8.8% of cases resulting
in fatality within a 2 year period but the rate of alkaloid consumption is unknown (Zheltova,
1952; Culvenor, 1983). The second outbreak involved poisoning from Trichodesma seeds in
food grain which was termed “Trichodesma toxicosis” by the researchers (Shtenberg and Orlova,
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1955) with the alkaloid content of the T. incanum seed determined as 1.5 to 3.1% dry weight. At
the time, this PA poisoning was termed “camel belly” due to the large number of patients
presenting with ascites. In 1993 over 3,900 cases of liver toxicity were recorded in Tajikistan
due to wheat contaminated with Heliotropium lasocarpium (Chauvin, 1994). In all of the above
recorded cases the intake of PAs and PANOs far exceed those recommended tolerable intakes
provided in Table 1.2. In fact the lowest reported intake of 2 mg of PAs per person would
exceed the limit of 1 µg kg-1 bw day-1, the least strict limit imposed by FSANZ (2001), by 28
times.

One would assume that the frequency of PA poisoning due to food grain contamination would
have decreased in later years, mainly due to increased awareness and better agricultural
management. Unfortunately, poisonings have continued to occur. In Northern Iraq in 1994
wheat contaminated with seeds from Senecio species affected three families incurring a mortality
rate of 14% (Altaee and Mahmood, 1998). Initial reports on the outbreak of PA intoxication in
the Gulran region of Afghanistan suggest that in excess of 200 people developed HVOD caused
by wheat contaminated with PAs originating from 'Charmac', a native weed in the Herat Province
(IRIN, 2010). The weed was identified as Heliotropium popovii and the major PA constituent
was heliotrine (Kakar, Akbarian, Leslie, Mustafa, Watson, van Egmond, Omar and Mofleh,
2010). The authors examined the Gulran area and conducted an outbreak investigation using a
case-control design. The diet of the population consisted mainly of wheat, bread and meat. It
was noted by the investigators that during 2007-2008 rain fall levels were normal and there were
no reports of drought or water shortages. The investigation included examining clinical history,
analysing serum and suspected PA-contaminated foods.
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© Dr. H van Egmond

© Dr. H van Egmond

© Dr. H van Egmond

Figure 1.7: (from left to right) The weed Charmac, which contaminated wheat grain in the
Gulran district, and the resulting abdominal swelling (ascites) post-consumption (photographs
from Dr. H. van Egmond).
Samples of flour had a median PA concentration of 4 mg kg-1 (4,000 µg kg-1) with heliotrine,
heliotrine N-oxide and lasiocarpine detected. Samples of ‘qurut’ (a cheese produced from goats
milk) had a median PA concentration of 0.09 mg kg-1 (90 µg kg-1) and also contained heliotrine
and its N-oxide. Large amounts of trichodesmine were also found, a PA which is not detected in
Charmac. Therefore, it is suspected that the goats had grazed upon the weed/Charmac along with
another PA-plant containing trichodesmine. The quantities of PAs detected exceeded by far the
recommended maximum limit of 0.007 µg kg-1 bw day-1.

The World Health Organisation (W.H.O.) established the Disease Early Warning System
(DEWS) in Afghanistan in 2006. The DEWS team responded to the Gulran district due to
suspected PA-poisoning resulting in 38 cases of massive ascites and 4 deaths (Kakar et al., 2010).
Ultimately, to negate further re-occurrence in these areas improved food safety and Good
Agricultural Practices (GAP) must be employed. Table 1.3 summarises cases of PA poisoning
caused from contaminated grains. Wiedenfeld (2011) also summarises PA intoxications linked
to the consumption of contaminated grains and herbal teas which is comprised of 28 individual
cases where the source of PA poisoning was explicitly identified.

26

PA Plant

PA(s) identified

Quantity
Ingested

Country of
incidence

Reference

Senecio illiciformis

senecionine

N.R.

South Africa

Wilmot and Robertson (1920)

Senecio spp.

senecionine

N.R.

South Africa

Selzer and Parker (1951)

Senecio spp.

N.R.

N.R.

Iraq

Al-Hasany and Mohamed (1970)

heliotrine

2 mg person-1

Afghanistan

Tandon et al. (1978) ;

Senecio burchelli

(suspected cause)
Heliotropium

-1

popovii
Crotalaria spp.
Crotalaria nana

day
crotananine
cronaburmine

Mohabbat et al. (1976)
-1

40 mg person

India

-1

day

Tandon et al. (1976)
Krishnamachari et al. (1977)

monocrotaline

Siddiqui et al. (1978)

fulvine

Huxtable (1989)

Heliotropium

heliotrine

lasiocarpum

lasiocarpine

N.R.

Uzbekistan

Dubrovinskii (1952)

Tajikistan

Zheltova (1952)
Chauvin et al. (1994)

Trichodesma

trichodesmine

0.5–3.3

incanum

incanine

mg kg-1 bw

Senecio vulgaris

senecionine

N.R.

Heliotropium

Heliotrine

(Charmac)

heliotrine N-oxide

-1

4 mg kg

Uzbekistan

Shtenberg and Orlova (1955)

Northern Iraq

Altaee and Mahmood (1998)

Afghanistan

Kakar et al. (2010)

N.R. = not reported

Table 1.3: Summary of reported cases of human PA poisoning due to contaminated grains.
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1.4.2

Teas and herbal products

Human intoxications from PAs can also arise from the use of medicinal or herbal products. A
substantial amount of countries do not enforce restrictions on herbal preparations, therefore this
tends to lead to self-medication. Herbal products are seen by consumers as safe, natural and
effective despite the lack of quality control and regulations (Stickel, Patsenker and Schuppan,
2005). In the U.S. herbal products can be sold without prior demonstration of their safety and
efficacy as they are defined as dietary supplements (Bent 2008).

The author Bent (2008)

explains that the Food and Drug Administration (FDA) bears the burden of proving that a dietary
supplement is unsafe before it can be removed from the market, a direct contrast to
pharmaceutical products. Also in the U.S., herbal preparations follow the guidelines of the
Dietary Supplement and Health Education Act (DSHEA) 1994. This states that producers of
herbal products should determine the safety and purity of their goods prior to marketing but there
is no requirement to register their products prior to distribution. The European Commission
introduced the directive 2004/24/EC in 2004 to align the process of licensing a herbal or
medicinal product (European Commission 2004). It applies to products with a ‘tradition’ of use
and that have proven efficacy and safety through scientific publications or ‘well established’
records of use. In herbal usage polls carried out in both Europe and America, Stickel et al.
(2005) summarised that 21% of patients receiving medical care for liver complaints had taken
herbal products and 13% had used herbal preparations throughout their treatment.

In the West Indies, predominantly Jamaica, poisoning resulted from regular consumption of
“bush tea” with many cases resulting in veno-occlusive disease for children (Stuart and Bras,
1955). The “bush-tea” was used as a common cold remedy (Fu, Chou, Xia, Yang, Yan, Doerge
and Chan, 2001).
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Research has shown this was due to monocrotaline and fulvine from Crotalaria plants but no
data exists on the quantity consumed by the patients nor the number of HVOD cases as a direct
consequence of PA intake. Similar cases have been recorded in Africa and one known case in
Ecuador due to both Crotalaria and Senecio plants. Stillman, Huxtable, Consroe, Kohnen and
Smith (1977) reported on two cases of HVOD in Mexican-American infants, a 6-month-old
female and a 2-month-old male. Both had consumed tea prepared from Senecio longilobus
containing riddelline and retrorsine N-oxide. Unfortunately, both infants died after intakes of 70
to 147 mg over 14 days for the female and 66 mg over a period less than 14 days for the male
(Huxtable, 1980). There is evidence to show that PA induced tumours occur in rats (Mattocks,
1986; IPCS, 1988) but no clear evidence that PA induced tumours occur in humans. However,
frequent liver tumours present in natives of Central and South Africa who consume bush teas
with PA plants (Chen et al., 2010). Three cases of HVOD were reported in India and one in
Hong Kong from the use of Heliotropium containing tea. Of these four cases two were fatal from
daily intakes equivalent to 30 mg of PAs day-1 over a period of 20-50 days (Molyneux and
James, 1990; Culvenor, 1983).

Despite events of HVOD prior to 1980 it was not until then that the medicinal product commonly
known as “Comfrey” from Symphytum officinale was investigated for hepatoxicity. Symphytum
officinale is more common in Europe whereas S. x uplandicum (Russian Comfrey) is more
widely used in Australia and America (Culvenor, 1983). During the 1980’s four individual cases
were recorded; two in America, one in the U.K. and one in New Zealand, the latter resulting in
death. The consumption of comfrey varied from root powder, dietary capsules, tea, and ingestion
of plant leaves in salad. Betz, Eppley, Taylor and Andrzejewski (1994) investigated the content
of hepatotoxic PAs in commercial comfrey products and found that 80% of those tested
contained 0.1 to 400 mg L-1 PAs, with root products having a higher content than those made
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from the leaf. Analysis of commercial comfrey tea products by Oberlies, Kim, Brine, Collins,
Handy, Sparacino, Wani and Wall (2004) confirmed Betz et al. (1994) previous conclusion in
that there was a greater content of PAs in root products. However, Oberlies et al. (2004)
suggested that the PA content in leaf teas may be significantly undervalued due to the lack of
consideration for PANOs. Subsequent to these publications and other scientific literature, the
American Herb Products Association (AHPA) notified members to the potential toxic effects of
comfrey, limiting the use of comfrey to external applications only. In 2001 the American FDA
investigated at least seven cases of HVOD associated with comfrey and on completion of their
review advised all dietary supplement manufacturers to remove comfrey products from the
market, specifically Symphytum officinale (common comfrey), S. asperum (prickley comfrey)
and S. x uplandicum (Russian comfrey). In Europe, the Federal Health Department of Germany
imposed restrictions on PA-containing plants, including comfrey, to a maximum internal intake
of no more than 1 μg day-1 for a maximum of 6 weeks per year (Bundesanzeiger, 1992).

Senecio tephrosioides known as 'huamanripa' is a Chilean herb used to treat bronchitis and other
respiratory complaints.

It was reported to have caused HVOD in a Peruvian woman after

ingestion of herbal tea containing 'huamanripa' (Tomioka, Calvo, Siguas, Sánchez, Nava, García,
Valdivia and Reátegui, 1995).

Failure to discontinue use of traditional herbal medicines

containing PAs brought about another 2 cases of HVOD from Tussilago farfara (coltsfoot). In
1995 an Austrian child developed HVOD after consumption of coltsfoot tea with an estimated 60
μg kg-1 bw day-1 being consumed over a 15-month period (Roulet, Laurini, Rivier and Calame,
1988). Another incidence of PA poisoning due to coltsfoot was reported by Bach, Thung and
Schaffner (1989) where a 47 year old woman consuming 10 cups of comfrey tea per day had
developed HVOD. Analysis of commercial samples of comfrey tea reported the presence of the
PA senkirkine at a concentration of 19.5 to 46.6 mg L-1 (Jiang, Liu, Goh, Yu, Li, Ong and Ong,
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2009) and 2.5 to 11.2 mg L-1 (Lebada, Schreier, Scherz, Resch, Krenn and Kopp, 2000).
Applying the lower concentration detected of 2.5 mg L-1 and a consumption of 10 cups per day
(approx. 200 mL per cup) meant this woman was regularly consuming 5 mg of senkirkine.

A Brazilian medicinal tea containing Ageratum conyzoides was found to contain lycopsamine
and lycopsamine N-oxide (Bosi, Rosa, Grougnet, Lemonakis, Halabalaki, Skaltsounis and
Biavatti, 2013). It was noted by the authors that this tea is freely available and popular, enjoying
frequent consumption. Likewise a Mexican “miracle tea” was investigated by Fragoso-Serrano,
Figueroa-González, Castro-Carranza, Hernández-Solis, Linares, Bye and Pereda-Miranda (2012)
who tested 22 commercial samples which were found to contain senecionine (232 mg kg-1) and
retrorsine (331 mg kg-1). Recently the German Federal Institute for Risk Assessment (BfR)
conducted a study of 221 retail herbal teas determining a PA concentration ranging from 0 to
3.43 mg kg-1. The higher PA content was found in teas classified as “Camomile”, “Nettle” and
“Melissa”. The BfR stated that although a risk assessment was not practical due to the sample
size they urged for regular testing of herbal produce for PAs and PANOs. Their findings would
suggest that frequent consumers of said herbal teas are at increased risk of impaired health due to
PA toxins. Table 1.4 summarises reports of PA poisoning due to herbal preparations and Table
1.5 illustrates some common PA-containing plants and lists their uses.

There has been a surge in the use of herbal medicines (Pak, Esrason and Wu, 2004) including
traditional Chinese medicines (TCMs) in the Western world (Stickel et al., 2005). Senecio
scandens has been used in TCM for the treatment of various ailments including gastroenteritis,
conjunctivitis, and respiratory tract infections (Wang, Huang and Chen, 2013). S. scandens
contains hepatotoxic PAs.

In two separate reports, the PA content of the dried herb was

determined to be 109 μg g−1 (Zhang, Wang, Wang, Chen, Ma, Zhang, Zhang, Bligh and Wang,
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2008) and 10.82 μg g−1 (Li, Lin, Fu, Chan, Li, Jiang and Zhao, 2008). Li et al. (2008) reported
that the TCM “Qian Bai Bi Yan Pian” in tablet form is comprised of the herb S. scandens (76%)
and based on the average daily dosage given by the Chinese Pharmacopoeia would contain an
intake range of 3.9 to 5.2 μg kg-1 bw day–1 of toxic PAs. There are only 5 PA species that are
documented to be officially used as the plant sources for TCM herbs in the Chinese
Pharmacopoeia; Lithospermum erythrorhizon (Zi Cao), Arnebia euchroma (Ruan Zi Cao),
Eupatorium fortunei (Pai Lan), Senecio scandens (Qian Li Guang), and Tussilago farfara (Kuan
Dong Hua). However, Fu et al. (2002) reported that approximately 44 PA containing plants are
used in TCMs in different areas in China and are documented in the Traditional Chinese
Dictionary.
PA Plant

PAs identified

Quantity
Ingested

Country

Reference

Crotalaria retusa;

monocrotaline;

N.R.

West Indies

Bras et al. (1954)

Crotalaria fulva

fulvine

Crotalaria juncea

trichodesmine;

Stuart and Bras (1957)
N.R.

Ecuador

Lyford et al. (1976)

riddelline;

4.7-10.5 mg day-1

U.S.A.

Stillman et al. (1977)

retrorsine N-oxide

within 14 days

senecionine;
riddelliine
Senecio longilobus

Fox et al. (1978)
Huxtable (1980)

Heliotropium

heliotrine N-oxide

eichwaldi
Heliotropium

-1

30 mg day

over

India

Datta et al. (1978)

Hong Kong

Kumana et al. (1985)

20-50 day period
heliotrine;

30 mg person-1
-1

lasiocarpum

lasiocarpine

day

Symphytum officinale

symphytine;

N.R.

S. x uplandicum

symglandine;

Culvenor et al. (1986)
U.S.A.

Culvenor et al. (1981)

Australia

Ridker et al. (1985)

Europe

Huxtable et al. (1986)
Rasenack et al. (2003)

Senecio tephrosioides
Tussilago farfara

N.R.

N.R.
-1

senecionine

0.06 mg

senkirkine

day-1

kg bw

Peru

Tomioka et al. (1995)

Central Europe

Roulet et al. (1988)
Lebada et al. (2000)

Table 1.4: Summary of reported cases of human PA poisonings due to ingestion of medicinal
herbs or herbal products.
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Borage

Used in salads (flowers) and spice

(Borago officinalis)

(leaves). In herbal medicine as a
prophylactic, for the treatment of
rheumarthritis, cough and throat
infections.

Butterbur

Used for hayfever, gastrointestinal

(Petasites hybridus)

tract, gallbladder and pancreatic
diseases, for the treatment of
headaches and to promote sleep.

© RWD

Comfrey

Used in salads. As a poultice on

(Symphytum officinale)

fractures and contusions, and for
the treatment of gastrointestinal
and respiratory tract infections.

© Graham Calow (2006)

Russian Comfrey
© Graham Calow (2008)

Eaten in salads and blended with

(Symphytum × uplandicum) slurry to be used as an organic
fertiliser.

Coltsfoot

Treatment

of

coughs,

(Tussilago farfara)

influenza,

gastroenteritis

colds,
and

metabolic stimulation.

© Mary Holland

Table 1.5: Common PA-containing plants and their medicinal use (photographs display
individual copyrights).
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“Gynura segetum” a traditional herbal product used for haemostasis in Chinese herbal medicine
was tested for PAs and found to contain seneciphylline, senecionine, seneciphylline and
seneciphylline N-oxide (Qi, Wu, Cheng and Qu, 2009). While identification was performed by
the authors no quantification was reported. “Daun dewa” (Gynura pseudo-china (L.) DC.) is a
PA containing plant used regularly in Indonesia, India, Thailand and China for treating uterine
hemorrhages, dysentery, and inflammation of open wounds (Windono, Jenie and Kardono,
2012). Another popular TCM “Chuan Zi Wan” from the Ligularia species was shown to contain
up to 26 hepatotoxic PAs identified by their characteristic mass fragments reported in literature.
The authors estimated that the TCM preparation contained PAs amounting to 7.92 mg g−1 (Tang,
Chen and Hattori, 2012). Herbal retail preparations of “Tusanqi” provided by patients with
hepatic sinusoidal obstruction syndrome (HSOS) were positive for the PAs senecionine and
seneciphylline although the authors do not report the quantities detected (Gao, Wang, Zheng and
Lin, 2012). Roeder (2000) investigated 38 plants used regularly in Chinese herbal medicine
which contained approximately 90 PAs.

The listing was in agreement with other Chinese

publications (Zhao, Chan and Ogle, 1989; Chen and Huo, 2010). Table 1.6 summarises the most
commonly used PA-containing plants which are used in TCM.

A detailed discussion on PAs in herbal teas and TCMs is given in Chapter 5 and its related
publication.

34

PA plant species

Principal PA(s)

Quantity

Chinese Herb

Medicinal use

Zi Xiao Rong

Treatment of cough,

Detected
Crotalaria assamica

monocrotaline

2.9% in seeds

Benth

toothache and swelling

Crotalaria sessiliflora

monocrotaline

L.

integerrimine

promote urination and as

trichodesmine

an anticancer agent

Cynoglossum

heliosupine

officinale

lasiocarpine

N.R.

Ye Bai He

1.5-2.0% of plant

Used to dispel heat,

Radix cynoglossi

Dispel heat, expectorant,

officinalis

relieve cough

Jusanqi or

Treatment of bleeding,

Radix Gynurae

relieve pain, cure injury

Da Wei Yao

Treatment of ulcers,

heliotrine
trachelanthamine
Gynura segetum

seneciphylline

(Lour.) Merr.

senecionine

N.R.

integerrimine
Heliotropium indicum

heliotrine

0.4 % of plant

L.

supinine

wounds, ringworm,

lasiocarpine

rheumatism, common
colds, tonsillitis, and
urinary tract stones

Senecio scandens

seneciphylline

Buch.-Ham.

senecionine

Tussilago farfara L.

senkirkine

up to 109 mg kg-1

Qianliguang

Treatment of acute
inflammatory disease

-1

up to 150 mg kg

senecionine

Kuan Dong Hua

Cold, asthma, influenza,
gastroenteritis, blood
purification and externally
for wounds

Table 1.6: Summary of the most commonly used PA-containing plants in TCM.
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1.4.3

PA-poisoning through foodstuffs

Other foods that are prone to PA-contamination are honey, bee pollen, milk, eggs and meat from
PA-exposed livestock, and therefore are possible sources of PA-poisoning to humans. Although
there are no known reports of these foodstuffs alone causing PA toxicosis in humans there is
evidence that they could contribute to HVOD. For example “qurut”, a fermented goats’ milk
consumed in the Gulran district of Afghanistan, was found to contain PAs where the population
had induced PA toxicosis from contaminated grain (Kakar et al., 2010). Rasenack, Müller,
Kleinschmidt, Rasenack and Wiedenfeld (2003) reported that post-mortem results of a preterm
neonate confirmed PA poisoning with Symphytum alkaloids, the same which were detected in a
herbal mixture used in cooking by the family.

Deinzer, Thomson, Burgett and Isaacson (1977) reported on the occurrence of PAs in honey (up
to 3.9 mg kg-1 PA concentration) collected from Senecio jacobaea L. (tansy ragwort), a weed
indigenous to Northern America, Europe, South Africa, Australia and New Zealand.
Examination of honey from Echium plantagineum (Salvation Jane or Paterson’s Curse) for PAs
showed that the alkaloid concentration was 1.9 mg kg-1 (Culvenor, 1981). The author reported
that up to a quarter of the honey produced in Australia is derived from Echium spp. and high
consumers of “unifloral” honey could possibly intake up to 20 μg of PAs day-1. Other reports
have estimated that the daily intake rate is lower but still in excess of recommended tolerable
intakes as summarised in Table 1.2. More recent findings of PAs in retail honeys strengthen the
possibility that PA-poisoning could result from ingestion of honey. Retail samples, taken at the
point of consumption, and bulk samples which are blended before being packaged for sale have
been shown to contain PAs and PANOs up to 2.2 mg kg-1 (bulk) and 2.9 mg kg-1 (retail) (Beales,
Betteridge, Colegate and Edgar, 2004; Betteridge, Cao and Colegate, 2005). PA contamination
of retail honeys is discussed in depth within the publications of Chapter 4. The use of honey as
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an ingredient (content range 5 to 37%) in other foods and the potential PA contamination
downstream has also been investigated (Kempf, Wittig, Reinhard, von der Ohe, Blacquière,
Raezke, Michel, Schreier and Beuerle, 2011b). From the samples taken PAs were persistent in
fennel honey (10 to 130 µg kg-1), mead (10 to 484 µg kg-1) and candy (10 to 40 µg kg-1). Thus,
honey coated breakfast cereals, cereal bars and baked goods which have not been analysed to
date could potentially contain PAs.

Bee pollen products, royal jelly, honeycomb and propolis are marketed as “superfoods” having
nutritional and therapeutic properties and thus have become a popular food supplement The
main constituents of pollen are amino acids, vitamins, minerals, flavonoids and phytoestrogens
(Silva, Camara, Lins, Barbosafilho, Silva, Freitas and Santos, 2006). It was noted that the
concentration of PAs in pollen were significantly higher than that of in honey (Boppré, Colegate
and Edgar, 2005). Research on 55 commercial bee pollen products detected PAs in 31% of
samples ranging from 1.08 to 16.35 mg g-1 (Kempf, Heil, Haßlauer, Schmidt, von der Ohe,
Reinhard, Schreier and Beuerle, 2010b). The authors state that given a mean concentration of
5.17 mg g-1, a 30% probability of occurrence and a daily dose of 10 g (recommended serving)
would result in an intake of 15 mg day-1.

The concentration was based on retronecine

equivalents and as such did not account for any possible otonecine-type PAs which could be
present. Thus, the intake is significantly above recommended guidelines as stated in Table 1.2.

PA-poisoning in livestock is well-documented and while no record exists of human PApoisoning due to consumption of milk (alone) or meat, it is unrealistic to not consider such an
occurrence. The first studies on the PA content in milk were through the feeding of Senecio
jacobaea (tansy ragwort) to cows and goats resulting in levels of 16.7 and 81.0 μg 100 mL-1 of
milk respectively (Dickinson, Cooke, King and Mohamed, 1976; Deinzer, Arbogast and Buhler,
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1982).

Through a more defined procedure Candrian, Zweifel, Lüthy and Schlatter (1991)

determined a maximum alkaloid concentration of 10.2 μg 100 mL-1 of milk. The PA-content of
goat’s milk is a higher toxicity risk to humans since they are browsing animals. In contrast, cattle
are grazing animals and so the toxicity is lessened (Molyneux and James, 1990). It has been
proposed that higher PA contaminated milk comes from animals that have a greater resistance to
PA toxicity such as sheep (Panter and James, 1990). More recently, Hoogenboom, Mulder,
Zeilmaker, van den Top, Remmelink, Brandon, Klijnstra, Meijer, Schothorst and van Egmond
(2011) conducted an investigation into the carryover of PAs in feed to milk in dairy cows.
Although 80% of the PAs in the feed (contaminated with Senecio jacobaea) were in the N-oxide
form none were observed in the milk. The overall carryover was deemed to be 0.1% (4% for the
PA jacoline). Even though the percentage carryover was lower than expected, the authors state
that the possibility of PAs in milk is still “relevant for consumer health considering the genotoxic
and carcinogenic properties demonstrated for some of these compounds” (Hoogenboom et al.,
2011).

Experimental data available suggests that residues of PAs and their metabolites can be
transferred into eggs from laying hens feeding on unfettered grain contaminated with
Heliotropium seeds (Edgar and Smith, 2000; Byron, 1998). An earlier study on both chickens
and ducks feeding on commercial poultry grain showed that ascites and liver lesions developed.
It was the author's opinion that H. europaeum had been harvested within the wheat (Pass, 1979).
It is evident that animal feed should be screened for PA-contamination, not only for animal safety
but for the safety of our food chain. The PA-content in honey, milk and eggs is lower than that
contained in medicinal, herbal preparations and bee pollen products but the levels are such that
hepatic disease is a measurable possibility.

38

It has also been reported that leafy PA-containing plants such as Symphytum (comfrey) and
Borago (borage) are consumed in salads (Edgar et al., 2011). In 2009 the German Federal
Institute for Risk Assessment (BfR) detected Senecio vulgaris (common groundsel) in packed
salads being sold in Germany. The leaves of S. vulgaris are similar to that of rocket (Figure 1.8)
and as such misidentification is possible but nevertheless this was a clear indication of poor
quality control procedures. The analysis of the contaminated salad found a PA concentration of
2.6 mg per 45 g of salad (one retail portion as shown in Figure 1.8).

S. vulgaris (detected in salad)

Rocket (Eruca sativa)

© Wiedenfeld (2011)

© Wiedenfeld (2010)

Figure 1.8: The salad product on sale in Germany contaminated with Senecio vulgaris and the
similarity of S. vulgaris to rocket (Eruca sativa) (photographs obtained from Wiedenfeld, 2011).

Consumption of just 5 g of this lettuce would result in an adult consuming approximately 280 µg
of PAs which is four times the limit given by EFSA of 70 µg per day (based on 0.007 µg kg-1 bw
day-1 for a 70 kg adult, Table 1.2).
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1.6

Liquid Chromatography-Mass Spectrometry (LC-MS)

1.6.1

Introduction to LC-MS

Liquid chromatography-mass spectrometry (LC-MS) has many analytical applications ranging
from elemental, pharmaceutical, petrochemical and environmental analysis to food safety,
biological and clinical analysis.
spectrometric analysis.

Researchers from various disciplines depend upon mass

In the pharmaceutical industry researchers use LC-MS for drug

discovery and development, relying upon the specificity, dynamic range and sensitivity of MS to
differentiate closely related metabolites in a complex matrix. Biochemists apply LC-MS to
protein, peptide and oligonucleotide analysis whilst clinical chemists utilize it for drug testing
and neonatal screening. Food safety researchers opt for LC-MS to measure trace contaminants
and residues within the food chain such as pesticides and mycotoxins.

LC-MS has proven beneficial in the analysis of PAs since it simtaneously detects both the
tertiary (free base) PA and the PANO, thus negating the need for N-oxide reduction which is
necessary for GC-MS. It has significant sensitivity advantages over HPLC-UV and GC-FID.
Also, GC-MS reports retronecine-type equivalents whereas LC-MS identifies and quantifies the
individual PA/PANO or all four structural PA types as given in Figure 1.1. Thus, LC-MS was
the experimental technique of choice for the research presented herein to detect, identify and
quantify PAs and/or PANOs, trace contaminants, within the food chain.

The technologies

available and employed were liquid chromatography coupled to (i) an iontrap mass spectrometer
and (ii) a triple quadrupole mass spectrometer with positive electrospray ionisation used on both.

An overview of the theory of these techniques is given in the following sections of this chapter.
Other ionisation techniques such as negative mode or Matrix-assisted laser desorption/ionisation
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(MALDI) for biomolecules are not discussed.

Nor are MS technologies such as single

quadrupole, high mass accuracy via Time-of-flight (TOF) or Orbitrap, and hybrid instruments
such as QTOF, QTrap, quadrupole-orbitrap or linear ion trap-orbitrap (LTQ).

1.6.2

Theory of LC-MS

Separation of test sample components is achieved using high performance liquid chromatography
(HPLC) where the analytes are differentially partitioned between the mobile phase and the
stationary phase of the analytical column. The mechanism of retention and separation will
depend upon the mode of chromatography used, namely reverse-phase, normal phase, ion-pair or
ion-exchange chromatography. The sample is introduced to the HPLC system via injection from
the autosampler into the mobile phase stream. Best chromatographic performance is obtained
when the sample solvent has equal or lower eluotropic strength than the flowing mobile phase.
Thus, sample preparation in the starting mobile phase composition or in a less organic solvent
than the mobile phase is preferred. Once the sample is injected onto the analytical column it will
partition or distribute between the mobile and stationary phase. If a compound has greater
affinity for the stationary phase it will be retained longer on the column, immobilised to the
surface thus having increased retention (time, tR and retention factor, k). The degree to which the
sample analyte will partition between the mobile and stationary phase is governed by its
distribution co-efficient, demonstrated by the equation;
Kx = Cstat
Cmob
The distribution co-efficient will be constant for an analyte under given chromatographic
conditions. When the analyte band elutes from the column a chromatographic peak is formed, of
which the optimum peak shape is symmetrical. Elution may be performed using isocratic (good
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for high throughput) or gradient (necessary for poorly resolved peaks, separation and/or peak
shape) conditions. An important consideration is that of solvent miscibility for mobile phases
and when UV detectors are employed, the UV cut-off point for solvents. Other considerations
include the use of mobile phase modifiers, controlling pH, adjusting flow rate, column selection
and operating temperature, and band broadening.

The Van Deemter equation (HETP = A + B/u + Cu) provides an explanation of the terms or
factors which contribute to band broadening. Briefly; (i) Eddy diffusion, the ‘A’ term, relates to
variations in the mobile phase flow or analyte flow path. The analyte band can be broadened due
to variations in the column packing and as a result the analyte has multiple paths. Variations can
be minimised by using well packed columns or smaller particle size (but this can increase back
pressure within the system). (ii) Longitudinal diffusion, the ‘B’ term, occurs when the HPLC
system has internal volumes, within the PEEK tubing, which are unnecessarily large. (iii) Mass
transfer, the ‘C’ term, relates to the analyte residence time on the porous stationary phase. Mass
transfer effects can be minimised with lower linear velocities, i.e. lower flow rates, or higher
column temperatures.

In MS the analyte(s) of interest is detected based on its mass to charge ratio (m/z). The analyte
species are converted into gas phase ions within the ion source of the mass spectrometer. The
most common ionisation modes in MS are electrospray ionisation (ESI), atmospheric pressure
chemical ionisation (APCI) and atmospheric pressure photo-ionisation (APPI). The processes
that take place in the source are complex and are sample matrix and mobile phase sensitive, with
salts and other ionisable compounds competing with the analytes for charge.
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During the investigations of this research the experimental technique of choice was LC-(+)ESIMS. ESI is explained in section 1.6.3. Since APCI and APPI were not employed in this research
they are concisely explained as follows;

o In APCI the LC eluent is discharged from the capillary as a liquid and surrounded by a flow
of inert nebulising gas in a heated region. A Corona electrode pin is placed at the end of the
heated region with a potential applied that ionises the eluent molecules.

The ionised

molecules impart a charge to the analyte molecules via a charge transfer or molecular
associations.
o APPI is a complementary technique to both ESI and APCI for compounds which are not
easily ionised such as non-polar polycyclic aromatic hydrocarbons. Ionisation is by means of
photo-irradiation. A molecular radical is produced on absorption of a photon.

1.6.3

Electrospray Ionisation in MS

Two processes take place in the ion source; ionisation and desolvation. In an ESI source
ionisation precedes desolvation whereas in an APCI source desolvation precedes ionisation.
Ionisation is achieved by the application of high voltage to the source, desolvation by the
application of gas flow (pneumatic nebulisation) coupled with heating.

In terms of ionisation,

ESI sources promote a process known as ion evaporation which leverages the innate polarity of
the analyte and maximises the production of molecular ion species (Johnstone and Rose, 1996).
Solvent molecules become charged and undergo ion/molecule reactions.

In LC-MS it is necessary to ensure adequate heat and gas flow for nebulisation of the eluent
stream and the desolvation process. To prevent condensation from the aqueous content of the
mobile phase, the source should be operated at temperatures above 100oC.
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The electrospray ionisation, a soft ionisation technique, involves the transformation of ions from
the LC eluent into ions in the gas phase. Figure 1.09 shows a simplified schematic of an ESI
interface and Figure 1.10 the ion source housing on the Thermo Scientific TSQ Quantum
Discovery Max MS.

Figure 1.9: schematic of an ESI interface (Cech and Enke, 2001).

The LC eluent enters the ESI capillary which is held at a positive or negative potential
(depending on the mode required). In this research project PAs are basic compounds which in
low pH or acidic mobile phase give the protonated (positive) molecular ion.
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Figure 1.10: the ion source housing on the Thermo Scientific TSQ Quantum Discovery Max MS
(author’s own photograph) and a cross-sectional view of the chamber (Thermo Scientific, 2012).

An electric field is generated between the capillary tip and inlet to the MS. The LC eluent is
pumped through the capillary tip, to which a high voltage is applied, and ions of the same
polarity come to the solution surface forming a “Taylor cone” (Cech and Enke, 2001). The
heated auxiliary gas interacts with the primary spray to help to break up the molecules of the
analyte(s). The more uniformed the droplet size the more efficient it dries which is optimum for
the tube lens to focus the droplets into the skimmer (sampling cone). The skimmer allows the
correct amount of droplets through to the mass analyser to increase signal to noise (S/N) ratio and
sensitivity. Solvent evaporation from the droplets is aided by an increase in the temperature of
the ambient air within the ionisation housing. This is supplemented by an inert desolvation gas,
generally nitrogen. The temperature and gas flow are optimised based upon the properties of the
droplet and the eluent flow rate. Two main theories govern solvent evaporation (i) Dole’s
“charged-residue” model and (ii) the “ion evaporation” model proposed by Iribarne and
Thompson in 1979 (Cech and Enke, 2001).

The “charged-residue” theory is that desolvation shrinks the droplet size and increases the charge
on the droplet. When the charge reaches a maximum, the Rayleigh limit, Coulomb repulsion
ensues causing an “explosion” forming smaller, lower charged droplets.
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The alternative theory of “ion evaporation” is that droplets with a radius < 10 nm can form under
field desorption and release a gaseous ion. The evaporation process duration is a few hundred
microseconds to a few milliseconds.

Figure 1.11: Coulomb explosions producing charged droplets within the spray chamber (adapted
from de Hoffmann and Stroobant, 2007).

Adhering to a few simple guidelines will improve results obtained by LC-ESI-MS;
-

Minimise salts, e.g. sodium, by eliminating soap and detergent

-

Use ultra/high purity LC-MS grade solvents

-

Eliminate the use of TFA and strong acids

-

A low acid concentration in mobile phase is preferred, depending on the pKa values for the
target analytes (impacts upon ionisation efficiency)

-

Use a low probe voltage

-

Increase the organic solvent content but always have some water in the mobile phase.

1.6.3.1 Advantages and Disadvantages of ESI
ESI-MS application areas are diverse ranging from large macromolecules to small organic and
inorganic molecules. Modern ion signals from ESI-MS provide “a clear and deep perception
about the analytes properties far beyond the conventional mass and structural properties of the
analytes” (Banerjee and Mazumdar, 2010). There are few disadvantages to ESI-MS. Those that
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do exist are more so associated with the sample preparation for ESI. Table 1.7 provides a list of
advantages and disadvantages for the use of ESI.

Advantages

Disadvantages



Mass range up to 70,000 Da



Good sensitivity

salts and ion-pairing reagents (TFA) can



Soft ionisation – capable of producing non-

lower vapour pressure, reducing signal and

covalent complexes in a gaseous phase

thus decreasing sensitivity






Presence of buffers (phosphate, Na+, K+),

Easily connected to liquid



Complex mixtures can reduce sensitivity

chromatography/LC eluent flow



Sample purity is important to increase
sensitivity

Easily connected to a wide range of MS
technologies







Simultaneous mixture analysis can be

Off-axis configuration good for higher flow

difficult,

rates and minimising matrix interferences

transitions

Multiple charging allows for detection of



particularly

for

identical

Sample carryover (significantly reduced in

high mass ions with relatively low m/z

off-axis configurations and software data

range

acquisition modes)

Table 1.7: Advantages and disadvantages of electrospray ionisation (ESI).
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1.6.4

Triple Quadrupole (QqQ) Mass Spectrometry (MS) Technology

The method of acquiring LC-MS data can be highly sensitive, specific and selective. It is usually
used to make quantitative measurements of target materials, or to establish the presence of target
material at low levels. In quadrupole devices electric fields are used to separate ions according to
their m/z as they travel along the central axis of four parallel equidistant rods. Triple quadrupole
instruments can perform selected ion monitoring (SIM) in addition to selected reaction
monitoring (SRM) where specific product ions are derived from selected precursor ions. The
first quadrupole is set at the target m/z value and controlled fragmentation is performed in the
second quadrupole. A product ion from that process is selected as the target ion for the third
quadrupole and the ion current resulting from the whole process is recorded. This has the effect
of reducing both signal and noise, but noise is reduced to a greater degree, thus increasing the
signal-to-noise ratio.

Figure 1.12: schematic of a Thermo Scientific TSQ Quantum Discovery Max QqQ MS
displaying its unique 90 degree geometry collision cell (Thermo Scientific, 2012).

The alignment of two mass filters in succession with a collision quadrupole in between allows
the structure of the ionised sample molecules to be elucidated.
performed (de Hoffmann and Stroobant, 2007);
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Four main modes can be

(1) In a Product ion scan (daughter scan) the first quadrupole (Q1) is set to select a parent ion of
a known m/z to be fragmented in the second quadrupole (q2) by collision-induced
dissociation (CID). The third quadrupole (Q3) is set to scan the entire m/z range, giving
information on the size/abundance of the fragments produced. From the ion fragmentation
information, the structure of the original ion can be deduced. This experiment is commonly
performed to identify transitions used for quantification by tandem MS.
(2) In a Precursor ion scan (parent scan) a certain product ion is selected in Q3 and the
precursor masses are scanned in Q1. This experiment is selective for ions having a particular
functional group (e.g. a phenyl group) released by the fragmentation in q2.
(3) In a Neutral loss scan both Q1 and Q3 are scanned together, but with a constant mass offset.
This allows the selective recognition of all ions which, by fragmentation in q2, lead to the
loss of a given neutral fragment (e.g. H2O, NH3, etc.). Similar to the precursor ion scan, this
technique is also useful in the selective identification of closely related classes of compounds
in a mixture.
(4) In Selected reaction monitoring (SRM) or Multiple reaction monitoring (MRM) both Q1
and Q3 are set to a selected mass, allowing only a distinct fragment ion from a certain
precursor ion to be detected. SRM is a very selective analysis mode, which can increase
sensitivity. If Q1 and/or Q3 are set to more than a single mass, this configuration is called
multiple reaction monitoring.
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1.6.5

Ion Trap (IT) Mass Spectrometry (MS) Technology

Ion trap (IT) MS uses an oscillating electric field to store ions. Ion traps can be 2D - linear ion
traps (LITs) or 3D - quadrupole ion traps (QITs) preferably termed a “Paul” ion trap (de
Hoffmann and Stroobant, 2007). Ion traps are used to perform sequential fragmentation, MS(n),
by fragmenting ions of interest to derive more structural information on a single analyte.

Figure 1.13: schematic of an ion trap MS and the spray chamber of an Agilent 6300 series
(Agilent Technologies, 2006).

Referring to Figure 1.13 above; charged ions produced from ESI within the spray chamber are
drawn into the capillary into a higher vacuum region. As the ions exit the capillary tube they are
accelerated towards skimmer 1. Skimmer 1 removes neutral excess gas and solvent molecules
whilst skimmer 2 focuses ions and removes more neutral species before the ions reach the
octopole. The octopole homogenises any energy distributions of the ions before they enter the
quadrupole trap.

The ion trap mass filter accumulates all ions.

The oscillating potential

difference established between the ring and endcap electrodes form a substantially quadrupolar
field which can trap ions of a particular mass range. For efficient trapping and cooling of ions
generated by the ESI helium gas is introduced. The helium also serves as a collision gas during
MS(n) operation. Mass accumulation times in the trap are generally < 200 ms (milliseconds).
Ions are ejected from the trap in mass order to a high energy dynode detector which counts the
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ions and amplifies the signal. Once the ions have been counted and amplified, they are recorded
in the mass spectrum (Agilent Technologies, 2006).

1.6.6

Collision-Induced Dissociation (CID)

Collision-induced dissociation (CID) is a mechanism by which molecular ions are fragmented in
the gas phase typically by acceleration of an electrical potential to a high kinetic energy in the
vacuum region. This is followed by collision with neutral gas molecules from helium, nitrogen
or argon. A portion of the kinetic energy is converted by the collision resulting in chemical
bonds breaking and the molecular ion being reduced to smaller fragments.

Figure 1.14: “Fast” collision-induced dissociation (CID; adapted from de Hoffmann and
Stroobant, 2007).

1.6.7

Advantages and Disadvantages of MS Technologies Employed

As previously stated IT-MS and QqQ-MS were utilised in this work as these were the MS
technologies available in the research laboratory. Therefore, other MS analysers such as single
quadrupole, Time of Flight (TOF), Orbitrap, and hybrid mass analysers are not discussed. Both
IT and QqQ mass analysers exhibit advantages and disadvantages, not only in the physical
technology/instrumentation but also in their individual software capabilities.
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1.6.7.1 Ion Trap Mass Spectrometry (IT-MS)
In IT-MS ions are stored in the trap and manipulated using DC (direct current) and RF (radio
frequency) electric fields in a series of carefully timed events providing MS/MS capabilities, high
resolution and high sensitivity. The main limitation is the timing of the trapping of the ions as
undesirable effects such as space charge effects and unimolecular decomposition can occur.

Advantages
Disadvantages
n
 Powerful MS/MS and MS capabilities for  Limited dynamic range or space charge
ion fragmentation experiments
effects (now overcome with larger traps
 High scan speed
and software functionalities)
 Relatively low cost
 Ion-molecule interactions
 Adaptability - hybrid instruments
 Relatively low resolution
 Advancements in software functionalities
 One-third cutoff rule (associated with
n
traditional ion trap CID spectra)
have increased performance (e.g. Auto-MS
and data dependent studies)
Figure 1.8: Advantages and disadvantages of ion trap mass spectrometry (IT-MS).

1.6.7.2 Triple Quadrupole Mass Spectrometry (QqQ-MS)
A significant advantage of QqQ-MS lies in the fact it can be used over four modes of analysis to
obtain both structural information and superior quantitation.

Advantages
Disadvantages
 MRM/SRM studies allow increased
 Limited resolution (with some systems)
selectivity, lower S/N and LOQ
 Peaks heights are variable with mass (peak
 Four analysis modes
height vs. mass response must be tuned)
 Quantitative experiments
 Low energy CID dependent upon energy,
collision gas and pressure
 Good reproducility
 Low energy CID
Figure 1.9: Advantages and disadvantages of triple quadrupole mass spectrometry (QqQ-MS).
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1.6.8

Role of LC-MS in food safety

Food safety concerns have risen globally as the number of food contamination incidents and
product recalls have increased. As a result, the ‘from farm to fork’ methodology was adopted
within Europe initiating a science-based approach to food safety testing and the establishment of
key legislation (Malik, Blasco and Picó, 2010). Accurate surveillance of contaminant levels in
food and agricultural produce is vital to ensure the safety of the food chain.

The “basic

analytical requirements in food analysis are high resolution, high throughput, high sensitivity
detection and quantification of contaminants at or below the maximum residue limit (MRL) or
tolerance of the compound in a given food matrix” (Soler, Manes and Picó, 2008).

E.Coli O157:H7
from undercooked
hamburger meat;
600 illnesses, 4 deaths

E.coli in bean sprouts;
4000 illnesses, 53 deaths

Sudan I Dye from
contaminated
chilli powder

Melamine in infant formula;
860 illnesses, 6 deaths

1993

2003

2005

2006

2008

2009

2013

Undeclared horse meat
in beef products

E.coli in spinach;
205 illnesses, 3 deaths
Hepatitis A from
green onions;
660 illnesses, 4 deaths

2011

Pork dioxin crisis

Figure 1.15: Notable food safety incidents over the past 2 decades.

Liquid chromatography-mass spectrometry (LC-MS) has been a central technique in food safety
and quality control. Its utilisation has increased in food manufacturer’s quality control and R&D
divisions as a flexible alternative to traditional methods due to its high sensitivity and faster
throughput (Szpylka, 2013).

The European Commission has incorporated the use of mass

spectrometry for food safety under decision 2002/657/EC which contains specific legislation on
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sampling, sample preparation and requirements for methods of analysis to control contaminants
in foodstuffs. The main advantage of using LC-MS/MS is the reduced amount of sample cleanup required because of the mass spectrometer’s high specificity. LC-MS is particularly suited for
the analysis of food contaminants as it provides a large amount of information for a complex
matrix, thus enabling the screening, confirmation and quantification of hundreds of components
within one analysis, both parent compounds and their metabolites (Malik et al., 2010).

LC-MS is the technique of choice for environmental contaminants, natural and marine toxins,
veterinary drug residues, pesticides, and contaminants from food processing using two distinct
approaches; (i) analysis using nominal masses and performing MS/MS (QqQ or QqLIT) and (ii)
obtaining accurate mass measurements (TOF, QqTOF, Orbitrap).
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1.7

Previous analysis of PAs

In analysing PAs both the tertiary PA and its corresponding N-oxide are generally present. In
some cases, as discussed in section 1.1.2, the PANO quantity present can exceed that of the PA.
The following sections give a brief overview of the previous analysis of PAs and in most cases
there are further discussed in the publications of this research.

1.7.1

Extraction methods

PAs have been extracted from both fresh and dried plant material. Methods include steeping
fresh plant material in methanol or aqueous acids followed by heating or ultrasonic agitation
(Crews, Berthiller and Krska, 2010). Fresh plant material has also been air-dried or freeze-dried.
Traditionally, PAs and their N-oxides are extracted from dried, ground/powdered plant material
with hot or cold alcohol (methanol). The alcohol solvent is evaporated and the resulting oily
residue is dissolved in acidic aqueous solutions to uptake the bases. Hydrochloric acid is avoided
due to its reaction with PA epoxide groups making sulphuric acid the popular choice. The
waxes, fats and chlorophyll are removed by LLE with petroleum, ether or hexane (Mattocks,
1986). The PANOs are reduced to the corresponding basic alkaloid with stirring over zinc dust.
The solution is made alkaline on the addition of ammonia and the PAs are finally extracted with
a non-polar organic solvent such as chloroform (IPCS, 1988). Alternatively, alcohol can be
continuously circulated through the plant material using Soxhlet extraction or reflux and then
passed through a cation exchange resin (Mattocks, 1971).

Lebada et al. (2000) compared several solvent compositions for their efficacy in extracting
senkirkine and senecionine (not their N-oxides) from Tussilago farfara. The greatest yields were

55

obtained with heating under reflux using 50:50 v/v methanol and aqueous citric acid at pH 2 for
15 minutes whilst prolonged Soxhlet extraction over 48 hours proved least satisfactory.

To determine the full profile of PAs and their N-oxides two analyses are carried out concurrently;
the first of the extracted PA free bases alone and the second of the total free bases obtained by
reduction of the N-oxides (Crews et al., 2010). The proportion of the N-oxides is determined by
difference. In a study conducted by Beales, Colegate and Edgar (2003) the authors found that
reduction efficiency can vary with the batch of zinc dust being used and with the reaction time.
Yields were optimised between 30 minutes and 4 hours but found to decrease with reaction
overnight. Thus, today it is more practical to avoid reduction and determine both free bases and
N-oxides by using HPLC (Crews et al., 2010).

When attempting to isolate PAs from animal tissues, it must be considered that the toxic
alkaloids are often metabolised readily (within a few hours) and that the quantities recoverable
are small (IPCS, 1988). Thus, urine and blood samples are taken for detection of metabolites.
On this analytical scale the most useful technique is LC-MS.

1.7.2

Clean-up procedures

Clean-up procedures which employ LLE are being used less frequently when analysing PAs due
to the time consumption and having to deal with large quantities of undesirable solvents such as
diethyl ether, chloroform and dichloromethane. To achieve sufficient clean-up of the acidic
aqueous extract for chromatography the sample must be washed several times. Thus, solid phase
extraction (SPE) has become more favoured. Early SPE methods did not support non-cyclic
diesters and were replaced with cation-exchange mechanisms.
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Mroczek, Glowniak and

Wlaszczyk (2002) highlighted that use of C18 sorbent allowed the co-elution of matrix
interferences for chromatography and that a polymeric strong cation-exchange (SCX) SPE could
isolate both free bases and N-oxides whilst minimising possible interferences.

1.7.3

Ehrlich Reaction

This method was developed to be specific for unsaturated pyrrolizidine alkaloids (IPCS, 1988).
The procedure involves oxidising the PA to its N-oxide using hydrogen peroxide, a step which
can be omitted if the N-oxides are being estimated alone. The resulting product reacts with
acetic anhydride to form a pyrrolic derivative (dehydro-alkaloid) that produces a purple colour
when reacted with a modified Ehrlich reagent (containing boron trifluoride). This method was
successfully applied to tissue samples (Mattocks, 1986). An improved “field test” version was
published in 1987 (Mattocks and Jukes) for use with plants or any materials of plant origin, such
as cereals or herbal teas. The purple (magenta) colour in the "test" sample compared to the
"blank" indicates the presence of unsaturated PA(s). The intensity of colour can give a rough
indication of the quantity of alkaloids present, and whether further chemical testing is required
(IPCS, 1988). This colourimetric technique could be used as an initial qualitative screening
procedure, particularly for plant materials. The protocol would allow an estimation of the total
PA-content of the plant material and may help to overcome instances where the relevant PA
reference standards are not available. The test was reported to be linear over a range of 5 to 100
µg for most retronecine-type PAs (Mattocks and Jukes, 1987).
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1.7.4

Chromatographic methods

1.7.4.1 Thin-layer chromatography (TLC)
TLC using silica plates eluted with chloroform or an aluminium oxide adsorbent have been used
for detecting PAs.

Many protocols use Ehrlich reagent (4-dimethylaminobenzaldehyde) by

spraying the plates with a solution of orthochloranil followed by Ehrlich’s and heating after each
spray (Molyneux and Roitman, 1980). The pyrrole gives a violet-blue appearance. The PANOs
are detected by spraying a solution of acetic anhydride, heating the plate, and then spraying
Ehrlich’s reagent (IPCS, 1988). Stelljes, Kelley, Molyneux and Seiber (1991) employed the use
of TLC to separate PA fractions prior to identification by GC-MS.

1.7.4.2 Gas chromatography (GC)
Gas chromatography coupled to mass spectrometry (GC-MS) has been frequently used for the
identification and quantitative determination of PAs but GC-FID has also been reported. For
example, PAs were extracted from honey and identified by Deinzer et al. (1977) and Culvenor,
Edgar and Smith (1981) using GC-MS. This protocol identifies retronecine-PA equivalents
rather than individual PA identification. PANOs generally undergo thermal decomposition when
analysed by GC and thus they are first reduced to the corresponding tertiary alkaloid.
Alternatively, PANOs can be derivatised using trimethylsilylation (IPCS, 1988).

However,

derivatisation seems to cause some alteration or destruction of senecionine and seneciphylline
(Crews et al., 2010) and thus tends not to be used today. Soft chemical ionisation techniques are
advisable to induce the formation of the protonated molecular ion (Bicchi, Caniato, Tabacchi and
Tsoupras, 1989) and base peak accomplished using methane, isobutene and ammonia. Electronimpact ionisation (EI) is used to distinguish between similar PA compounds (Crews et al., 2010).
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1.7.4.3 High performance liquid chromatography (HPLC)
Analytical and preparative scale HPLC separation of PAs was first described by Segall (1979a;
1979b). HPLC methods are non-destructive and have the benefit of analysing both the tertiary
PA and its N-oxide simultaneously without the need for PANO reduction. Many different
stationary and mobile phases have been employed (see publication in Chapter 4 for tables of
previous analysis). With reverse-phase chromatography using an acidic mobile phase the PA
will elute prior to its N-oxide. This is reversed with the use of an alkaline mobile phase as the
PANO becomes more polar eluting earlier (Qi et al., 2009). Although UV has been employed
the optimum wavelength is low (220 nm) meaning that typically retronecine PAs are derivatised
with orthochloranil, followed by boron trifluoride and Erhlich’s reagent. Thus MS is a more
popular detector.

1.7.4.4 Liquid Chrmoatography-Mass Spectrometry (LC-MS)
APCI-MS has been reported (Beales et al., 2004) in the analysis of PAs but ESI is generally more
suitable for polar compounds. It has been shown that for the polar PANOs ionisation was
significantly lower in APCI than in ESI mode to the extent that APCI would not be applicable for
the trace analysis of some PANOs (Beales et al., 2003; Crews et al., 2010). Single-stage LC-MS
can be limited as PAs can share the same molecular mass and empirical formulae, being
stereoisomers. Ion traps, TOF and QqQ MS have all been used in the analysis of PAs.

A disadvantage for the quantitative analysis of PAs remains the lack of commercially available
standards which hinders accurate LC-MS quantification. A common approach is to estimate the
PA-concentration by quantifying against a single standard, by retronecine equivalents or for an
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N-oxide against the tertiary PA.

However, PAs can ionise very differently and thus their

response factors are not equivalent leading to under- or over-estimation of results.

The mass spectra of retronecine-type PAs and PANOs (including diester, monoester and nonester PANOs) display two characteristic fragment ions at m/z 120 and 138. For the N-oxides of
diester PAs, including both open chain diesters (such as lasiocarpine N-oxide) and macrocycle
diesters (e.g. N-oxides of retrorsine, senecionine, seneciphylline and monocrotaline) these exhibit
two additional characteristic ion clusters at m/z 118–120 and 136–138. Ruan, Li, Xia, Fu, Peng,
Ye and Lin (2012) proposed that these characteristic fragment ion clusters were generated
through three individual fragmentation pathways;
(1) the cleavage of two ester groups at C-7 and C-9 positions to produce a fragment ion at
m/z 154, which is fragmented further to give ions at m/z 136 and 137 through the loss of
H2O and an OH group, respectively.
(2) involves the simultaneous loss of the said two ester groups and a molecule of water to
generate the ion at m/z 136 followed by further loss of a molecule of H2O or an OH group
giving the fragment ions m/z 118 and 119, respectively.
(3) the loss of the oxygen atom attached to the nitrogen of the necine base to form the
corresponding PA.

These pathways are shown in Figure 1.16 (a) to (c). Ruan et al. (2012) also observed that only
one ion cluster at m/z 136–138 was observed in monoesters (e.g. heliotrine and lycopsamine Noxide) and that the presence or absence of the ion cluster at m/z 118–120 can be used to
differentiate retronecine-type diester PANOs from non-ester and monoester PANOs with the
ester substituted at the C-9 position.
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Note: In this study the retronecine-type PAs (crotaline, echimidine, retrorsine, senecionine,
seneciphylline and trichodesmine) contained the fragment m/z 120, characteristic of its moiety.
Lycopsamine displayed the fragment m/z 138 instead of m/z 120, consistent with literature for
monoester PAs (Ruan et al. 2012). The retronecine-type PANOs (crotaline N-oxide, retrorsine
N-oxide, senecionine N-oxide and seneciphylline N-oxide) are all macrocyclic diesters having
characteristic ion clusters at m/z 118–120 and 136–138. The otonecine-type PAs (otosenine and
senkirkine) exhibited characteristic fragments m/z 150 and 168 whilst fragments m/z 138 and m/z
156 were observed for the heliotridine-type PA (heliotrine). All were in agreement with the
findings of Ruan et al. (2012).
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Figure 1.16: Fragmentation pathways as described by Ruan et al. (2012); (a) pathway 1, (b)
pathway 2 and (c) pathway 3.
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1.7.5

Use of Enzyme Linked Immunoassays (ELISA)

Most ELISA techniques for PAs are based on antibodies raised against retrorsine (Crews et al.,
2010). ELISA tests tend to be highly specific for single targets with some cross reactivity to
other PAs but only with similar structural analogues rather than multi-target analysis
(Oplatowska, Elliott, Huet, McCarthy, Mulder, von Holst, Delahaut, van Egmond and Campbell,
2014).

It has been used to estimate total PA content of plants and feed (Lee, Schoch,

Stegelmeier, Gardner, Than and Molyneux, 2001) and a sensitive quantitative technique for
detecting retrorsine and monocrotaline using immunogens based on quaternary pyrrolizidinium
salts (Roseman, Wu and Kurth, 1996).

Recently a multiplex qualitative screening assay for the detection of a number of pyrrolizidine
alkaloids in honey and feed was developed and validated by Oplatowska et al. (2014). The
detection capability was determined to be 25 μg kg-1 which in light of current LC-MS methods is
poor but the authors suggest that the detection levels could be lower with a more elaborate
sample preparation. However, similar to the Ehrlich’s reaction for PAs, ELIZA is a useful
screening process.

1.7.6

Other Techniques

1.7.6.1 Near Infrared and Raman Spectroscopy
Near Infrared spectroscopy (NIRS) is a fast and non-destructive analytical method. A study by
Graham et al. (2012) demonstrated that both NIRS and Raman technology could be applied as
rapid screening techniques for the detection of oil adulteration in the food and feed industry.
Carvalho et al. (2013) predicted, with moderate accuracy (63%), pyrrolizidine alkaloids in
Jacobaea vulgaris, Jacobaea erucifolia and Senecio inaequidens plant material using NIRS.
62

However, work by Moghaddam (2010) concluded that there are many wavelengths related to,
and affected by, PAs and that most of these wavelengths are also affected by other known
biochemicals such as nitrogen, proteins and starch. Selected wavelengths for Jacobaea vulgaris
were common with Senecio inaequidens. The author concluded that the accuracy of NIRS was
weak due to the relatively low concentrations of PAs and the different PA chemotypes present
(Moghaddam, 2010). The application of NIRS and Raman spectroscopy for PAs could prove
very beneficial as a non-destructive, in-process control detection method and therefore warrants
further investigation.

1.7.6.2 Precursor Ion Scan (PIS) on Mass Spectrometry (MS)
Utilising the precursor ion scan (PIS) function on a mass spectrometer is another worthwhile
technique and could possibly overcome the lack of commercially available PA reference
standards.

The PIS acquisition can be used to detect peaks (or parent masses) from the

characteristic product ions at m/z 120 and 138 for retronecine-type PAs and ion clusters at m/z
118-120 for retronecine N-oxides (Figure 1.16). Ruan et al. (2012) successfully applied this
technique with a HPLC-QTrap-MS method to analyse two PA-containing plant samples Gynura
pseudochina and G. Japonica. A further investigation by this research group (Zhu et al., 2014)
developed a UHPLC-QTOF-MS method to detect retronecine-type PAs and their N-oxides in 15
PA-containing plants (members of Senecio, Gynura and Parasenecio genus). Quantitation was
carried out using extracted ion chromatograms (EICs) at accurate mass of m/z 120.0813 and m/z
138.0919 with a 5 ppm window. This approach has limitations in that it is not as accurate as
directly quantifying against the corresponding PA/PANO and its application is to retronecinetype PAs and their N-oxides (excluding other classifications of PAs as per Figure 1.1).
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1.7.6.3 QuEChERS
QuEChERS is an acronym for Quick Easy Cheap Effective Rugged Safe. It was originally
developed for pesticide residue extraction (Anastassiades, Lehotay, Stajnbaher, & Schenck,
2003). It is a valuable analytical approach which simplifies the analysis of multiple pesticide
residues in fruit, vegetables, cereals and processed products. The QuEChERS protocol entails a
number of simple steps which are fast and easy to perform, namely salting out extraction induced
by phase separation of the aqueous and organic solvent followed by dispersive SPE (dSPE) for
clean-up.

It has been applied to other contaminants and residues such as mycotoxins

(Yogendrarajah et al., 2013), steroids (Klinsunthorn et al., 2011) and veterinary residues
(Kinsella et al., 2009; Whelan et al., 2010) in many different matrices. On conducting a literature
review, there are only three publications to date on the use of QuEChERS for PAs (Kempf et al.,
2011b; Martinello et al., 2014; Bolechova et al., 2015).

In a recent study on PAs in animal feed a modified QuEChERS procedure was employed for
sample extraction using acetonitrile and aqueous formic acid with phase separation induced by
magnesium sulphate and sodium chloride (Bolechova et al., 2015). The authors did not perform
a dSPE clean-up on the extracts. An average recovery of 72 to 94% was obtained at a 5 µg kg-1
spiking level for five PAs (monocrotaline, retrorsine, seneciphylline, senecionine and
senkirkine). Two publications utilised a modified QuEChERS approach for the detection of PAs
in honeys (Kempf et al., 2011b; Martinello et al., 2014). The extraction step was similar for both
using acetonitrile and sodium citrate in water followed by phase separation with magnesium
sulphate and sodium chloride. Kempf et al. (2011b) did not perform a dSPE and reported
recoveries of 97.5 to 104.6% (%RSD ranging from 4.9 to 38.8%). Martinello et al. (2014) did
employ dSPE with primary secondary amine (PSA), magnesium sulphate and carbon, reporting
recoveries of 67 to 122%. Both of these methods were optimised for the detection of nine PAs.
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2.0

Aims and Objectives

The aim of this research was to investigate the presence of, and quantify, pyrrolizidine alkaloids
(PAs) and pyrrolizidine alkaloid N-oxides (PANOs) in food using liquid chromatography-mass
spectrometry.

The research objectives of this project were;
1) To develop and validate an effective methodology for the accurate quantification of
pyrrolizidine alkaloids (PAs) and pyrrolizidine alkaloid N-oxides (PANOs) using liquid
chromatography-mass spectrometry (LC-MS) technologies.
2) To optimise and validate an effective sample extraction and clean-up procedure for the
analysis of PAs and PANOs in a range of food matrices.
3) To investigate a range of food produce, including honey, herbal teas, traditional Chinese
medicines (TCMs), milk and cheese, for PA-contamination.
4) To conduct a comprehensive survey of honey sold on the Irish market for PA-contamination
and to determine the risk to the Irish population through an exposure assessment study.
5) To contribute to the analytical research area of PAs thereby improving food safety.
6) To become an expert in analytical method development.
7) To establish scientific collaborations and disseminate research findings on PAs in the food
chain through international peer-reviewed publications and presentations.
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3.0

Experimental Methods

Note: Each analytical chapter (4 to 6 inclusive) of this thesis describes in full the experimental
approach taken within each study. Therefore, the purpose of this experimental chapter is to
provide an overview of how the methods were developed and optimised for their application in
the analysis of PAs in honeys, herbal products, milk and cheese.

3.1

Preparation of materials

3.1.1 Reference Standards

Reference standards were purchased from the suppliers as listed in Table 3.0 with molecular
structures presented for all ten PAs and four PANOs in Table 3.1.
PA/PANO

Supplier

Purity

Crotaline
Crotaline N-oxide

Sigma Aldrich
Phytolab GmbH & Co.

≥98%
≥99%

Echimidine
Heliotrine
Lycopsamine

Phytolab GmbH & Co.
Latoxan
Phytolab GmbH & Co.

≥90%
≥98%
≥95%

Otosenine
Retrorsine
Retrorsine N-oxide
Seneciphylline

Phytolab GmbH & Co.
Phytolab GmbH & Co.
Phytolab GmbH & Co.
Phytolab GmbH & Co.

≥95%
≥95%
≥99%
≥99.5%

Seneciphylline
N-oxide
Senecionine
Senecionine N-oxide
Senkirkine

Phytolab GmbH & Co.
Phytolab GmbH & Co.
Phytolab GmbH & Co.
Carl Roth
GmbH & Co.
Latoxan

Trichodesmine

%Purity
confirmed by

Quantity
obtained
1.0 g
10.0 mg

≥98%

TLC and NMR
HPLC-MS, IR, TLC
and NMR
HPLC-UV
TLC
HPLC-UV, IR, GC
and ICP-MS
N.R.
N.R.
HPLC-MS, IR
HPLC-UV, IR, GC
and MS
HPLC-MS, IR

≥99%
≥95%
≥99.5%

GC, ICP-MS, NMR
HPLC-MS, IR
GC, TLC, NMR

10.0 mg
10.0 mg
10.0 mg

≥98%

TLC

25.0 mg

10.0 mg
50.0 mg
10.0 mg
10.0 mg
10.0 mg
10.0 mg
10.0 mg
10.0 mg

Table 3.0: Supplier listing, detailing % purity, for reference PA and PANO standards.
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Table 3.1: Molecular structures for PAs and PANOs included in this study.
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Both PA and PANO reference standards were prepared in HPLC grade methanol from the
original supplier vial (of 10 mg) to primary stock standard solutions of 1 mg mL-1 (10 replicates).
These stock standards were dried under nitrogen and stored at -20oC. Weekly working standards
were prepared using serial dilution and stored between 2 to 4oC in solution (methanol). The
freeze dried vial was allowed to equilibrate at room temperature before the addition of 1.0 mL of
HPLC grade methanol and mixed using a vortex for 1 minute. Working standards were prepared
by mixing all PAs and PANOs and subjecting this mixture to serial dilution to produce a 7-point
calibration curve range. All PAs and PANOs are soluble in methanol whilst some are insoluble
or produce turbid solutions in water (or solutions composed of a high % of water).

During the course of the optimisation of the method (as per section 3.3) it was noted that
preparation of standards in methanol afforded better chromatographic peak shape and ionisation
than those standards prepared in a diluents of the starting mobile phase composition. This is
illustrated in Figure 3.0 with the PA lycopsamine.

Figure 3.0: Comparison of chromatographic peak obtained for the PA lycopsamine when
prepared in starting mobile phase composition versus 100% HPLC grade methanol.
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3.1.2 Controls

Control samples were prepared by spiking a blank matrix, a sample (honey, herbal teas, TCMs,
milk and cheese) which was found to have no detectable levels of PAs and PANOs included
within the analysis, after being subjected to extraction and clean-up as per the experimental
protocol with a mixture of reference standards at two concentration levels (with the exception of
the work as presented in Griffin et al. (2013) where one concentration level was employed as
samples were analysed in duplicate). Controls were used to determine the intra- and inter-day
variability and reported in terms of relative standard deviation (%RSD), a measure of a statistical
estimate's reliability obtained by dividing the standard deviation by the mean and expressed as a
percentage.

3.2

Sample preparation procedures

3.2.1

SPE: Theory and Protocol

One of the main objectives of this project was to develop a simple but robust sample extraction
and clean-up protocol that could be applied to a range of food matrices and suitable for LC-MS
analysis with minimum ion suppression (or enhancement) effects from the sample matrix. High
sensitivity was an essential requirement for the analysis of PAs and PANOs in food produce as
concentration levels can be low and the food matrices are challenging, particularly for produce
such as honey. An assessment of all published methods for the analysis of PAs and PANOs was
conducted and can be seen in Griffin et al., 2014b (for honeys), Griffin et al., 2014a (for teas and
TCMs) and in Chapter 6 (for milk). Liquid-liquid extraction (LLE) is a popular method for
detecting PAs in plant extracts but the long extraction times (up to 24 hr), use of heat and
hazardous chemicals (such as dichloromethane, diethyl ether and chloroform) rendered this
method unsuitable as it did not meet the objectives of this project. Other literature has shown
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that SPE is effective at reducing interferences from a complex food matrix such as honey in the
analysis of insecticides (Blasco, Vazquez-Roig, Onghena, Masia and Picó, 2011) and at reducing
ion suppression effects for LC-MS analysis (Furey, Moriarty, Bane, Kinsella and Lehane, 2013).
The use of a polymeric SCX-SPE for PA analysis was recommended by Mroczek et al. (2002).
Using SCX-SPE allows PAs to interact via a cation exchange mechanism and PANOs by polar
interactions with the active sites of the sorbent. Thus, both analytes, PAs and PANOs, are
isolated simultaneously by SCX and mixed-mode.

The SPE protocol developed and presented herein had significant time, labour and commercial
cost improvements over previous publications (Betteridge et al., 2005; Boppré et al., 2005;
Dübecke et al., 2011);

(i)

The SPE cartridge bed size was reduced from 500 mg to 60 mg. This provides both a
cost and time saving. Large bed sizes are more expensive to purchase (approximately
double the price), take longer to condition and require larger volumes of both solvents
and sample.

(ii)

Sample size was reduced to the equivalent of 1 g of honey versus previous publications
having 10 to 20 g. The supernatant loading of honey samples was therefore reduced by
approximately 10 times from 25 mL to 2.5 mL. This introduces less sample matrix
interferences and also reduces the time spent on loading.
It should be noted that 1 g of honey was deemed a sufficient sample size in respect of
sample homogeneity for retail honeys. On average the maximum contents of a retail
honey jar is 454 g and as such can be easily homogenised. However, for bulk honeys (> 1
kg/container) the sample size would need to be optimised and possibly increased. For
larger imports (> 10 kg/container) composite sampling would be necessary.
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(iii)

For a viscous sample matrix, such as honey, it was not necessary to maintain the warming
of the supernatant prior to loading nor divide the supernatant volume and load to separate
SPE cartridges, as per a previous publication (Betteridge et al., 2005).

(iv)

The polymeric bed provided superior sample elution with no incidences of cartridge
blockage. Filtration to remove particulate matter was performed by Dübecke et al. (2011)
“overnight”, an excessively labour intensive step which was not required in the protocol
presented herein.

Under mildly acidic conditions most PAs are more stable, although epoxide functionalities are
present in some PAs which are sensitive to halogenic acids. Halogenated solvents promote
quaternisation of tertiary PAs to corresponding salts with modified characteristics (EFSA, 2011).
For this reason sulphuric acid was chosen for the acidic extraction protocol.

The chosen SPE cartridge (Phenomenex Strata-X-CTM 60 mg bed/3 mL volume, as per section
3.2.2) was conditioned with methanol (2 mL) to remove any random impurities and allow the
sorbent to be solvated. Following this the cartridge was equilibrated with water (2 mL) to
prepare for sample loading.

The sample was loaded onto the cartridge manually, using a

handheld pipette since the aliquot was relatively small (2.5 mL). The sample volume was
matched to the bed size so as to not overload the capacity of the cartridge. Samples were loaded
under atmospheric pressure, i.e. no vacuum was applied to the manifold, and allowed to dry for 1
minute before washing. Wash solvent strength and volume were optimised to flush as many
matrix interferences as possible from the cartridge without losing the PA and PANO analytes.
An aqueous buffer of 0.1% formic acid (2 mL) was used to remove water soluble interferences
followed by methanol (2 mL) to remove hydrophobic substances without disrupting the PA and
PANO analytes. Finally, the elution step consisted of ammoniated methanol (6 mL) which
removed the analytes of interest, both PAs and PANOs. The ammoniated methanol solvent
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strength was increased from 0.1% to 5%. This was optimised to ensure complete elution of the
analytes but without disrupting and eluting the more strongly retained interferences from the
cartridge. This was verified by post-column infusion studies to investigate matrix interferences.
The same protocol was applied to honeys (chapter 4), herbal products (chapter 5) and milk and
cheese (chapter 6) except in the instances where the ratio of sample mass to extraction solvent
(0.05 M H2SO4) volume was necessarily changed.

Figure 3.1: General overview of the SPE protocol (A = analyte, M = matrix components).

To ensure the correct SPE sorbent/cartridge was chosen a study of five different SPE cartridges
was conducted using an extract of honey spiked with a mixture of ten PAs and four PANOs (as
per the listing provided in Table 3.0 and 3.1) at 3 different concentration levels; low, medium and
high (7.1, 71.4 and 357.1 ng mL-1). Selection criteria included analyte selectivity, elimination of
matrix interfences and analyte recovery. Recovery studies for individual PAs and PANOs were
quantified against their corresponding calibration curves followed by an assessment of matrix
clean-up performance. Table 3.2 summarises the SPE cartridges selected for this comparison
study.
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No.
1.

Supplier

Brand

Phenomenex Inc. Strata-X-C

Sorbent Type
TM

Cation mixedmode polymeric

Size

Moiety

Method

60 mg bed;
3 mL volume

Sulfonic acid-modified
divinylbenzene polymer

As per Figure 3.1

O
H+
S

-

O

O

2.

Agilent
Technologies

Bond Elut
Plexa PCX

Cation mixedmode polymeric

30 mg bed;
3 mL volume

Functionalised hydrophilic
styrene divinylbenzene
CH

R

3.

4.

5.

Agilent
Technologies

Waters

SampliQ
SCX

Cation mixedmode polymeric

Oasis HLB
Polymeric
(hydrophobic- reverse phase
lipophilicbalanced)
Phenomenex Inc. Strata-XTM
Polymeric
reverse phase

CH2

CH

C ross link ed

Condition: 2 mL methanol
Equilibrate: 2 mL deionised water
Load: 2.5 mL aliquot and dry for 1 minute
Wash (1): 2 mL 0.1% formic acid in water
Wash (2):2 mL methanol
Elute: 9 mL 3% ammoniated methanol

60 mg bed;
3 mL volume

Sulfonic acid-modified
divinylbenzene polymer

As detailed in No.2 above

200 mg bed;
3 mL volume

As detailed in No.1 above
Hydrophilic N-vinylpyrrolidone
and lipophilic divinylbenzene

As detailed in No.2 above

200 mg bed;
3 mL volume

Neutral polar functionalized
styrene-divinylbenzene
O

N

Table 3.2: Summary of SPE cartridges tested during a comparison study for sample clean-up optimisation.

Condition: 2 mL methanol
Equilibrate: 2 mL deionised water
Load: 2.5 mL aliquot and dry for 1 minute
Wash (1): 2 mL 90:10v/v 0.1% formic acid
in water/methanol, Wash (2): 2 mL methanol
Elute: 9 mL 3% ammoniated methanol

3.2.2

Results and Discussion of SPE Comparison

Mroczek et al. (2002) were the first to report on the use of SCX-SPE (Merck LiChrolut SCX)
filled with polymeric sorbent to analyse both N-oxides and free bases of PAs. N-oxides are
retained on the cation-exchange materials by binding to the active sites of the sorbent rather than
a cation-exchange process (Crews et al., 2010). It was determined that SCX was superior to C18
sorbents which allowed the elution of co-extracted materials (Mroczek et al., 2002).

Polymeric cation-exchange sorbent (such as Strata-X-CTM from Phenomenex Inc. or SampliQ
from Agilent Technologies) consists of a styrene-divinylbenzene backbone and carries a sulfonic
acid functionality as well as other polar moieties capable of hydrogen bonding and dipolar
interactions. Due to these structural features, these sorbents were expected to furnish cleaner
extracts from a complex matrix such as honey which is a mixture of neutral, acidic and basic
components (Blasco et al., 2011).

The mixed-mode cation-exchange resin provides better

hydrophobic and polar retention characteristics compared to a neutral polymer with the same
backbone structure, such as the Strata-XTM. The authors Huq, Dixon, Kelly and Kallury (2005)
described that the greater hydrophobic retention of the Strata-X-CTM sorbent was due to the
electron withdrawing nature of the sulfonic acid group, inducing more electron polarisation due
to the aromatic ring.

All results were obtained using the same LC-MS conditions. In brief these were; LC-(+)ESIQqQ-MS using a Phenomenex Kinetex PFP (150 x 2.1 mm, 2.6 µm) analytical column with a
gradient mobile phase consisting of (A) 0.05% formic acid in water with 5% acetonitrile and (B)
100% acetonitrile, at a flow rate of 0.2 mL min-1. The analytical column was maintained at 35oC
and the sample injection volume was 10 µL. All samples were tested in triplicate.
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Table 3.3 summarises the results obtained for all PA and PANO analytes for the five SPE
cartridges tested showing the percentage recovery obtained for the triplicate injection of the
medium concentration level, 71.4 ng mL-1.

Strata XC
*

Analyte

Crotaline
Crotaline N-oxide
Echimidine
Heliotrine
Lycopsamine
Otosenine
Retrorsine
Retrorsine N-oxide
Senecionine
Senecionine N-oxide
Seneciphylline
Seneciphylline N-oxide
Senkirkine
Trichodesmine

%

Bond Elut

SD

%

SD

SampliQ
%

HLB

SD

%

Strata X

SD

%

SD

109

20

145

23

90

14

ND

ND

ND

ND

94

8

85

15

ND

ND

ND

ND

ND

ND

107

3

101

16

97

19

89

13

101

19

101

5

95

19

86

9

90

17

91

6

83

6

107

20

122

25

83

5

76

8

110

11

93

13

101

6

120

18

127

20

100

6

104

23

90

10

ND

ND

97

12

97

16

112

16

ND

ND

ND

ND

ND

ND

120

4

122

22

110

13

90

8

98

8

109

18

104

17

ND

ND

ND

ND

ND

ND

100

5

86

21

110

13

ND

ND

ND

ND

94

15

87

20

ND

ND

ND

ND

ND

ND

101

8

93

8

83

9

68

8

104

22

86
5
108
22
* note all results obtained under the same LC-MS conditions
% = % recovery based on triplicate injections
SD = standard deviation
ND = not detected

115

13

ND

ND

131

24

Table 3.3: Summary of results from the SPE comparison study for the analysis of PAs and
PANOs at the concentration level of 71.4 ng mL-1.
From the results the best performance was obtained on the Phenomenex Strata-X-CTM (mean
recovery of 101% ±9 SD) and the Agilent Bond Elut Plexa PCX (mean recovery of 103% ±18
SD). However, the Strata-X-CTM was chosen as both the percentage recovery and standard
deviation range were narrower and more consistent. Figure 3.2 illustrates the TICs for the SPE
test cartridges obtained at the 71.4 ng mL-1 concentration. As is clear from the chromatograms
shown, the Strata-X-CTM provides superior clean-up and recovery over the other test SPE
cartridges.
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Figure 3.2: TICs for the SPE test cartridges obtained at the 71.4 ng mL-1 concentration.

The final developed and optimised method of acidic extraction for honey samples followed by
SCX-SPE clean-up using the Phenomenex Strata-X-CTM cartridge is given in Figure 3.3. The
estimated time for sample preparation (n = 20) based upon (i) using a 20-sample SPE manifold,
(ii) optional adjustment to an accurate 10 mL using a volumetric flask, and (iii) centrifuge and
turbovap of appropriate capacity is 1 hour per 20 samples. This is a significant time saving over
previously published methods (Dübecke, Beckh and Lüllmann, 2011; Kempf, Beuerle,
Bühringer, Denner, Trost, von der Ohe, Bhavanam and Schreier, 2008; Betteridge et al., 2005
and Beales et al., 2004).
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Honey Sample Preparation/Extraction
Honey homogenised (40 oC)

Solid Phase Extraction/Clean-up
Strata-X-CTM
60 mg/3 mL cartridge

4.0 g (±0.1 g) honey + 6.0 mL
0.05M sulphuric acid in 15 mL
centrifuge tube

Condition:
2 mL methanol

Vortex 1 min

Centrifuge 6,000 rpm (3,421 g) 10 min

Equilibrate:
2 mL deionised water

Transfer 10 mL volumetric flask
(adjust to mark with 0.05M
sulphuric acid, if necessary)

Load:
2.5 mL of sample

Wash (1):
2 mL 0.1% aq. formic acid

Wash (2):
2 mL methanol

Elute:
9mL 3% ammoniated methanol

Dry under N2 in Turbovap (45 oC)

Reconstitute in 1.0 mL methanol and
syringe filter (0.22 µm) to LC vial

Figure 3.3: Flow diagram for the sample preparation of honeys (extraction followed by SCXSPE on Strata-X-CTM).
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3.2.3

Modified QuEChERS

Since it was first introduced in 2003 QuEChERS (Quick Easy Cheap Effective Rugged and Safe)
has grown in popularity and has proven its use in multi-class, multi-residue analysis of pesticides.
The two step extraction technique is based upon salting out extraction followed by clean-up using
dispersive SPE (dSPE). Salting out historically involved sodium chloride (NaCl) but this can
hinder the recovery of base-sensitive compounds such as PAs. Therefore, the developed method
used for the detection of PAs in milk and cheese samples is based upon the AOAC (American
Association of Analytical Chemists) 2007.01 method which employs an acetic acid/sodium
acetate buffer instead of NaCl. After extraction in acetonitrile the extract is cleaned using dSPE
with primary-secondary amine (PSA) and graphitized carbon (C) to clarify the extract.
Dispersive SPE aims to retain matrix/undesired components whilst allowing the analyte of
interest to remain in the liquid phase, an opposite mode of action to SPE.

QuEChERS was applied to milk and cheese extracts for PA analysis as it had been used
previously by a collaborating laboratory for the testing of anthelmintics in such matrices
(Kinsella et al., 2009; Whelan et al., 2010).

Prior to extraction the sample should be

homogenised; milk by manually shaking and cheese by thoroughly mixing with water. Water is
a necessary component for partitioning to occur.

Acetonitrile is recommended for use in

QuEChERS over other solvents, such as acetone and ethyl acetate, due to its high polarity and
tendency for separation on the addition of salts. When salts are added it is advisable that the
extraction tubes are shaken by hand immediately to avoid clumping. For clean-up of high fat
matrices, such as cheese, PSA is recommended. These considerations were undertaken when
developing a QuEChERS procedure as outlined in Figure 6.1 and discussed for its application in
Chapter 6.
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3.3

Method Optimisation

3.3.1 Liquid Chromatography

Mobile phase
The pka range for PAs is approximately 5 to 7 (senkirkine 6.65, senecionine 5.44, seneciphylline
5.44, and retrorsine 5.37) with protonation occurring at a pH below their pka values. Therefore,
an acidic aqueous mobile phase was chosen (pH 3.0). PAs are basic compounds and as such an
acidic mobile phase will protonate silanols on the surface of the stationary phase preventing ionexchange interactions between the positively charged basic compounds and negatively charged
silanols. This should also reduce peak tailing which can occur from ion-exchange interactions.
The mobile phase generally consisted of (A) 0.05% formic acid in water and (B) 100%
acetonitrile. However, in later analysis the composition of mobile phase (A) was changed to 95:5
v/v 0.05% formic acid in water/acetonitrile to prevent the possibility of microbial growth in the
aqueous phase. Formic acid was chosen over (i) trifluoroacetic acid (TFA) as this was shown to
suppress the signal response and (ii) acetic acid as this led to poor peak shape. All mobile phases
were adequately degassed, filtered (0.45 µm) and equilibrated to room temperature before use.

LC Column(s)
In the early stages of method development it was noted that a selection of C18 and C18 polar
endcapped analytical columns, similar to those used in previously published articles on PAs (see
Chapter 4 publications for tables summarising previously used methods) such as Phenomenex
Aqua C18 and Waters XBridgeTM, afforded poor elution in that the analytes eluted too early,
eluted together with little resolution or had poor peak shape. It was therefore decided to trial a
Thermo Scientific™ Hypersil GOLD™ aQ polar endcapped C18 column which was new to the
market and promoted as providing excellent peak shape for polar basic compounds, such as PAs,
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by controlling secondary interactions and having stability in 100% aqueous mobile phases.
Figure 3.4 displays a comparison in the chromatography obtained for the PA crotaline (m/z 326,
71.4 ng mL-1) with a Phenomenex Aqua C18 column versus the Thermo Scientific™ Hypersil
GOLD™ aQ column under the same LC conditions with the column maintained at 30oC and a
binary gradient separation performed using a flow rate of 0.2 mL min-1. The mobile phase
consisted of 0.05% formic acid in water (A) and 100% acetonitrile (B) with a gradient elution of
0–2 min 20% B and 2–15 min with a linear increase in B from 20-50%, and the injection volume
was 10 µL.

Figure 3.4: Comparison in the chromatography obtained for the PA crotaline (m/z 326) with a
Phenomenex Aqua C18 column versus the Thermo Scientific™ Hypersil GOLD™ aQ column
under the same LC conditions.
The Thermo Scientific™ Hypersil GOLD™ aQ column was selected for the initial investigation
into PAs in commercial honey with the outcome of this experimental work being published in
Griffin et al. (2013). After this publication it was decided to expand the investigation into
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commercial honey as PA-positive samples had been detected. It should be noted that initial
investigation and development work was performed blind, i.e. no PA-positive sample was
available, rather it was assumed that PA-positive samples existed on the marketplace based upon
earlier publications (Beales et al., 2004; Betteridge et al., 2005 and Kempf et al., 2008). In the
initial investigation of fifty commercial honeys, 16% (n = 8) were positive for the PAs included
within the study.

Although the Thermo Scientific™ Hypersil GOLD™ aQ column performed well in the study it
was found to degrade relatively quickly, approximately 300 sample injections (not including
calibrants, blanks and/or injections in methanol). The degradation can be seen in Figure 3.5.
This is in comparison to the Phenomenex Kinetex PFP which performed in excess of 700
samples injections before seeing equivalent degradation.

Thus in an effort to improve

chromatographic performance a study of a selection of analytical columns deemed appropriate
(based on the chemistry of PAs) for the analysis was undertaken. A list of these columns is
provided in Table 3.4.

Since core-shell columns were increasing in popularity these were

included within the study. All columns were newly purchased and dedicated solely to PA
research work.

An evolutionary event in HPLC technology was the commercialisation of a new generation
HPLC column packed with superficially porous particles also known as core–shell (Yang,
McCabe and Pursch, 2011).

Core-shell columns offer higher efficiency particles allowing

reduced run times while still maintaining or improving chromatographic resolution. Core-shell
particles maximise the performance of the column without generating excessive back pressures.
They consist of an impermeable inner core surrounded by a layer of fully-porous silica.
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The superficially porous particles have been reported to offer comparable separation efficiency to
that of columns packed with sub-2-mm totally porous particles (Yang et al., 2011).
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Figure 3.5: Column degradation seen in the Thermo Scientific™ Hypersil GOLD™ aQ after
approximately 300 samples injections (honeys).

Supplier

Column

Particles

Dimensions

Part Number

Phenomenex Inc.

Kinetex PFP

Core-shell

150 x 2.1 mm, 2.6 µm

00F-4477-AN

Agilent Technologies

Poroshell SB-C18

Poroshell

100 x 2.1 mm, 2.7 µm

685775-902

Thermo Scientific

Accucore PFP

Solid core

100 x 2.1 mm, 2.6 µm

17426-102130

Thermo Scientific

Accucore aQ C18

Solid core

150 x 2.1 mm, 2.6 µm

17326-152130

Supelco

Ascentis Express

Fused-core

100 x 2.1 mm, 2.7 µm

53569-U

Halo C18

Fused-core

150 x 2.1 mm, 3.0 µm

92812-702

ACE 3-C18

Inert high

150 x 2.1 mm, 3.0 µm

ACE-111-1502

100 x 2.1 mm, 3.0 µm

5020-07414

150 x 2.0 mm, 3.0 µm

G803031

F5
Advanced Materials
Tech. Ltd.
Advanced Chromatography
Tech. (ACE) Ltd.
GL Sciences

purity silica
InertSustain C18

Evolved
surface silica

Shodex

*

ODP2 HP-2D

Polymer resin

* hydrophilic polyhydroxymethacrylate gel of totally porous spherical resin

Table 3.4: List of analytical columns included in the PA column selection study.
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The benefits of these column particles in reducing the mass transfer term and narrowing the
particle size distribution have been observed for small molecule separations but have not been as
successful with larger molecules (Gritti and Guiochon, 2007). All the selected columns were
primed for use according to manufacturer’s instructions and equilibrated for 20 void volumes of
the column with the starting mobile phase before use. All columns were subjected to similar
conditions as follows;

o Instrument: Accela LC system hyphenated to a triple quadrupole (QqQ) TSQ Quantum
Discovery Max mass spectrometer.
o LC conditions: Mobile phase composed of (A) 0.05% formic acid in water with 5%
acetonitrile and (B) 100% acetonitrile, at a flow rate of 0.2 ml min-1 under optimised gradient
elution. The column compartment was maintained at 35°C (± 1°C).
o MS Parameters: The HESI was operated in positive mode with a spray voltage of 3600 V,
vaporiser temperature of 80°C and an auxiliary gas (nitrogen) flow rate set to 30 arbitrary
units. A sheath gas of nitrogen was used to dry the excess solvent at 35 arbitrary units. The
capillary temperature was maintained at 250°C. Argon was used as the collision gas at 1.5
mTorr. Parameters including collision energies and tube lens voltage were optimised for all
compounds using an automated tuning function and this tune file was saved and applied to
the method.
o Data acquisition: This was performed using the “EZ method” in SRM mode.
o Sample: PA and PANO mixture at 71.4 ng mL-1 prepared in blank honey extract. A 10 µL
volume was injected from the autosampler.

Table 3.5 summarises the results obtained from the column study.

The better performing

columns were core-shell and generally PFP columns, such as the Phenomenex Kinetex, Thermo
Accucore and Supelco Ascentis Express.
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Supplier
Phenomenex Inc.

Column
Kinetex PFP

Particles
Core-shell

Description of results obtained
Sharp peaks for all analytes, low baseline noise
giving high S/N ratio.

Agilent Technologies

Poroshell

Poroshell

SB-C18

Poor peak shape for some analytes (heliotrine,
seneciphylline,

senecionine,

senkirkine

and

echimidine), broad and unsymmetrical.
Thermo Scientific

Accucore PFP

Solid core

Good peak shape for all analytes, relatively sharp,
and high S/N ratio.

Thermo Scientific

Accucore

Solid core

aQ C18

Peak shape on most analytes good (broad peaks,
>1min at base, for senecionine, senkirkine and
echimidine). S/N is relatively low in comparison to
PFP columns.

Supelco

Ascentis

Fused-core

Express F5
Advanced Materials

Halo C18

and high S/N ratio
Fused-core

Tech. Ltd.
Advanced Chromatography

Poor peak shape on all analytes, broad (>1min at
base) and unsymmetrical

ACE 3-C18

Silica

Tech. (ACE) Ltd.
GL Sciences

Good peak shape for all analytes, relatively sharp,

Relatively good peak shape but poor S/N ratio in
comparison to other columns tested

InertSustain

Silica

C18

Poor peak shape on the majority of analytes, in
particular later eluting (seneciphylline, senecionine
and their N-oxides, senkirkine and echimidine) and
low S/N ratio

Shodex

*

ODP2 HP-2D

Polymer

Broad analyte peaks (>1min at base) and low S/N
ratio

* hydrophilic polyhydroxymethacrylate gel of totally porous spherical resin

Table 3.5: Summary of results obtained from the column study for the analysis of PAs.

The PFP column, a pentafluorophenyl stationary phase, contains a stable reversed phase packing
with electron-deficient phenyl rings due to the presence of electronegative fluorines. Interactions
form from pi-pi bonds, mild steric and polar interactions which all provide superior retention for
PAs (basic polar compounds). The MS signal for PAs and PANOs was a factor of 7 times
greater on the PFP phase than on C18 or aQ C18 or polar endcapped phases. Similar findings have
been previously reported for tropane alkaloids, in particular benzoylmethylecgonine (cocaine)
and its metabolites (Needham, Jeanville, Brown and Estape, 2000). Figure 3.6 displays the TICs
obtained for the three PFP phase columns included in this study.
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Figure 3.6: Comparison of TICs from all PFP columns included in the column
selection study for the analysis of PAs and PANOs.
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All three columns, as per Figure 3.6, provided excellent chromatographic results.

The

Phenomenex Kinetex PFP column was chosen due to higher sensitivity, resolution and signal-tonoise (S/N) ratio for all PA and PANO analytes. Although stability/robustness was tested
(between 50 to 100 injections per test column) it was not done extensively with all columns listed
in Table 3.5. However, as previously stated the Phenomenex Kinetex PFP column offered over
700 sample injections before noticeable column degradation in comparison to 300 sample
injections with the Thermo ScientificTM Hypersil GOLDTM aQ (as per Figure 3.5). The C18
columns did not provide the same chromatographic efficiency as the PFP.

Figure 3.7 (a)

illustrates the chromatography acquired using the Agilent Poroshell SB-C18 and the broad
fronting peaks obtained for some PA analytes such as (b) echimidine.
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Figure 3.7: (a) TIC obtained for PA analytes such the Agilent Poroshell SB-C18 column and (b)
the broad fronting chromatographic peak for the PA echimidine (m/z 398) on the same analytical
column.
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Also, since the completion of this research work a publication by Mathon et al. (2014) stated that
the Phenomenex Kinetex PFP column was the only column in their investigation work on PAs to
give baseline resolution versus C18, polar and phenyl-hexyl stationary phase columns.

3.3.2 Mass Spectrometry

Data Acquisition
Data was acquired by the relevant data acquisition software, Xcalibur™ (Thermo Scientific) and
DataAnalysis™ and LibraryEditor™ software (Bruker Daltonik GmbH). The features of the
acquired data are governed by the acquisition parameters and the scan(s) function. Briefly,
acquisition parameters would deal with the following attributes: the mass-to-charge range
scanned, scan cycle repetition rate, and the decision whether to acquire pre-processed
(centroided) data or unprocessed (profile) data. The unprocessed data acquisition collects a
signal over several scans and can therefore generate excessively large data files. Thus, the
centroid data acquisition is more frequently used. The scan function defines whether the mass
spectrometer scans and acquires a range of masses, or monitors one or more masses. The former
yields full scan data comprising complete mass spectra, the latter selected or targeted ion data.

Considerations for quantitative measurements
The processes that take place in a mass spectrometer ion source are complex. The response to a
sample at the detector depends on several parameters that need control. It is often advantageous
to introduce a similar species, present at a constant (and similar to the target range) concentration
as an ‘internal standard’ or a stable labelled analogue of the target compound. Although an
internal standard and/or deuterated standard were sought none were commercially available.
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Qualification check
It is not only scientifically prudent but also necessary to be able to demonstrate that a mass
spectrometer is qualitatively and quantitatively accurate before producing quality critical data.
This was achieved by running a control sample before acquiring analytical data.

Instrument calibration
Calibration was performed on a monthly or bimonthly basis to set the electron multiplier gain (a
limiting factor for sensitivity as this detects the ion signals from the mass analyser), calibrating
mass, resolution (in both positive and negative mode) and system tube lenses to achieve optimum
mass spectral performance. Calibrations were carried out in accordance with manufacturers’
guidelines and using a calibration solution, e.g. polytyrosine.

Sample ionisation, the ion source, tuning and optimisation
Instrument tuning is a combination of the optimisation of the conversion of the liquid phase
analyte to its characteristic gas phase ions in the mass spectrometer inlet, the optimisation of ion
transmission efficiency through the instrument, and the optimisation of peak shape.

3.3.2.1 QqQ MS Tuning (Thermo Scientific TSQ Quantum Discovery Max)
Firstly, the default parameters for the HESI probe were used as a starting point for tuning the PA
and PANO analytes. A mixture of the reference compounds was prepared in methanol. All
tuning and optimisation was performed by infusion with a T-junction to the mobile phase flow.
This set up is explained further in Figure 3.19.
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1. Source Parameters
• [1] Probe position/housing

2. Ion Optics
• [6] Tube lens Voltages

(default setting of 1 µm and

(both optimised through the

vertical position ‘C’)

automatic function)

• [2] Capillary temperature
(ramped from 200 to 350o

3. MS2 Parameters
• [7] Collision pressure (set at
default 1.5 mTorr)
• [8] Collision energy (optimised
by ramping 20 to 60 V with 8
increments)

C)

• [9] Resolution (default setting

• [3] Vaporisation temperature
o

of 0.7 FWHM)

(ramped from 0 to 150 C)

• [10] Scan Width (default

• [4] Sheath gas flow (ramped

setting of 0.002 m/z)

from 0 to 50 units)

• [11] Scan Time (optimised

• [5] Auxiliary gas flow (ramped

using EZ method)

from 0 to 50 units)

Figure 3.8: MS parameters for tuning and optimisation.

Figure 3.9: Optimised source parameters for the QqQ-MS method.

Optimised source parameters are displayed in the provided screenshot, Figure 3.9. Secondly, the
optics are optimised, this includes the tube lens. The tube lens restricts the expansion of the ion
beam as it exits the ion transfer tube. A graphical view of this optimisation is shown below in
Figure 3.10 for the PA senecionine (m/z 336).
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Optimizing Tube Lens for Q1MS
4 % Improvement

Previous Setting = 94.78
New Setting = 112.62
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Figure 3.10: Tube lens optimisation for the PA senecionine (m/z 336).

Lastly, the MS2 parameters for the method were optimised including collision energy. MS/MS
spectra that employ CID vary with collision energy, generally expressed in units of eV (or volts).
A charged ion is accelerated to a kinetic energy by applying a potential difference producing a
MS/MS spectrum. For all PAs and PANOs the collision energy was optimised over a range of 20
to 60 volts, ramping upwards over eight steps with the four most intense product ions being
recorded. Figure 3.11 illustrates the plot obtained for the optimisation of collision energy for the
PA senecionine. Appendix A displays plots for all PAs and PANOs.
Breakdown Curve of Ion 336.0 m/z
Intensity: 7.08e+05
Pressure: 1.5 mTorr
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34 v

RelativeIntensity

80

60

40

20

0
5

20

35
50
Collision Energy (V)

65

80

Figure 3.11: Collision energy optimisation for the PA senecionine (m/z 336).
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Resolution and scan width were then optimised. The scan width selected should be as small as
possible. The QqQ-MS method developed used the Thermo ‘EZ’ method which is favoured for
SRM analysis. The scan width is set to a default of 0.002 m/z meaning that the MS will scan
between M-0.001 and M+0.001 and centred on the mass of interest, thus it is important not to
enter nominal masses but analyte masses correct to two decimals. The resolution is also set to a
default of 0.7 FWHM (full width at half maximum). In SRM mode the scan time represents the
time taken for the MS to scan each transition inputted into the method. The scan time should be
adjusted so that chromatographic peak will be correctly sampled and have a sufficient number of
data points across the peak (minimum required; 15). Background noise and thus signal to noise
ratio can be improved with an increased scan time however care must be taken to allow the dwell
time to sufficiently gather enough data points across the chromatographic peak.

In the EZ method a constant cycle time can be chosen to equally space data points across all
peaks. The MS adjusts the scan time to be equal to the cycle time and divided by the number of
SRM transitions inputted into the method. For example, a MS acquisition time of 12 minutes
with a total of 45 transitions would equal a cycle time of approximately 0.3 seconds. Figure 3.12
displays a screenshot of the EZ method setup. Retention time windows were used to segment the
MS acquisition so that SRM scan records for each target analyte within the time zone of known
retention, thus improving method sensitivity. To further improve the robustness of the method a
divert valve was utilised to eliminate unwanted contaminants from entering the MS. The first 2
minutes (for gradient elution, or 1 minute for isocratic elution) of the elution and the column
wash during equilibration was diverted to waste which was particularly useful for complex food
matrices such as honey, herbal products and dairy samples.
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Figure 3.12: EZ method for the analysis of PAs and PANOs.

3.3.2.2 IT-MS Tuning (Agilent 6300 Ion Trap)
Similar optimisation was performed for the IT-MS method. However, the source parameters on
the Agilent 6300 IT-MS did not require as much tuning as those on the TSQ Quantum. The
default parameters used for a flow rate of 0.2 mL min-1 were; positive ESI mode with nebuliser
pressure at 20 psi and drying gas (nitrogen) at 10 L min-1, and capillary temperature of 350ºC.
MS conditions were optimised using the SmartFrag collision energy ramping tool which uses
collision-induced dissociation (CID) voltage ramping over a range of energies (30–200% of the
amplitude) to ensure the precursor ion receives the necessary energy for maximum fragmentation
with minimal ion loss from the trap. It eliminates time-consuming manual CID voltage
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optimisation. The fragmentation amplitude ranged from 0.5 to 1.2 V (Table 1 in Griffin et al.,
2013).

To ensure a minimum of 15 data points acquired per chromatographic peak and

reproducible integration for quantitative analysis time segments were used at 6.5 and 11.5 min
(Figure 3 in Griffin et al., 2013).

Figure 3.13: Illustration of the Agilent IT-MS software interface.

3.3.3

Matrix Study

Matrix effects and adduct formation can be a major cause for concern if they comprise or even
invalidate both qualitative and quantitative results.

Matrix effect is defined as the ion

suppression or enhancement of the ionisation of analytes, which is evaluated by comparing the
corresponding peak areas from a spiked extract with that of the standard prepared in solvent.
Also, the influence of mobile phase composition on ionisation efficiency in MS is recognised and
mobile phase additives can have an impact on matrix induced ion suppression/enhancement of an
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analyte (Lambert, 2004). “If ion suppression is not assessed and corrected in an analytical
method, the sensitivity of the LC–MS method can be seriously undermined, and it is possible that
the target analyte may be undetected even when using very sensitive instrumentation” (Furey et
al., 2013).

Post-column infusion experiments were conducted to determine ion suppression/enhancement
effects.

This approach is similar to that described by Allis, Dauphard, Hamilton, Ni

Shuilleabhain, Lehane, James and Furey (2007).

The experimental setup used in these

experiments involved the infusion of standard mixture into a blank matrix solution. A T-junction
was placed between the LC system and the MS source, and the standard mixture was monitored
by MRM while being introduced at a flow of 10.0 µL min-1 into the LC eluent. The standard
mixture (71.4 ng mL-1) was placed in a 1.0 mL glass gastight syringe (Hamilton) and delivered
with a syringe pump. A blank matrix sample (subjected to acidic extraction and SPE clean-up)
was injected (10 µL) via the autosampler into the LC system. The response of the standard
mixture was monitored continuously to produce a profile of the matrix effect. This was repeated
several times (n = 3) to ensure the effect was reproducible. All blank sample matrices (honey,
milk, cheese, teas and TCMs) were tested in the same manner.

Figure 3.19 provides an

illustration of the post-column infusion setup.

Matrix-matched calibration curves were also studied for ion suppression or enhancement effects.
These experiments were preformed on all food matrices tested and over five concentration levels
(3.6, 7.1, 35.7, 57.1 and 71.4 ng ml-1) for each PA and PANO. The possible matrix effects are
investigated by comparison of the response of peak areas of the individual analytes between the
blank spiked extract and the reference standard prepared in solvent (such as HPLC grade
methanol). Example illustrations of matrix studies for ion suppression/enhancement are given in
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Chapter 4 (Figure 2 of the article submitted to Food Additives and Contaminants, October 2014),
Chapter 5 (Griffin et al., 2014a) and Chapter 6 (Figures 6.4, 6.5 and 6.6).

3.3.4

Data Processing

The identity of the PA and PANO analytes were confirmed when the criteria for ion ratio (±20%)
and retention time (±0.2 min) were met in comparison to the positive control samples. Hence,
for a deviation in the ion ratio the value must be less than 20% and for retention time the value
should be less than 2.5%. The ion ratio was calculated as follows:
Ion ratio (%) = A (lowest intensity ion) x 100
B (highest intensity ion)

For the Thermo Scientific instruments data is acquired and processed using Xcalibur software.

Figure 3.14: Xcalibur™ Software “Road map” homepage.
In the “Qual Browser” function of Xcalibur™ many tools are available to the user to review
acquired data, manipulate chromatograms and/or spectra, perform integration, activate library
searches and produce reports. Figure 3.15 is a screenshot of Qual Browser with the first data cell
illustrating a chromatogram for a PA and PANO reference standard mixture and the second cell
displaying the transitions for the lycopsamine peak at the retention time of 3.15 minutes.
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Figure 3.15: XcaliburTM Software “Qual Browser”.
Automated processing can be performed using the “Quan Browser” function. After a trial
injection a processing method is optimised by selecting the “Processing Setup” icon from the
“Road map” homepage. This processing method is selected when setting a new sequence or can
be retrospectively applied to a previously obtained sequence. The data files are then viewed
using this processing method in the “Quan Browser” field.

Figure 3.16: a screenshot of the “Quan Browser” function.
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3.3.5

Spectral Library

A fully automated processing method was created for analysis performed on the Agilent 6300
series IT-MS. In liquid chromatography, absolute retention times or retention times relative to a
standard can be used to qualify chromatographic peaks for integration and quantification. To
further aid identification, a spectral library may be created.

The data system acquires the

chromatogram and spectral data of the chromatographic peaks in question. These peaks are
compared with those stored in a user-created library. A spectral library was built for all PA and
PANO analytes included in this research work. This was performed by acquiring LC-MS data of
both the solvent (methanol) and matrix prepared analytes over a linear range.

The program lists the match factor, reversed search match factor, probability, and names of the
compounds in the library most resembling your unknown spectrum. The number is calculated
using the dot product mass spectral search NIST algorithm, which is equal to the cosine of the
angle between the unknown and the library spectral vectors.

Mass peaks are scaled using the

square root of their abundance. Scores for Fit (F), Reserve Fit (R), Purity (P) and Match Factor
(M) are generated. The fit correlates the number of spectral peaks and intensities between the
sample and library entry. The reverse fit demonstrates the uniformity between these peaks, thus
if the reverse fit score is low it signifies that there are too many interferences in the obtained
sample spectrum. The purity score is representative of an amalgamation between fit and reverse
fit. Incorporating the user pre-specified parameters allows for the match score to be returned
giving an overall effective score with a maximum of 1000. Thus, a positive sample will return a
match score ideally above 900, with 1000 indicating an exact correlation.
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Figure 3.17: Illustration of library matching performed on the Agilent 6300 series IT-MS.

Although the accurate set-up of a spectral library may be initially labour-intensive it can prove
extremely beneficial in the longterm. It is particularly useful when processing large sample
sequences where positives can be identified in a matter of minutes (Gomez-Romero et al., 2011).
They can become a powerful and valuable tool when used in combination for multi-analyte or
multi-toxin assays. For example, animal feed could be screened for mycotoxins, plant toxins
(including pyrrolizidine alkaloids) and environmental contaminants (including pesticides).
The application of the spectral library to PA-positive honey samples is discussed in Chapter 4
and in the associated publication Griffin et al. (2013).
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3.4

Method Development Considerations

Analyte &
Sample

Aim of
Method

•Understand both analyte and sample of interest
•Knowledge of the matrix: (i) what other compounds are present? (ii) what are the
potential interferences (iii) conduct matrix matched calibration and post-column
infusion studies
•Concentration and quantity: (i) concentration range (ii) possibility of finding a positive
sample (retail) (iii)is there more than one analyte?
•Chemical and physical properties of the analyte (pKa, MW, solubility, etc.)

•Purpose of the analysis: what is the end goal?
•(i) Detect, (ii) Identify (iii) Quantify and (iv) Profile
•Applicable to a range of sample matrices
•High through-put analysis or robust routine testing

How to
Achieve

•(i) Suitable detection technique
•(ii) Identification using a targeted approach employing certified reference standards,
fragmentation patterns and comparison with published literature
•(iii) Quantitation by external calibration, specificity, accuracy and precision
•(iv) Profile using a comprehensive method and development of a spectral library
•Conduct an extensive literature review

Analysis

•LC-MS methods provide advantages over GC-MS for detection of these analytes; no
derivatisation necessary, all analytes detected simultaneously (PAs and PANOs)
•Systematic screening protocol for selection of method parameters (mobile phase, pH,
additives, stationary phase, ionisation modes)
•Sample preparation: specificity, reproducibility, robustness, cost and ease for routine
analysis and applicable to a wide range of matrices

Validation

•Check overall performance requirements; accuracy, precision, reproducibility, linearity,
limits of detection and limits of quantitation
•Check method optimisation and robustness; determine the experimental factors that have
significant impact on the method
•Validate the method in accordance with ICH guidelines and EU directives

Figure 3.18: Considerations for method development.
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3.5

Analytical Method Validation

The process of validating an analytical method is to demonstrate that the method is suitable for
its intended purpose, i.e. to confirm through systematic evaluation that a method will consistently
produce accurate results when applied in different situations. To consistently produce accurate
results, an analytical method must be specific, linear, precise, sensitive, robust and possess good
recovery.

It is common practice to associate accuracy with recovery only; indicating the

deviation between the mean value and the true value. Typically accuracy is tested through
spiking at 80%, 100% and 120% of a determined level, i.e. an MRL.

Percentage recovery (%) = calculated concentration of analyte x 100
theoretical concentration of analyte

Throughout this research accuracy was determined for all PA and PANO analytes by spiked
controls (spiking reference compounds into the relevant blank matrix).

The precision of the analytical method is a measure of its reproducibility from sample
preparation through to detection (European Commission, 2002). Precision is expressed as the
relative standard deviation (RSD):

RSD (%) = standard deviation x 100
mean

Precision can be investigated at three levels; (i) repeatability within a sequence, (ii) intermediate
precision by using a different analyst or instrument and (iii) reproducibility by conducting
analysis in a different laboratory. All three levels of precision were used during this research
work.

Intra and interday variability was recorded, two mass analysers were utilised and

confirmatory analysis conducted by our collaborators at Teasgac Ashtown Food Research Centre.
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Linearity is determined by calculating the regression line by least mean squares method versus
the analyte concentration. The correlation coefficient is used as a measure of linear association
between the two variables, for LC this is peak area versus the analyte concentration. For all PA
and PANO calibration curves the regression line was not forced through the origin and a zero
analyte concentration point was not part of the data set. The correlation coefficient (R), slope of
the line, Y intercept and residual sum of squares were calculated and reported for each plot. The
correlation coefficient (R) acceptance criterion was set to > 0.99.

The range of the method is demonstrated as the range, upper and lower, of the analyte(s) that
has/have been determined by acceptable accuracy, precision and linearity (European
Commission, 2002). The range for the LC-MS analysis of ten PAs and four PANOs was 5.7 to
357.1 µg kg-1.

The limit of detection (LOD) is the lowest concentration or amount of analyte in a sample that
can be detected but not necessarily accurately or precisely quantified under the method
conditions. The limit of quantification (LOQ) is the lowest concentration or amount of analyte in
a sample that can be determined with acceptable precision and accuracy under the method
conditions (European Commission, 2002). LOD and LOQ were determined experimentally for
all PAs and PANOs as 3 times and 10 times the signal to noise (S/N) ratio, respectively.

Robustness was investigated and built into the method on development. Robustness illustrates
the reliability of an analysis with respect to deliberate variations in method parameters. A control
sample (a blank sample extract which was spiked with all PA and PANO analytes at a known
concentration) was analysed on each variation to ensure that the validity of the analytical
procedure was maintained. The following variations were investigated;
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Sample and standard solution stability at room temperature over a period of 3 days. All
standards in methanol were stable over this period when protected from light, heat and stored
in a sealed container. Honey, tea and herbal samples were stable over 24 hours whilst dairy
samples of milk and cheese were maintained at 4oC.



Changes to the pH of mobile phase aqueous content (0.05% formic acid in water) was
investigated over a range ±0.2 units with no variations detected in results obtained.



Changes to the organic content of mobile phase composition (A) when prepared as 95:5 v/v
0.05% formic acid in water/acetonitrile. No variations were detected over a range of ±10%
for both formic acid of 0.045 to 0.055% and organic content of 45 to 55 mL acetonitrile per
litre.



Changes to column lots; this was investigated for the analytical column Phenomenex Kinetex
PFP, 150 × 2.1 mm (2.6 μm particle size), with no variations detected.



Changes to column temperature; the column compartment was maintained at 35oC ±1oC.



Changes to flow rate; the flow rate was maintained at 0.2 mL min-1 for MS detection.

A system suitability check was not run as part of this method validation and as such resolution,
tailing or capacity factor were not measured.

However, the use of control and retention

check/marker solutions prepared from PA and PANO reference standards were incorporated into
the validated methods.

Selectivity, the ability to measure accurately the analyte in the presence of sample matrix, was
determined by individual matrix-matched calibration curves for all PAs and PANOs. Specificity,
ensuring the signal measured relates to the analyte(s) of interest without interference from
impurities (European Commission, 2002), was upheld by direct comparison to individual
reference standards analysed during the same chromatographic sequence.
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It is recognised that the highest level of uncertainty in LC-MS methods come from sample matrix
interferences. Infusion experiments were conducted which involved the continuous introduction
of PA and PANO standard solution by means of a syringe pump connected to the eluent flow
from the analytical column. After injecting a blank sample extract into the LC system the MS
baseline is monitored for suppression or enhancement in ionisation of the analytes due to the
presence of matrix interferences.

Figure 3.19: Post-column infusion study set-up to investigate possible ion suppression or
enhancement effects.
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Chapter 4
Analysis of PAs in honey via LC-MS
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4.0

Analysis of PAs in Honey via LC-MS

This chapter is comprised of four separate but complimentary analytical investigations into the
detection, persistence and profiling of PAs and PANOs in honeys. These investigations are listed
below and are presented as published articles in peer-reviewed scientific journals (# 1, 2 and 4)
or prepared journal articles under review by co-authors (# 3).

1) Griffin CT, Danaher M, Elliott CT, Kennedy DG, and Furey A. (2013). Detection of
Pyrrolizidine Alkaloids in Commercial Honey using Liquid Chromatography-Ion Trap Mass
Spectrometry, Food Chemistry, 136 (3-4); 1577-83.
2) Griffin CT, O’Mahony J, Danaher M, and Furey A. (2014b).

Liquid Chromatography

Tandem Mass Spectrometry Detection of Targeted Pyrrolizidine Alkaloids in Honeys
purchased within Ireland, Food Analytical Methods, 8 (1); 18-31, doi 10.1007/s12161-0149855-1.
3) Griffin CT, Conroy ER, O’Mahony J, Gibney M, Danaher M, and Furey A. (2015). Dietary
exposure assessment of pyrrolizidine alkaloids in honey purchased in Ireland over a three
year period (under review by co-authors).
4) Griffin CT, Mitrovic S, Danaher M, and Furey A. (2015). Development of a fast isocratic
LC-MS/MS method for the high-throughput analysis of pyrrolizidine alkaloids in Australian
honey, Food Additives and Contaminants, Part A, doi 10.1080/ 19440049.2014.996789.

4.1

Aims and Objectives

The aim of this work was to;
-

develop a sensitive and robust analytical method for the detection of PAs and PANOs in
retail honeys (at the point of consumption, thereby having a direct impact upon the
consumer),
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-

provide a comprehensive validated method for all of the PAs and PANOs reference standards
commercially available at the time of analysis,

-

assess the risk of PA exposure to the Irish population (adults, teenagers and children) from
the consumption of honeys.

4.2

Background

When this work began in late 2008, previous retail studies on PAs in honey were limited in (i)
the number of studies available (n < 10), (ii) selection of only one type of honey, e.g. floral from
Echium genus (Betteridge et al., 2005) and (iii) the number of retail samples tested (maximum
216 by Kempf et al., 2008). The European Food Safety Authority (EFSA, 2007) released a
report on PA contamination of animal feed in 2007. In this report one of their final conclusions
was that more data was required to quantify PA-containing honey and to assess PA exposure to
humans.

Therefore this was the starting point for the experimental work developed and

presented herein.

The research lab did not have any in-house testing methods for these

compounds or matrices. The challenge was to develop a simple yet robust method which could
be applied not only to a difficult matrix such as honey but to other foodstuffs. The analytical
instrumentation available was LC coupled to either ion trap MS or QqQ-MS.

4.2.1

Initial Experimental Work (Griffin et al., 2013)

Method development and optimisation for this work is detailed in Chapter 3 (sample preparation
as per section 3.2.1, column selection in section 3.3.1, instrument operating parameters in section
3.3.2.2 and development of a spectral library given in 3.3.5). In brief, a simple acidic extraction
of honey samples (4 g) with sulphuric acid (0.05M) followed by clean-up on SCX-SPE
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(Phenomenex Strata-X-CTM 60 mg) was developed. LC-MS was conducted on an Agilent 1100
LC coupled to a 6340 series ion trap MS with analyte detection and separation performed by
using a C18 polar endcapped analytical column (Thermo ScientificTM Hypersil GOLDTM aQ) and
acidic mobile phase (pH 3.0). The full experimental details are given in the attached publication
(Griffin et al., 2013) under section 2 “Materials and methods”. The method was difficult to
optimise and previous publications utilising LC-MS provided little assistance in the way of
chromatographic details. Many publications were outdated (Deinzer et al., 1977; Culvenor et al.,
1981), did not present chromatograms and full experimental workings (Kempf et al., 2010b) or
quantify results against individual PA reference standards (Kempf et al., 2008). So, it was
important to develop a method which would include the most comprehensive suite of reference
PA compounds to date (11 teritary PAs). It was also uncertain if any PA-positive retail honeys
could be identified and found on sale within Ireland.

An ion trap mass spectrometer was employed for detection and to determine common mass
fragments or characteristic mass fragments for PA analytes (see section 1.7.4.4 and Figure 1.16).
Utilising the instrument software (Bruker Daltonik GmbH) PAs were tuned using the
“SmartFrag” tool where the collision-induced dissociation (CID) voltage is ramped over a range
of energies (30–200% of the amplitude) to ensure the precursor ion is fragmented with minimal
ion loss from the trap. This negated the need for manual tuning which can be very timeconsuming (as outlined in Chapter 3, section 3.3.2.2). For accurate quantitative analysis a
spectral library was developed which allowed for fast identification and detection of PA-positive
honeys.

This was performed by analysing all 11 PAs spiked in blank honey extract and

importing the MS2 and MS3 spectra to the LibraryEditor™ software. A peak width of m/z 0.5
and isolation width of m/z 1.0 was applied for all analytes. On analysis the sample spectra was
matched to the library spectra using a NIST algorithm (as outlined in Chapter 3, section 3.3.5 and
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Figure 3.17).

This allowed for fast and unequivocal identification of positive samples by

generating a match and purity factor.

From the study (n = 50) a number of PA-positive samples (n = 8; 16%) were detected. The PAconcentration range of positive samples was wide; 182 to 4078 µg kg-1. From the 8 positive
samples 6 originated from outside the EU and 2 were blends of EU and non-EU honeys. Positive
samples from outside the EU had PA concentrations ranging from 190 to 4078 µg kg-1 whilst
samples labelled as blends of both EU and non-EU honeys had a relatively lower PA
concentration range of 182–634 µg kg-1. These concentration ranges correlate with the earlier
work of Betteridge et al. (2005). Strikingly, the honey with the highest PA-concentration (4078
µg kg-1) detected here when compared with the honey found to have the highest PAconcentration (2850 µg kg-1) by Betteridge et al. (2005) was sourced from the same supplier (of
Australian origin). As a result of this work a larger retail survey was warranted to provide a
comprehensive profile for all retail honeys sold and consumed within Ireland.

4.2.2

Expanded Retail Study (Griffin et al., 2014b)

An expanded retail honey study (n = 150) was justified based upon PA levels previously detected
(as per study 1 above). The aim of this work was to provide further data on the prevalence of
PAs within honey. Detection using targeted LC-MS/MS in MRM mode was used to obtain
information on both the concentration range and PA-profile for retail honeys on sale in the Irish
marketplace. In comparison with previously published LC-MS methods, this validated method
quantified each target analyte by matching it to its own certified reference standard. This
provided more accuracy over previously published work where quantitation was determined by
using retronecine equivalents (Kempf et al., 2008; Kempf et al., 2010; Dübecke et al., 2011).
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Using equivalents can underestimate the concentration of PAs as otonecine-type results are not
accounted for (see Chapter 1, Figure 1.1 for structural PA types). Sample preparation was by a
simple acidic extraction followed by SCX-SPE clean-up.

This protocol is a modified and

improved method from those previously reported (Betteridge et al., 2005; Boppré et al., 2005)
with regards to time and cost. This method was the same as that employed within the initial
study (Griffin et al., 2013). However, the samples were not run in duplicate nor was the PA
crotaline used as an internal standard. Instead an external calibration approach was used and
detection was verified by ion ratios (± 20%) of two transitions. The LC-MS/MS was performed
on an Agilent Infinity 1290 LC coupled to a 6460 QqQ-MS. The software used dynamic MRM
(dMRM) which permits greater sensitivity and selectivity thus improving quantitation over
traditional time segments (such as that used with the LC-IT-MS method).

The results showed that out of 150 honeys 23% (n = 34) were positive for PAs and/or PANOs.
Table 5 of the enclosed publication (Griffin et al., 2014b) lists all 34 PA-positive honeys
detected. The PA-positive samples had a concentration range of 3 to 546 µg kg-1. The current
recommendations of EFSA (2011), the Committee on Toxicity (COT, 2008) and the German
Federal Institute of Risk Assessment (BfR, 2011) are for a person to not exceed an intake of
0.007 μg kg-1 bw day-1 of 1,2-unsaturated PAs. For an average adult of 70.8 kg (Walpole et al.,
2012), this equates to a maximum daily intake of 0.4956 μg PA/day.

Using the findings

presented in Table 5 of the publication, a consumption of 1 tablespoon (equivalent to 10 g of
honey) of samples 1 to 10 (68–546 μg kg−1) would exceed the maximum daily intake. Similiar to
the results in the initial study (Griffin et al., 2013) 80 % of PA-positives originated from
Australia/New Zealand.
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4.2.3

Retail Honeys Survey and Risk Assessment

A complete retail study (n = 369) was used to assess the dietary intake of PAs in the Irish
population from the consumption of honey. This work involved testing all 369 retail honeys (all
purchased within Ireland during the years 2009 to 2012) using the developed acidic extraction
and SCX-SPE clean-up protocol described in Chapter 3 of this thesis and outlined in Figure 3.3.
Analysis was conducted by LC-MS/MS in SRM mode using a Thermo Scientific TSQ Quantum
Discovery Max QqQ-MS (outlined in Chapter 3, section 3.3.2.1). Collaboration was initiated
with colleagues within the Safe and Healthy Foods research programme in University College
Dublin (UCD). A risk assessment was compiled using the PA-data from retail honeys (n = 369)
and dietary intake data from the Irish Universities Nutrition Alliance (IUNA) and analysed using
Creme modelling software.

From the total survey (n = 369) it was found that 24% of honeys on sale in Ireland contained PA
toxins above the LOD for the analytical methods employed (mean LOD 1.1 µg kg-1). Figure 4.0
illustrates the origin of the honeys tested from information obtained from the suppliers’ labels.

Figure 4.0: The origin of honeys tested (n = 369) from information obtained from the suppliers’
labels (blue indicates EU countries whilst orange the rest of the world).
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The mean PA concentration in positive honey was 81 µg kg-1. A PA profile was acquired from
these PA-positive samples. Lycopsamine (m/z 300) and echimidine (m/z 398) were the most
predominant PAs occurring in 92% and 44% of positive samples, respectively. This observation
was consistent over the four years of sampling. Figure 4.1 provides a breakdown in the PA
profile of positive honeys detected across the four years (2008 to 2012) of investigation. PANOs
were found to a far lesser concentration. This correlates with an observation by Betteridge et al.
(2005) that honey has “an innate capacity to naturally reduce N-oxides to their parent tertiary
bases”. The authors observed this finding when PA-free honey was fortified with PANOs
(reference standards used) and the subsequent levels of parent PAs were between 5 and 14 %.
Another group (Colegate et al., 2005) spiked a blank honey extract (one with no detectable levels
of PAs or PANOs) with an extract of Echium plantagineum which was determined to contain
95% PANOs and found a respective increase in the parent or tertiary PA.

Average concentration (µg kg-1)
of PAs and PANOs detected
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Senecionine
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Seneciphylline N-oxide
Seneciphylline

100

Heliotrine
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50

Lycopsamine

0
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2009

2010
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Year of Sampling

Figure 4.1: Breakdown of the PA profile for positive honeys detected over the four years (2008
to 2012) of this study.
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A margin of error (MOE) approach was chosen by EFSA (2011) when estimating exposure of
PAs to humans and for PAs this equates to a maximum dose of 0.007 µg kg-1 bw day-1. This is
based upon toxicity studies in rodents where the PA lasiocarpine induced carcinogenic effects at
a concentration of 70 µg kg-1 of body mass. The internationally excepted MOE of 10,000 for
genotoxic and carcinogenic compounds was applied. The dietary intake of PAs and PANOs
investigated during this study was calculated by using both a probabilistic and deterministic
approach. The deterministic or point-estimate approach is traditionally present in exposure
assessments. The risk from a substance is estimated to a value that ensures protection for most of
the population but in most cases can overestimate the actual exposure. Probabilistic approaches
take into consideration variability in the data and employ mathematical tools, such as the Monte
Carlo simulations (BfR, 2014), to ascertain probability distributions.

Probabilistic models

encompass a wider distribution, with intakes among groups of individuals within a population,
consideration for variability within the food consumed and consumption patterns, and the
occurrence of PAs in foods containing honey. The exposure assessment accounts for every
variable and weights the outcomes by the probability of its occurrence. The consumption intakes
were obtained from the Irish Universities Nutrition Alliance (IUNA) who possess an extensive
collection of national nutritional surveys. Thus, using a modelling software package such as
Creme (operated by our research collaborators at UCD), large scale consumption data sets,
chemical concentration data (as compiled within this study), recipe and detailed food group data
are combined. This allows the user to conduct an accurate risk exposure assessment for any
given population.

Table 4.0 summarises the probabilistic estimated daily intakes of the sum of PAs for adults,
teenagers and children in Ireland who consume honey (or foods with honey listed as an
ingredient) contaminated with the PA-levels detected in the survey.
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Daily exposure to PAs and PANOs (µg kg-1 bw day-1)
Mean
P95
LB
UB
LB
UB
0.0023
0.0046
0.0127
0.0196
0.0022
0.0046
0.0117
0.0213
0.0054
0.0037
0.0264
0.0157

Population
Adults
Teenagers
Children

Abbreviations: P95 = 95th Percentile, LB = lower bound, UB = upper bound.

Table 4.0: Summary of the estimated daily intakes of the sum of PAs (µg kg-1 bw day-1) for
adults, teenagers and children in Ireland who consume honey (or foods with honey as an
ingredient from IUNA dietary surveys).
The calculated PA exposure for the 95th percentile (top 5% consumption-wise) for adults,
teenagers and children all exceed the recommended maximum intake limit of 0.007 µg kg-1 bw
day-1. Figure 4.2 displays the total sum concentration (µg) of PAs per 20 g of the honeys

Total Sum of PAs and PANOs (µg) per 20 g honey

determined as positive (n = 90) in relation to the maximum intake limit (0.007 µg kg-1 bw day-1).
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Figure 4.2: The total sum concentration (µg) of PAs and PANOs per 20 g of positive honey (n =
90) in relation to the maximum intake limit (0.007 µg kg-1 bw day-1) proposed by EFSA (2011).
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The results of the upper bound (UB) scenario (Table 4.0) give the worst case PA exposure for the
Irish population based upon the PA analyses in honey marketed in Ireland over the period 2008–
2012 and food consumption data derived from the Irish Universities Nutrition Alliance (IUNA,
2012). It should be noted however, that both the LB and UB scenarios for the mean data could
also exceed the recommended maximum intake levels as these calculations are based solely on
the consumption of honey and products which contain honey as listed in the food group data
from the IUNA dietary surveys. The estimations do not include other possible PA-containing
foods such as herbal teas and herbal products as discussed in chapter 5 of this thesis. Further
data on PA-containing foods could be added to this model to facilitate a more thorough risk
assessment for PAs in the food-chain within Ireland.

4.2.4

Isocratic Method for PAs

This experimental work developed the first isocratic method for PAs and PANOs. It was applied
to Australian retail honeys. The aims of this work were two-fold; firstly to develop a reliable and
rapid detection method for PAs and PANOs and secondly to profile Australian honeys. The
isocratic method presented in Griffin et al. (2015) is comparable to the gradient elution method
presented within this chapter. The method utilised the same MS conditions as those detailed in
Griffin et al. (2014a) and LC conditions were modified only in the mobile phase percentage
composition. There was no loss of sensitivity or reduction in chromatographic peak shape
observed.

The significance of isocratic elution is that it allows for shorter analysis times

facilitating a high-throughput which is particularly advantageous for regulatory testing
laboratories.

In excess of 200 injections per 24 hours are possible displaying a >50%

improvement on all previously published methodologies.
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From the previous survey of retail honeys (n = 369) it was observed that 20% of honeys on sale
in Ireland originate from Australia and New Zealand. The honeys tested from this region had
above average concentrations for PA toxins in comparison to the rest of the world (145 µg kg-1 vs
81 µg kg-1, total sum of PAs in positive honeys). Thus, consumption of these honeys could
negatively impact on the health of an Irish consumer based upon the risk assessment findings.
Figure 4.3 summarises the positive results (from the survey of 369 honeys) in terms of the
average PA and PANOs concentration (µg kg-1) versus the percentage of samples positive. The
origin of the samples is also displayed.

As can be seen from the overall results, honeys

originating from Australia contained the highest PA concentration. The most predominant PAs,
in both frequency and concentration, were lycopsamine and echimidine detected in 92% and 44%

Average conc. PAs and/or PANOs in positive samples
(µg kg -1)

of positive honeys, respectively.
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Figure 4.3: Summary of positive honeys in terms of the average PA and PANOs concentration
(µg kg-1) versus the percentage of samples positive labelled by country of origin.
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It was therefore decided to source Australian and New Zealand honeys (n = 59) which were on
sale in Australian supermarkets to determine if the results for PA-concentration and PA-profile
were comparable.

A licence for importation was acquired (see Appendix B) from the

Department of Agriculture, Food and the Marine. Forty-one samples were positive for PA toxins
with only 7 of these below the maximum intake limit of 0.007 µg kg-1 bw day-1 based upon an
adult consuming two tablespoons of honey. The analysis showed lycopsamine and echimidine
were predominant, correlating to an earlier finding, and found in 76% and 88% of samples
respectively.

4.3

Conclusions

PAs are an emerging risk to the food chain, particularly for high consumers of honey and
children. The work contained within this chapter, and over 4 publications, provides quantitative
data on the occurrence of PAs at the point of consumption within Ireland. It also determined that
imported honey from Australia and New Zealand (accounting for approximately 20% of the
honey market in Ireland) contained high PA concentrations in comparison with honey purchased
in Ireland originating from other regions of the world. The number of indigenous honeys on sale
in Ireland is low but of those tested (n = 19) no PA toxins were detected. Analytical methods,
such as those outlined herein, can ensure early detection of potential PA-related risks to the food
chain and consumer population. The gradient elution LC-QqQ-MS method is one of the most
comprehensive methods published on PAs to date. However, the isocratic method could prove to
be the method of choice in the future as it provides comparable sensitivity and selectivity to the
gradient elution method in half the analysis time. Consequently, this method allows for fast and
accurate detection of PA toxins in foods.
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Chapter 5
Analysis of PAs in Teas and Herbal Products via LC-MS
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5.0

Analysis of PAs in Teas and Herbal Products via LC-MS

This chapter contains the publication Griffin CT, Gosetto F, Danaher M, Sabatini S, Furey A.
(2014). Investigation of targeted pyrrolizidine alkaloids in traditional Chinese medicines and
selected herbal teas sourced in Ireland using LC-ESI-MS/MS. Food Additives and Contaminants:
Part A, 31(5); 940-961.

5.1

Aims and Objectives

The aim of this work was to;
-

develop a sensitive and robust analytical method for the detection of PAs and PANOs in
herbal products such as teas and traditional Chinese medicines (TCMs),

-

provide a comprehensive validated method including all of the PAs and PANOs reference
standards commercially available at the time of analysis,

-

5.2

apply the method, for the first time, to commercial herbal products sold within Ireland.

Background

Hepatotoxicity of herbal products is extensively acknowledged and there is a wealth of reviews
(Teschke, Frenzel, Schulze and Eickhoff, 2013; Bunchorntavakul and Reddy, 2013; Bent, 2008;
Stickel et al., 2005) published on the topic. There has been a significant increase in the use of
herbal products over the past two decades even though there still exists a lack of scientific
evidence to establish the safety and efficacy of some herbal products (Bent, 2008; Stickel et al.,
2005). From an extensive literature review it was noted that there was a dearth of analytical and
quantitative research of PAs within commercial herbal products. This ranged from inadequate
method validation, quantitation of results, and presentation of chromatograms to the testing of a
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limited number of commercial products. Thus, the aim of this work was to bridge this analytical
gap by providing a fully validated and comprehensive method for the testing of PAs and PANOs
in herbal products and applying the method to herbal teas and TCMs commercially available
within Ireland.

Within this chapter’s published journal article (Griffin et al., 2014a) Table 1 provides a summary
of the previous literature on the analysis of commercial tea/herbal products. Herbal teas have
been shown to contain PAs (Huxtable, 1980) including traditional “bush” teas (Stuart and Bras,
1955; Fragoso-Serrano et al., 2012), TCMs (Fu et al., 2002; Zhou et al., 2013) and dietary
supplements (Ridker et al., 1985; Betz et al., 1994) and in certain reports PA toxicity resulted in
acute poisonings (Roulet et al., 1988; Bach et al., 1989). The majority of previous investigations
focused on the raw plant species contained within a herbal product rather than analysing the
commercial goods themselves (Li et al., 2008; Zhang et al., 2008; Qi et al., 2009; Tang et al.,
2012; Windono et al., 2012). There have been only a limited number of commercial products
tested for PAs; some quantitatively (Gray et al., 2004; Oberlies et al., 2004) and others for PA
identification only (Wuilloud et al., 2004; Ruan et al., 2012; Bosi et al., 2013). As with other
experimental work presented within this research it was important to test commercially available
herbal products at the point of consumption for PAs, to determine the quantity of PAs reaching
the consumer.

5.3

Discussion

5.3.1

Herbal Teas

Teas were chosen based upon the likelihood of containing PAs and/or PANOs. For example,
‘Camomile & Honey’ as it has been demonstrated that PA contamination of honey, when used as
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an ingredient, can infiltrate and persist in products further along the food chain (Kempf et al.,
2011a). The authors demonstrated that mead and candy contained PAs, up to 0.5 and 0.04 µg g-1
respectively, from the honey ingredient used to produce these products even though they have
undergone treatments such as dilution, fermentation and heating. Another tea was marketed as a
“slimming aid” and due to previous publications on comfrey (Symphytum officinale), a PAcontaining plant, being used as a digestive and slimming remedy this tea was selected. In total
18 herbal teas were purchased from supermarkets, health and Asian food stores.

Figure 5.0 provides a flow diagram for the sample preparation method. This extraction and
clean-up protocol was developed using knowledge acquired in processing honey samples. The
SPE protocol is identical to that used for honeys except for a slightly stronger eluting solvent (5%
ammoniated methanol versus 3% for honeys as per Figure 3.3). This was purely to ensure full
recovery of potential PA analytes as the aqueous wash step appeared to eliminate the majority of
matrix interferences. The acid extraction was optimised to provide the correct ratio between
sample mass and acidic solvent volume. The average mass of the contents of one herbal tea bag
was approximately 1.5 g (± 0.1 g) and so this mass was chosen for the extraction protocol. Trial
extractions were conducted using a representative sample to prove that the mass and
homogenisation times were adequate for the protocol. Previous publications tend to use Soxhlet
extraction with long extraction times (generally 2 hours) or liquid-liquid extraction involving the
use of harmful chemicals (halogenated or ozone depletors). The use of a simple acidic extraction
followed by SCX-SPE clean-up provides a quicker, safer, cheaper and more sensitive method of
determining PAs and PANOs in herbal teas.
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Herbal Sample Preparation/Extraction
Teas: 1.5 g (± 0.1 g)
+ 8.5 mL 0.05M
sulphuric acid in
15 mL centrifuge tube

TCMs: Grind to powder,
0.5 g (± 0.05 g) + 9.5 mL
0.05M sulphuric acid in
15 mL centrifuge tube

Solid Phase Extraction/Clean-up
Strata-X-CTM
60 mg/3 mL cartridge

Vortex 30 sec

Water bath (40 oC)
30 min

Water bath (40 oC)
1 hr

Condition:
2 mL methanol

Centrifuge 6,000 rpm (3,421 g) 10 min

Equilibrate:
2 mL deionised water

Transfer 10 mL volumetric flask
(adjust to mark with 0.05M sulphuric
acid, if necessary)

Load:
2.5 mL of sample

Wash (1):
2 mL 0.1% aq. formic acid

Wash (2):
2 mL methanol

Elute:
6mL 5% ammoniated methanol

Dry under N2 in Turbovap (45 oC)

Reconstitute in 1.0 mL methanol and
syringe filter (0.22 µm) to LC vial

Figure 5.0: Flow diagram for the sample preparation of herbal teas and TCMs (extraction
followed by SCX-SPE).
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The results were enlightening, in that nine of the 18 teas tested positive (50%) for one or more
PAs/PANOs included within the targeted study. The PA-content ranged from 10 to 1733 µg kg-1
(dry weight). Table 4 in the enclosed publication provides a full listing for all 18 herbal teas
tested. Tea #11 was marketed by the manufacturer as a “digestive aid” to help “alleviate
intestinal problems” but no ingredients were given on the packaging. This tea had the highest
PA-content and was positive for six of the 14 PAs and PANOs tested for. In drinking one cup of
this tea the consumer could potentially ingest 2.16 µg of toxic PAs which is over 4 times the
recommended maximum intake limit suggested by EFSA (2011). Figure 4 (of the publication)
displays the total sum of PAs and PANOs from this study in each sample based on a 3-cup intake
per day with respect to the daily maximum intake limit suggested by EFSA (2011).

Tea #3 had a PA-content of 29 µg kg-1 containing lycopsamine and senecionine. The tea was
classified by the manufacturer as an expectorant with black cohosh and elecampane listed among
its ingredients. Elecampane (Inula helenium) is a member of the Asteraceae plant family, a
family which contains many PA-containing plants although elecampane has not been analysed
for the presence of PAs. Therefore, the PAs detected in this tea could potentially have come
from Elecampane (Inula helenium). Black cohosh, in particular the rhizomes of Cimicifuga
racemosa or Actaea racemosa, has been used by herbalists to treat symptoms of menopause but
has been linked with herbal hepatotoxicity. In a publication by Borrelli and Ernst (2008) the
authors describe how an extensive systematic literature search was conducted in order to
investigate a potential link between black cohosh and hepatotoxicity. The authors concluded that
clinical studies suggested that black cohosh was safe but causal attribution was problematic.
Since black cohosh has been associated with hepatotoxicity further investigation of this herb is
required. Similar to black cohosh, chronic toxicity from PAs is difficult to definitively prove as
there is usually a time lapse in patient diagnosis. There can also be a failure to investigate and
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identify herbal products consumed by the patient, insufficient ingredient listing on the herbal
product(s) consumed, co-medication with synthetic or dietary herbal supplements and deficient
documentation and/or reporting of such cases. Therefore, a consumer of tea #3 which contains
toxic PAs (lycopsamine and senecionine) may also be consuming other potentially hepatotoxic
herbs in black cohosh.

Tea #13 was branded as ‘Camomile & Spearmint’ which are not known to contain PAs (no
previous literature on possible PA-content) and had no other ingredients listed on the packaging
yet this tea was positive for seven of the 14 PAs and PANOs tested for within this study. By
using identification points (IPs), as explained in the publication herein, to monitor a parent ion
and two daughter ions per target analyte they can ensure accurate detection of PAs using
relatively lower resolution MS instruments such as a QqQ (as opposed to QTOF or Orbitrap).
Figure 5.1: illustrates the match for both retention time and 3 daughter ion transitions for the PA
senecionine detected in tea #13 to the relevant reference standard. Given that the method has
proven accuracy it can only be assumed that either (i) quality control was seriously lacking and
significant contamination with PA-containing plants occurred, (ii) a PA-containing plant was also
used in the production of this tea but the plant was not listed as an ingredient, or (iii) Camomile
or Spearmint contain PAs. There is no published literature to demonstrate that either plant
contains PAs but Camomile is a member of the Asteraceae family which harbours other plants
that contain PAs. Tea #6 branded as ‘Rooibos’ or “Red Bush” is produced from Aspalathus
linearis, a member of the Fabaceae family, and was found to contain six of the fourteen PAs and
PANOs tested for within this study. The Fabaceae family contains the tribe Crotalarieae and are
known to contain PAs. Tea #10 was marketed as a “slimmer’s aid” and had the main ingredients
listed as senna leaf, frangula bark, hibiscus flowers and goldenrod herb.
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Figure 5.1: Comparison of tea #13 containing the PA senecionine to the calibration standard
illustrating the match for both retention time and SRM transitions of 3 daughter ions with
identical ion ratios.

Figure 5.2: Visual similarities between the flowers of European goldenrod (Solidago virgaurea)
and ragwort (Senecio jacobaea). There is a notable difference in their leaf structure (photographs
contain copyright information).
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Interestingly, goldenrod herb (Solidago virgaurea L.) from the Asteraceae family has very
similar flowers to that of ragwort (Senecio jacobaea) whose tribe Senecioneae is also a member
of the Asteraceae family (Figure 5.3). However, the PAs detected in this tea originate from the
Crotalarieae genus of the Fabaceae family which would indicate poor quality control or
agricultural practices.

Quality control and standardisation practices play a pivotal role in

guaranteeing the quality of herbal preparations and Good Agricultural Practices (GAP) are
integral to this (Folashade et al., 2012).
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5.3.2

TCMs

Fifty-four TCMs were tested within this study, all of which were readily available from retail
outlets trading solely in TCMs. A total listing of all TCMs is provided in Table 5 of the enclosed
publication. The majority of TCMs tested (89%) were in tablet form consisting of hard coated
pellets, as those depicted in Figure 5.3.

Figure 5.3: Typical TCM pills investigated during this study (photographs obtained from
http:\\www.acupunctureaz.us, 2013).

The recommended daily dose on the majority of TCM products tested was 8 pellets or pills which
equated to 0.5 g (± 0.05 g). Sample preparation involved the same protocol as that used for teas
(section 5.3.1). Trial extractions were conducted using a representative sample of TCM pellets to
prove that the mass of 0.5 g (equivalent to a daily dose) and homogenisation times were adequate
for the protocol. From the 54 samples tested 78% (n = 42) were positive for one or more of the
PAs and/or PANOs included in this targeted study. In the positive samples the total PA-content
ranged from 13 to 3668 µg kg-1 (dry weight). Similar to the data provided for herbal teas, Table
5 and Figure 6 of the enclosed publication displays the listing for all 54 TCMs and a graph
illustrating those positive samples which exceeded the maximum daily intake limit proposed by
EFSA (2011).

From the results of the study there were notable variations between both brands and batches. For
example, Ba Zhen Wan (samples #19 and #51) used for gynecopathy and anaemia were different
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brands and varied in concentration from 644 to 16 μg kg-1, respectively, while samples #4 and
#38 were from the same manufacturer but varied in detected concentrations of 0 (< LOD) and 65
μg kg-1, respectively. Among the listed ingredients for this product was Bai Zhu, the rhizomes of
Atractylodes lancea, belonging to the Asteraceae family of which many members contain PAs.
However, from a literature search there were no publications detailing investigations of this
particular plant (Atractylodes lancea) for PAs. Samples #12 and #16 named ‘Long Dan Xie Gan
Wan’ were sourced from different suppliers but had concentrations of 0 (< LOD) and 1918 μg
kg-1, respectively. Figure 5.4 displays (a) the TIC obtained for TCM sample #12 in which four
PAs are visible and (b) an overlay for the individual SRM chromatograms.

Qing Re An Cang Wan, Xie Gan Wan and Long Dan Xie Gan Wan samples were tested by the
Medicines and Healthcare products Regulatory Agency (MHRA) in 2007 and seized due to the
presence of aristolochia. This plant species contains acids which are known carcinogens and are
responsible for renal failure yet Aristolochia was not listed among the ingredients information
(MHRA, 2007).

The Health Products Regulatory Authority (HPRA), formerly the Irish

Medicines Board (IMB), have also issued advisory warnings on TCMs containing undeclared
prescription Active Pharmaceutical Ingredients (APIs) and heavy metals (HPRA, 2005; HPRA,
2007). The HPRA were notified by the New Zealand Medicines Agency that two named Chinese
herbal products (Nasutra and Dai Hua Jiao Nang) may contain undeclared prescription APIs;
sildenafil citrate (approximate content 35 mg) which is commonly known as Viagra and
sibutramine, a diet aid (approximate content 15mg). Similarly, the HPRA were contacted by the
MHRA in the U.K. due to an unannounced inspection and testing of products from a traditional
Chinese medicines supplier. The product (Fufang Lu Hui Jiaonang) contained extremely high
mercury levels, in fact 117,000 times more than is allowable in food substances in the U.K.
(MHRA, 2006).
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Thus consumers may be at risk of more than PAs and associated toxicity resulting from the
ingestion of these products may have had any PA-content masked by other health damaging
compounds.

(a)

9.36
NL: 4.33E5
TIC-MS

Relative Abundance

100

80

60

40

5.65

20
3.12
0

0

1

2

3

8.36
4

5

6

7

8

9

10

11

Time (min)

(b)

Relative Abundance

100

80

60

RT:3.12
AA:253470
SN: 19

NL: 3.95E4
+ESI SRM ms2 300.00
NL: 4.47E4
+ESI SRM ms2 314.00
NL: 8.03E3
+ESI SRM ms2 336.000
NL: 3.87E5
+ESI SRM ms2 366.000

RT:8.36
AA:86294
SN:13
RT:9.36
AA:4442414
SN:172

RT:5.65
AA:519497
SN:50

40

20

0

0

1

2

3

4

5

6

7

8

9

10

11

Time (min)

Figure 5.4: (a) LC-MS/MS TIC chromatogram of TCM sample #12, and (b) LC-MS/MS SRM
displaying the detected PAs; (1; Rt 3.12 min) lycopsamine 31 µg kg-1, (2; Rt 5.65 min) heliotrine
107 µg kg-1, (3; Rt 8.36 min) senecionine 43 µg kg-1, (4; Rt 9.36 min) senkirkine 1737 µg kg-1.
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5.4

Conclusion

The safety and efficacy of some herbal products have yet to be proven. The term ‘Natural’ does
not necessarily indicate that the product is safe. The herbal teas and TCMs listed as positive for
PAs and/or PANOs in this study could potentially contain other hepatotoxic and carcinogenic
compounds, which are not included in this targeted study, and would lead to an increase in their
overall toxicity.
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Chapter 6
Analysis of PAs in milk and cheese via LC-MS
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6.0

Analysis of PAs in Milk and Cheese via LC-MS

6.1

Aims and Objectives

The aims of this work were to;
-

apply the previously developed extraction, SPE clean-up and LC-MS/MS method to milk and
cheese samples for the detection of PAs and PANOs,

-

determine if PAs are present in commercial milk and cheese samples as previous research
groups have conducted dose feeding studies only (no previous publications of the analysis of
PAs in commercial milk or cheese samples),

-

develop a QuEChERS method for the detection of PAs and PANOs in milk and cheese
samples (based upon the use of this technique in determining veterinary residues, such as
anthelmintics or flukicides, in milk and cheese).

This represents a new application of

QuEChERS as the technique had yet to be applied to PAs.

6.2

Introduction

Pyrrolizidine alkaloids (PAs) can be transferred into the milk of livestock who consume or graze
inadvertently on PA-containing plants.

Excretion of PAs into milk by lactating cattle is

considered to be negligible (having low PA concentrations, possibly 0.1% carryover from PAcontaminated feed to milk) but the risk to human health should not be overlooked (Panter and
James, 1990; Hoogenboom et al., 2011), particularly since the lactating animal may not show
signs of alkaloidosis. Studies have been conducted on the transfer of PAs into milk. Deinzer et
al. (1982) analysed milk from goats fed Senecio jacobaea (ragwort) flowering tops at a dosage
level of 1% of their body weight per day. The alkaloids were extracted through reflux, with
clean-up by C18 column, followed by analysis via GC-MS. The PA content was deemed to range
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between 0.33 to 0.81 mg L-1 resulting in 0.1% of PAs which were ingested being carried over
into milk. Dickinson et al. (1976), in a similar study, detected PAs from 0.094 to 0.167 mg L-1 in
milk from cows who had ingested ragwort at a dosage of 10 g kg-1 bw day-1 for a duration of 2
weeks. However, the percentage recovery for the method (a colourimetric test developed by
Mattocks, 1967) was quoted at 20% and thus the authors stated that values should be multiplied
by a factor of 5 to adjust for actual content. Taking this percentage recovery into consideration
the concentration of PAs detected range from 0.47 to 0.84 mg L-1, correlating to those reported
by Deinzer et al. (1982). Candrian et al. (1991) monitored the PA transfer into milk from a
single dose of [3H] seneciphylline given at 1 mg kg bw-1 to dairy cows. It was determined that
0.16% of the dose was excreted into milk, comparable to 0.1% reported by Deinzer et al. (1982).

Ingestion of PA-containing plants resulting in acute toxicity is relatively infrequent. In general,
PA toxicosis is of a chronic nature and delayed manifestation of the toxicosis is common
(Molyneux et al., 1988). Lactating animals ingesting PAs over a period of time can transfer them
into milk without any overt signs of toxicity in the animal (Panter and James, 1990). The chronic
lethal dose of ragwort to cattle was estimated to be 2.5 mg kg-1 bw day-1 for 18 to 20 days
(Johnson, 1976). In another study (Goeger et al., 1982) this estimation ranged from 50 to 200 g
kg-1 bw for cattle and horses which are more susceptible than goats at 1.25 to 4.04 kg kg-1 bw.
Cattle and horses can be 14 times more sensitive than sheep and goats to PA toxicity, whereas
pigs are 200 times more sensitive than sheep and goats (Hooper, 1978).

Investigations have been conducted into the stability of PAs in hay, silage and animal feed. PAs
are bitter tasting and would normally be avoided by cattle. However, when cut and dried, PAcontaining plants such as Senecio jacobaea, can become more palatable and hence dangerous in
fodder.

PAs of Senecio alpines were the cause of alkaloidosis in Swiss livestock with
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seneciphylline detected as the major PA constituent (Lüthy et al., 1981). Candrian et al. (1984)
measured the decomposition of PAs from Senecio alpines using GC-FID and GC-MS and
quantified using the PA seneciphylline.

The authors reported that the PA content of hay

remained constant over the 2 month testing period whilst in silage PAs decomposed significantly
but the degradation was less complete at lower concentration ranges. The authors concluded that
decomposition of PAs in silage was not significant enough to render it safe for fodder (silage
contaminated with 3.5 to 23% of Senecio alpines still contained 20 mg kg-1, wet weight). In a
later study (Crews et al., 2009) the decomposition of Senecio jacobaea (ragwort) and its PA
levels were analysed using LC-TOF-MS. Plants were composted in black bin liners in direct
sunlight using thermal and microbiological breakdown. Every 2 weeks for 14 weeks a plant
sample was removed, freeze dried, Soxhlet extraction with methanol performed overnight before
direct injection onto the LC-MS. The authors’ findings indicated that free tertiary PAs were not
as quick to decompose as PANOs and that over an 8 week period the total sum of PAs decreased
from 340 to 6 mg kg-1. Hough et al. (2010) also looked at the degradation of PAs, along with
yew and rhododendron which are toxic to livestock. It was observed that jacobine and its Noxide showed degradation whilst seneciphylline and senecionine were more persistent. This
study also determined that as the free tertiary PAs degraded the PANOs did not increase,
indicating that decomposition is not via oxidation. Thus, depending upon the PA-plant present
and the time given for decomposition results can vary.

In a Dutch National Monitoring Program for animal feeds (Mulder et al., 2009) 147 samples
underwent screening for 40 PAs using LC-MS/MS. Samples were classified as either silage, hay,
grass (dried) or alfalfa. For both grass and hay results the risk of contamination with PAs was
deemed small as the samples had trace levels below 10 and 15 µg kg-1, respectively, and thus not
likely to present a risk to animals or humans through milk consumption. Only one hay sample
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had a significant amount of PAs, 549 µg kg-1, produced from a nature reserve area. The authors
state that nature reserve areas may be more prone to contamination with ragwort species than
plots that are in regular use for agriculture (due to pasture management). In contrast, the average
PA concentration in alfalfa samples (Lucerne, a livestock fodder) was 455 μg kg-1, approximately
30-fold higher than the average for grass and hay. Most of these samples had the same PA
profile originating from Senecio vulgaris (groundsel). Alfalfa (Medicago sativa) belongs to the
Fabaceae family and is an important agricultural crop. The authors recommended that the
production of alfalfa, in particular commercial products, should be monitored more carefully.
The authors also stated that the Council Directive 2002/32/EC (2002) on undesirable substances
in animal feed focuses mainly on toxic seeds of alkaloid containing plants, without specifically
mentioning Senecio species (Mulder et al., 2009).

The objective of this research was to determine if PAs and their PANOs could be detected in
milk and cheese from retail products. Previous experimental feeding studies where animals are
purposely fed PA containing plants have proven that PAs and PANOs can be transferred to the
animals’ milk.

However, there are no previous studies on commercial milk or cheese in

published literature and hence it has not been determined if the population is exposed to PAs
through these foods. A previously developed extraction, SPE clean-up and LC-MS/MS method
for honey was applied to milk and cheese samples. Also, a new QuEChERS method was
developed based upon the AOAC 2007.01 method for pesticide residues in foods. QuEChERS
has been applied by regulatory labs for determining veterinary residues in milk and cheese
(Kinsella et al., 2009; Whelan et al., 2010) and thus could be adapted to the detection of PAs and
PANOs.
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6.3

Experimental

6.3.1. Chemicals and reagents

Methanol, acetonitrile and water, all of HPLC grade, were obtained from Fisher Scientific
(Dublin, Ireland). Formic acid (99–100% purity) was purchased from Reagecon Ltd. (Co. Clare,
Shannon, Ireland). Sulphuric acid (98%) and ammonium hydroxide (33% NH3 in H2O) were
acquired from Sigma Aldrich (Wicklow, Ireland). Polymeric SPE cartridges, StrataTM-X-C 33
µm (60 mg, 3 mL), were purchased from Phenomenex Inc. (Macclesfield, Cheshire, UK), 0.22
μm PTFE Chromacol syringe filters and centrifuge tubes (50 mL) from Lab Unlimited (Dublin,
Ireland). Enviro-clean® sachets (mylar pouch) of magnesium sulphate (6 g) and sodium acetate
(1.5 g) were obtained from UCT (Bristol, Pennsylvania, U.S.) and dSPE tubes (15 mL)
containing PSA, carbon and magnesium sulphate from Agilent Technologies (Cork, Ireland).

Pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxides were purchased from Sigma Aldrich,
Ireland (crotaline, retrorsine and senecionine); Carl Roth, Germany (seneciphylline and
senkirkine); PhytoLab, Germany (echimidine, lycopsamine, otosenine, crotaline N-oxide,
retrorsine N-oxide, seneciphylline N-oxide and senecionine N-oxide) and Latoxan, France
(heliotrine and trichodesmine).

6.3.2

Samples

Commercial goats milk samples (n = 12) were purchased from supermarkets (n = 9; 75%) and
health food stores (n = 3; 25%). Goat milk samples (n = 36) were supplied from a goat farm in
Northern Ireland via Dr. Steven Crooks (Agri-Food and Biosciences Institute, Veterinary
Sciences Division, Stormont, Belfast). Commercial cheese samples (n = 72) were purchased
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from supermarkets (n = 36; 50%), health food stores (n = 33; 46%), local farmers markets (n = 2;
3%) and greengrocers (n = 1; 1%).

6.3.3

Preparation of reference standards and controls

All PA and PANO reference standard solutions were prepared at a concentration of 1 mg mL-1
from dilution of suppliers vials using HPLC grade methanol. These solutions were dried under
nitrogen (>98% purity) and stored at -20oC.

From these, weekly working standards were

prepared by serial dilution and stored between 2 and 4°C in solution (HPLC grade MeOH).

A milk sample that did not contain detectable levels of PAs or PANOs was used as a negative
control. This sample was extracted and subjected to both SCX-SPE and QuEChERS using the
procedures outlined in Section 6.3.5. The extract was fortified with PAs and PANOs at two
known concentration levels, 35.7 and 71.4 µg L-1 , to act as controls. A seven-point calibration
curve was prepared in methanol ranging from 7.1 to 357.1 µg L-1. All samples were quantified
against the individual PA or PANO calibration plots produced from the reference standards.

6.3.4

Instrumental Analysis

An Accela LC system consisting of a quaternary pump, thermostat autosampler, degasser and
column heater was hyphenated to a triple quadrupole (QqQ) TSQ Quantum Discovery Max mass
spectrometer (Thermo Scientific, Hemel Hempstead, UK). The instrument was controlled by
Thermo Scientific Xcalibur 2.0 software. Chromatographic analysis was performed using a
Kinetex PFP core-shell column (150 × 2.1 mm, 2.6 μm particle size) protected with a
KrudKatcherTM in-line filter (Phenomenex Inc.). The column was maintained at 35°C (± 1°C) and
the autosampler at 4oC (± 1°C). The mobile phase was (A) 0.05% formic acid in water with 5%
acetonitrile and (B) 100% acetonitrile, at a flow rate of 0.2 ml min-1. A gradient elution was used:
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0–2 min 10% B; 2–8 min linear increase in B from 10 to 25%; 8.5–10.5 min 80% B maintained
before returning to 10% B which allowed for column equilibration over 10 void volumes prior to
the next injection (18 minutes at 0.2 mL min-1). The autosampler needle and loop were washed
between injections with 80:20 v/v methanol/water in order to remove any possible carryover.
Both standard and sample injection volumes were 10 µL. The mass spectrometer was fitted with
a heated electrospray (HESI) source and operated in positive mode.

The MS acquisition

parameters for the EZ method in SRM mode (spray voltage, vaporising temperature, gas flow,
capillary temperature, tube lens voltage, collision energies and SRM transitions) were optimised.
Optimised parameters are reported in the publication Griffin et al., 2014, Chapter 5.

6.3.5

Sample Preparation

Test samples of goat’s milk were selected as Molyneux and James (1990) and Panter and James
(1990) reported that browsing animal’s milk may contain higher PAs. All test samples, milk and
cheese, were stored at -20oC from the day of purchase. Prior to testing the sample was allowed to
completely thaw at room temperature. Two methods of extraction and clean-up were performed;
acidic extraction followed by SPE sample clean-up and a modified QuEChERS technique as
described in Chapter 3. Note that in this instance “modified” refers to the fact that the developed
QuEChERS method is based upon the AOAC 2007.01 method for pesticide residues in foods
using acetonitrile for extraction and magnesium sulphate for partitioning.

6.3.5.1 Extraction followed by SPE

For milk samples 4.0 mL (± 0.1 mL) was transferred to a 15 mL centrifuge tube with 6.0 mL of
0.05 M sulphuric acid. This was based on previous honey sample analysis. For cheese samples
2.0 g (± 0.1 g) was weighed into a 15 mL centrifuge tube and 8.0 mL of 0.05 M sulphuric acid
was added. Half the quantity, 2.0 g as opposed to 4.0g, was used as the resulting mixture was
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viscous. Cheese samples were placed in a water bath at 40oC for 10 minutes in order to
homogenise the sample. All tubes were capped, vortexed for 30 seconds and centrifuged at 6,000
rpm (3,421 g) for 10 min. The resulting supernatant was transferred to a volumetric flask (10
mL), adjusting to the mark if necessary with sulphuric acid (0.05 M). Use of a volumetric flask,
a method which is not adopted by other publications, ensures that all extracts are of equal volume
prior to loading onto the SPE cartridge providing more accurate quantification. A 2.5 mL aliquot
was applied to a conditioned Strata-X-CTM cartridge. Potential PAs and/or PANOs were eluted
with ammoniated methanol (3%; 9 mL) and dried in a turbovap at 45oC under a nitrogen gas
flow. Dried extracts were reconstituted in HPLC grade methanol (1.0 mL) and filtered using a
syringe filter (0.22 µm) directly into a LC amber vial (2 mL). Figure 6.0 provides a flow
diagram for the sample preparation method followed by SPE clean-up.

6.3.5.2 Extraction followed by QuEChERS

Milk samples (10.0 mL ±0.1 mL) were transferred to 50 mL polypropylene centrifuge tubes (Lab
Unlimited, Dublin, Ireland).

Cheese samples (4.0 g ± 0.1 g) were weighed into 50 mL

polypropylene centrifuge tubes and water was added (6.0 mL ±0.1 mL). Cheese samples were
warmed in a water bath at 40oC for 10 minutes in order to homogenise and liquefy. To each
sample tube 10.0 mL of 1% acetic acid in acetonitrile (v/v) was added and the sample mixture
vortexed for 30 seconds. Phase separation was induced by adding the contents of the sample
tube to a 50 mL tube containing a mixture of 1.5 g sodium acetate, 6 mg of anhydrous
magnesium sulphate (Enviro-clean® from UCT) and 3.0 mL of 1% acetic acid in acetonitrile.
Samples were immediately shaken for 1 minute and centrifuged (6000 rpm; 3421 g) for 10
minutes. The entire supernatant, approximately 8.0 mL, was poured into a 15 mL centrifuge tube
containing 150 mg PSA (Primary and Secondary Amine exchange material), 15 mg carbon and
900 mg of anhydrous magnesium sulphate (dSPE from Agilent Technologies, Cork, Ireland).
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The samples were vortexed for 30 seconds and centrifuged (6000 rpm; 3421 g) for 10 minutes.
Two different protocols were employed for the purified supernatant; (A) an aliquot of the
purified supernatant (1.0 mL) was transferred to a 5.0 mL glass test tube, evaporated under
nitrogen at 45oC using a turbovap and the dried extract reconstituted in methanol (HPLC grade),
and (B) a 1.0 mL aliquot of the purified supernatant was taken for direct injection to LC-MS. In
both cases, extracts were filtered through a 0.22 µm PTFE 13 mm syringe filter (Chromacol) into
an amber LC vial. Figure 6.1 provides a flow diagram for the modified QuEChERS procedure.

To test the recovery of the QuEChERS protocol a blank milk sample, one which was determined
negative for PAs and PANOs by direct injection into the MS, was fortified with a 100 µg mL-1
reference PA and PANO mixture at four levels; (i) 500 µL to give 5 µg/10 mL, (ii) 100 µL to
give 1 µg/10 mL, (iii) 50 µL to give 0.5 µg/10 mL, and (iv) 10 µl to give 0.1 µg/10 mL.
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Sample Preparation/Extraction
Milk: 4 mL (± 0.1 mL)
+ 6.0 mL 0.05M
sulphuric acid in 15 mL
centrifuge tube

Cheese: 2.0 g (± 0.1 g)
+ 8.0 mL 0.05M
sulphuric acid in 15 mL
centrifuge tube

Water bath (40 oC)
10 min to allow for
homogenisation

Solid Phase Extraction/Clean-up
Strata-X-CTM
60 mg/3 mL cartridge

Condition:
2 mL methanol
Vortex 30 sec
Equilibrate:
2 mL deionised water

Centrifuge 6,000 rpm (3,421 g) 10 min

Transfer 10 mL volumetric flask
(adjust to mark with 0.05M sulphuric
acid, if necessary)

Load:
2.5 mL of sample

Wash (1):
2 mL 0.1% aq. formic acid

Wash (2):
2 mL methanol

Elute:
9mL 3% ammoniated methanol

Dry under N2 in Turbovap (45 oC)

Reconstitute in 1.0 mL and
syringe filter (0.22 µm) to LC vial

Figure 6.0: Flow diagram for the sample preparation of milk and cheese (extraction followed by
SCX-SPE).
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Sample Preparation/Extraction
Transfer 10.0 mL
milk to 50 mL
centrifuge tube

Transfer 4.0 g of cheese
+ 6.0 mL water in a 50
mL centrifuge tube
Modified QuEChERS & dSPE

Water bath (40 oC)
10 min to allow for
homogenisation

Add to 50 mL tube 1.5 g sodium
acetate + 6 mg MgSO4 + 3 mL of
1% acetic acid in acetonitrile

Add 10.0 mL of 1% acetic
acid in acetonitrile

Shake vigorously 1 min

Vortex 30 sec

Add test sample

Shake vigorously 1 min

Centrifuge 6,000 rpm (3,421 g) 10 min

Decant supernatant (~ 8 mL)
to dSPE clean-up tube

dSPE 15 mL tube; 150 mg PSA
+ 15 mg C + 900 mg MgSO4

Vortex 30 sec

Centrifuge 6,000 rpm (3,421 g) 10 min

From supernatant (~ 7 mL)
A
1.0 mL transferred to test tube, dried in
Turbovap under N2 @ 45 oC, and
reconstituted in 1.0 mL MeOH

B
1.0 mL

Syringe filter (0.22 µm) to LC vial

Figure 6.1: Flow diagram for the sample preparation of milk and cheese by modified
QuEChERS.
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Table 6.0: Methods of detection for PAs (and PANOs) in milk and in animal feeds.
Sample matrix

Sample preparation

PA feeding study in cows LLE,
(with S.jacobaea)
SPE

PAs in animal forage

reduction

Detection methods

and LC-MS/MS

Freeze-dried, SPE, and LC-MS/MS
LLE for reduction of
PAs to PANOs

PA analytes
detected
Jacoline,
jacobine,
jaconine, senkirkine,
otosenine,
florosenine
Various PA and
PANO profiles
(15 PAs and their Noxides)
Seneciphylline

Orally administered [3H] LLE, prep. column TLC and HPLC
seneciphylline in cows chromatography
milk
Senecio alpines in hay LLE and reduction
TLC, GC with FID and 15 PAs
and silage
MS
(including isomers)
Goats milk spiked with Reflux followed by GC with
tansy ragwort
ion-exchange and C18 63Ni-ECD
RP
prep.
column
chromatography
Senecio alpines in hay Soxhlet, LLE and GC-MS
and silage
reduction

PA feeding study in cows
N.R. = Not Reported

N.R.

N.R.

Jacobine

Seneciphylline,
senecionine,
integerrimine,
jacozine,
jacobine,
jaconine, jaconine
Jacoline detected
in milk

Comments

Reference

0.1% of initial dose detected Hoogenboom et al.,
in milk except for jacobine 2011
yielding a result of 4%
0 – 5.4 mg/kg (hay or silage, Mulder et al., 2009
identification of some PAs
and PANOs as equivalents)
0.16% of initial dose
detected in milk samples

Candrian et al., 1991

13 - 4000 mg/kg detected in Candrian et al., 1984
spiked hay and silage
samples
0.33 - 0.81mg/L (milk)
Deinzer et al., 1982

0.5 mg/L detected in urine, Lüthy et al., 1981
milk
not
tested
(identification based upon
MS in literature)
Chromatographic methods
not described

Dickinson
1976

et

al.,

6.4

Results and Discussion

Table 6.0 provides a summary of known publications to date on the investigation of PAs (and
their N-oxides) in milk and animal feeds.

As can be seen, there have been no previous

investigations into commercial milk or cheese samples. Therefore, it was important to determine
if PAs could be detected in such samples. All research relates to spiked feeding studies or the
contamination of animal feed or fodder. It has been estimated that 0.1 to 0.16% of PAs in
contaminated feed have been carried over into milk (Hoogenboom et al., 2011; Candrian et al.,
1991). Using data from the animal feeds study by Mulder et al. (2009) this would equate to 0.2
µg L-1 (or 0.04 µg per glass of milk, 200 mL). This figure is obtained by taking the mass of an
average dairy cow as 450 kg, a feeding rate of 1% of their body mass being 4.5 kg, considering
the detection result of 455 µg of PAs per kg (giving approximately 2000 µg) and a carryover of
0.1% (2000 µg x 0.1% = 0.2 µg L-1). This result is far less than those reported by Dickinson et
al. (1976) and Deinzer et al. (1982) of up to 0.167 mg L-1 and 0.81 mg L-1, respectively.

All previous sample preparation utilised the traditional PA extraction methods of liquid-liquid
extraction (LLE) or Soxhlet followed by reduction over zinc for N-oxide determination.
Detection methods generally employed LC-MS or GC-MS for PA analytes from the Senecio
genus.

6.4.1 Method development

LC-MS/MS conditions
The LC-MS/MS method development and optimisation has been previously discussed in Griffin
et al., 2014a and Chapter 5. The samples were identified based on equivalence to the individual
reference standards (with matrix-matched calibration curves) by (i) retention times of ± 0.2
minutes and (ii) mass spectra of target ion ratios for the quantifier and qualifier ions being ±
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20%. Identification relies upon the correct selection of diagnostic ions. This was achieved using
the Thermo Scientific TSQ Quantum Discovery MAX software which captures the [M+H]+ ion
while altering the collision energy to produce product ions. The optimisation software was set to
average the results of 5 plots. A representative plot illustrating the fragment ions and collision
energy is shown in Figure 6.2 for the PA seneciphylline. This was obtained by post-column
infusion as explained in Chapter 3; QqQ-MS Tuning (Appendix A contains plots for all PAs and
PANOs). Using a tighter tolerance of ± 20% for MS/MS ion ratios than that proposed by the
European Commission for safety in the food chain (2013) of 30% reduces the likelihood of false
positive results. Figure 6.3 illustrates how both parameters had to be met before a test sample
would be recorded as positive for PAs and/or PANOs.

Breakdown Curve of Ion 334.0 m/z
Intensity: 2.34e+06
Product Ions
Pressure: 1.5 mTorr
120.1 m/z
94.1 m/z
306.3 m/z
91.0 m/z

100

Coll.Energy
28 v
33 v
24 v
35 v

80

60

40

20

0
5

20

35
50
65
Collision Energy (V)

80

Figure 6.2: Plot for seneciphylline (m/z 334) illustrating the optimised fragment ions and
collision energies.
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Sample preparation
The extraction and SCX-SPE clean-up procedure employed for milk and cheese, as per Figure
6.0, was similar to that applied to honeys and discussed in Chapters 3 and 4. An identical SPE
protocol was used. The only difference between the methods is the ratio of sample mass to
solvent volume during the acidic extraction step. For example, 4 g of cheese to 6 mL of acid
produced too viscous an extract (4 g used for honeys). Therefore the mass was halved.
QuEChERS application was first published by Anastassiades and Lehotay et al. (2003) for the
application of pesticide detection in food and since then it has become a popular extraction and
clean-up methodology.

It is primarily used for pesticide residues in fruits and vegetables.

However, our research collaborators found that QuEChERS could be applied to other matrices
such as milk, liver and muscle tissues for the detection of veterinary residues (Kinsella et al.,
2009; Whelan et al., 2010). The advantage of QuEChERS is that it combines several steps,
reduces reagent and solvent costs and usage, and it requires little instrumentation and bench
space. The method, as per Figure 6.1, was optimised in order to avoid excessive protein crash
out/precipitation from the dairy produce in acetonitrile and minimise the affinity polar
compounds (analytes in this case) have for the aqueous phase by reducing the salt levels. The
method used here is one of many possible variations based upon the AOAC 2007.01 method for
pesticide residues in foods using acetonitrile for extraction and magnesium sulphate for
partitioning. The use of 1% acetic acid in acetonitrile and sodium acetate buffer is to protect
alkaline compounds from degradation.

6.4.2 Method Performance

Linearity
Calibration curves for all 10 free tertiary PAs and 4 PANOs ranged in concentration from 3.57 to
357.14 µg L-1 over 7-points and were prepared in (i) methanol and (ii) blank milk extract. Each
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concentration level was injected in triplicate in one day and for three consecutive days ensuring
repeatability for all analytes. The average correlation coefficient (R) for curves prepared in
methanol was 0.9982 and for curves in blank milk extract was 0.9951.

Precision and trueness
Method precision and trueness were established by using a blank milk extract (from SPE cleanup) spiked with all reference standards, PAs and PANOs, at two concentration levels, 35.7 and
71.4 µg L-1.

Precision was determined as intra-day variability of three injections (non-consecutive) at both
concentration levels analysed in one day and inter-day variability was performed using the higher
concentration level for six injections (non-consecutive) over 2 days. Both intra- and inter-day are
expressed as %RSD. Blank milk extract from SPE clean-up only was used as there was no
difference found following post-column infusion studies on LC-MS/MS for the analysis of milk
versus cheese extracts, or from SPE versus QuEChERS extracts. Figures 6.6 (a) and (b) display
results obtained from matrix interference assessments.

Limits of detection (LOD) and quantification (LOQ)
The average LOD and LOQ determined were in line with those reported in Chapter 5 (Table 3 of
the publication Griffin et al., 2014b) of 1.1 and 3.5 µg kg-1, respectively.
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Milk sample with m/z 334

100

6.18

Retention time not
within ± 0.2 min of
reference standard
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Relative Abundance
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0

+ c ESI SRM ms2 334.00 RT:6.84-7.09AV:53 NL:1.78E4

1

2

3

4

5
6
Time (min)

120.09
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306.27
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Relative Abundance

80
94.07
60

40

8

9

10

11

Ion ratios do not
match that of the
reference standard

60

40

20

20

0
94.074

7

+ c ESI SRM ms2 334.00 RT:6.08-6.31AV:47 NL:1.01E5
120.09

100

Relative Abundance

Figure 6.3: Example of how both parameters (retention time and ion ratios) had
to be satisfied before a test sample would be recorded as positive for PAs and/or
PANOs.

RT: 6.96
MA: 751784
SN : 183867

Reference Standard

94.075
m/z

120.089

120.090
m/z

306.266

306.267
m/z

306.268

0
94.074

94.07
94.075
m/z

306.27
120.089

120.090
m/z

306.266

306.267
m/z

306.268

The recoveries (%; n= 3) determined at both concentration levels ranged from 65 to 125% for
concentration level 35.7 µg L-1 and 73 to 122% for concentration level 71.4 µg L-1. This
information is detailed in Table 6.1 and found to be acceptable given the recommended criteria
from the European Commission (2013) of ≤20% RSD and within a recovery range of 70-120%.
Recoveries for the fortified QuEChERS samples (PAs spiked into milk and cheese samples prior
to extraction) at four concentration levels are given in Table 6.2 (a) samples which were dried
and reconstituted in methanol and (b) samples in which the supernatant from the final clean-up
were directly filtered into LC vials.

Compound

% Recovery (n = 3)

Crotaline
Crotaline N-oxide
Echimidine
Heliotrine
Lycopsamine
Otosenine
Retrorsine
Retrorsine N-oxide
Seneciphylline
Seneciphylline N-oxide
Senecionine
Senecionine N-oxide
Senkirkine
Trichodesmine

35.7
µg L-1
65
77
87
65
79
68
105
92
97
125
87
113
82
99

71.4
µg L-1
74
85
86
79
118
73
97
91
106
122
82
114
89
101

Intra-day (n = 3) %RSD

35.7
µg L-1
6
5
12
9
2
11
8
7
4
9
6
9
8
8

71.4
µg L-1
5
7
10
10
5
13
4
6
6
6
6
9
9
10

Intra-day (n = 3)
%RSD
71.4
µg L-1
7
11
6
9
8
10
8
12
10
12
8
8
9
10

Table 6.1: LC-MS/MS (SRM) validation data for PAs and PANOs in milk (extract via SPE).
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Concentration
PA/PANO
Crotaline
Crotaline N-oxide
Echimidine
Heliotrine
Lycopsamine
Otosenine
Retrorsine
Retrorsine N-oxide
Seneciphylline
Seneciphylline N-oxide
Senecionine
Senecionine N-oxide
Senkirkine
Trichodesmine
Overall Average

5 µg/10 mL
(%)

27
15
74
54
43
51
42
26
43
47
49
48
73
46

1 µg/10 mL
(%)

22
12
70
52
28
51
40
15
39
34
45
34
74
50

0.5 µg/10 mL
(%)

20
13
79
55
23
56
44
15
33
28
45
27
80
45

0.1 µg/10 mL
(%)

N.D.
29
65
46
N.D.
35
43
26
N.D.
N.D.
N.D.
N.D.
64
15

Mean
(%)
23
17
72
52
31
48
42
21
38
36
46
36
73
39
41

Table 6.2 (a): Recoveries for the fortified QuEChERS samples, at four concentration levels,
from extracts which were dried and reconstituted in methanol before LC-MS/MS (A from Figure
6.1).
Concentration
PA/PANO
Crotaline
Crotaline N-oxide
Echimidine
Heliotrine
Lycopsamine
Otosenine
Retrorsine
Retrorsine N-oxide
Seneciphylline
Seneciphylline N-oxide
Senecionine
Senecionine N-oxide
Senkirkine
Trichodesmine
Overall Average

5 µg/10 mL
(%)

29
18
73
45
30
51
37
24
38
46
44
43
65
54

1 µg/10 mL
(%)

25
13
76
46
15
57
42
13
37
33
44
32
70
57

0.5 µg/10 mL
(%)

17
12
79
46
N.D.
55
40
13
31
27
41
25
78
57

0.1 µg/10 mL
(%)

N.D.
29
67
38
N.D.
33
43
26
N.D.
N.D.
N.D.
N.D.
66
28

Mean
(%)
24
18
74
44
23
49
41
19
35
35
43
33
70
49
40

Table 6.2 (b): Recoveries for the fortified QuEChERS samples, at four concentration levels, in
which the supernatant from the final clean-up stage was directly filtered into LC vials for LCMS/MS (B from Figure 6.1).
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Selectivity
Selectivity was assessed by possible effects of the matrix, both milk and cheese, on the ionisation
of analytes. Any change in the mass spectrometry response of an analyte due to component(s) of
the sample matrix was monitored. Figure 6.4 displays the (a) chromatogram for the reference
standards mixture of PAs and PANOs (71.4 µg L-1) prepared in methanol matched to (b) the
chromatogram obtained for the reference standards of the same concentration spiked into a blank
milk extract. As previously discussed in other experimental chapters (3, 4 and 5) ion suppression
affects the reliability of the analytical result and thus the integrity of the analytical method.
Matrix-matched calibration curves and post-column infusion studies were performed. In matrixmatched calibrations the difference between the slopes of the two linear curves is observed by
overlaying the reference standard curve prepared in methanol with the standard curve prepared in
blank extract, as shown in Figure 6.5 for two representative PAs; seneciphylline (m/z 334) and
senecionine (m/z 336). This was performed for all PAs and PANOs with no obvious differences.

In performing a post-column infusion study a blank extract (no PAs or PANOs detected) for both
milk and cheese was monitored for matrix effects. The PA and PANO reference mixture (71.4
µg L-1) is introduced via a syringe pump (10 µL min-1) to be ionised concurrently as the matrix
elutes from the analytical/LC column. The matrix is injected from the autosampler (10 µL) under
the normal gradient conditions of the developed method. Figure 6.6 (a) displays the post-column
infusion result of a milk extract and Figure 6.6 (b) a cheese extract. The produced TICs for both
clearly overlay illustrating that no ion suppression or enhancement was detected.
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Figure 6.4: (a) LC-MS/MS TIC for the reference standard mixture (71.4 µg L-1); (1; Rt 2.74
min) crotaline, (2; Rt 3.07 min) lycopsamine, (3; Rt 3.30 min) crotaline N-oxide, (4; Rt 5.10 min)
retrorsine, (5; Rt 5.67 min) retrorsine N-oxide, (6; Rt 5.86 min) heliotrine, (7; Rt 6.24 min)
trichodesmine, (8; Rt 6.84 min) otosenine, (9; Rt 6.96 min) seneciphylline, (10; Rt 7.76 min)
seneciphylline N-oxide, (11; Rt 8.42 min) senecionine, (12; Rt 9.19) senecionine N-oxide, (13;
Rt 9.30 min) senkirkine, (14; Rt 9.41 min) echimidine, and (b) matched to a negative milk extract
(post SPE) spiked with the same reference standards (71.4 µg L-1).
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Figure 6.5: Matrix-matched calibration curves for two representative PAs; seneciphylline and
senecionine.
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Figure 6.6: (a) Sample matrix ion-suppression (enhancement) assessment; milk extract injection
(blue TIC), post-column infusion of PA and PANO reference mixture (71.4 µg L-1) while
simultaneously injecting a blank milk extract (red TIC), and an overlay of a reference mixture of
PA and PANOs to illustrate the region of elution.
100

90

80

Relative Abundance

70

60

50

40

30

20

10

0
0

1

2

3

4

5

6
7
Time (min)

8

9

10

11

Figure 6.6: (b) Sample matrix ion-suppression (enhancement) assessment; cheese extract
injection (blue TIC) and post-column infusion of PA and PANO reference mixture (71.4 µg L-1)
while simultaneously injecting a blank cheese extract (red TIC).
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6.4.3 Screening of Samples

No positive sample was detected, i.e. one showing the presence of one or more PAs and PANOs
included in this study above the LOD, among the 48 milk and 72 cheese products. As previously
illustrated a 0.1% carryover of PAs into milk may only equate to 0.2 µg L-1. At this level results
would be below the LOD for this method (1.1 µg L-1). It should be noted that previously
published results (0.167 mg L-1 and 0.81 mg L-1 as presented in Table 6.0) were obtained from
spiked feeding studies and thus the PA-content in milk would be greater than milk from animals
under normal grazing conditions. There are other considerations for commercial samples such as
batch blending and pasteurisation. These variables could possibly dilute or decrease the PAcontent in milk and cheese samples. Also, PA-negative results may be as a result of good pasture
management and Good Agriculture Practice (GAP) which is adopted in the farming community
in Ireland. However, much work is still needed on the investigation of PAs in dairy produce
(including sheep and goats produce), on the metabolism of PAs ingested by dairy animals and if
PA-metabolites can accumulate in muscle.

It has been suggested that up to 90% of PA

metabolites are excreted within 24 hours through the kidneys (Stewart and Steenkamp, 2001).
This could provide further reasoning for the PA-negative results obtained herein. The possibility
of PAs binding to proteins within milk and cheese samples should also be investigated as these
complexes could be eluted during the wash step of SPE clean-up, retained on the SPE cartridge
or trapped in the aqueous phase of QuEChERS and thus not detected by the methods reported in
this investigation.

Test samples of goats’ milk were selected as it had previously been reported that browsing
animals’ milk may contain higher PAs (Molyneux and James, 1990; Panter and James, 1990).
The extraction followed by SPE clean-up provided excellent recoveries (91% ± 16% SD) for the
desired analytes in the milk and cheese matrices. The SPE cartridge did not experience any
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blockages although low vacuum was applied to the manifold (< 10 in Hg or 5 psi), particularly
for cheese samples.

The new application of QuEChERS for PAs and/or PANOs detection would need further
optimisation as the mean recoveries from the fortified extracts were 41% for those samples
subjected to drying and reconstitution in methanol prior to analysis (Figure 6.1, route A) and
40% for those which were directly injected (Figure 6.1, route B). Modifications can be made by
adjusting solvents, pH, salts, volumes, water content and clean-up sorbents in the dispersive SPE
(dSPE) step. Both sets of recoveries were very similar for all PAs and PANOs included in this
study.

Therefore, taking the supernatant after dSPE direct to LC-MS/MS analysis would

eliminate the need for additional work (drying and reconstituting in solvent/methanol). It was
also determined that no difference existed between blank milk or cheese extracts obtained via
SPE clean-up or through QuEChERS (%RSDs were equivalent; 6% determined for QuEChERS
as opposed to 7% for SPE at the concentration level of 35.7 µg L-1 and 7% versus 8%,
respectively, for the concentration level of 71.4 µg L-1).

Since the completion of this research work a study on PAs in animal feed using a modified
QuEChERS procedure has been published (Bolechova et al., 2015). The authors did not perform
a dSPE clean-up on the extracts and achieved an average recovery of 72 to 94% at a 5 µg kg-1
spiking level for five PAs (monocrotaline, retrorsine, seneciphylline, senecionine and
senkirkine). Eliminating the dSPE clean-up from the protocol detailed herein could improve the
percentage recoveries obtained. Also, the authors did not find the use of sodium chloride
detrimental to the basic PAs during salting out.

238

6.5

Conclusions

There were no detectable levels of the ten PAs and four PANOs included in this study in retail
milk (n = 48) and cheese (n = 72). This indicates that even if some of the produce originated
from an animal that had grazed on PA containing plants, the transfer into the retail produce tested
here was significantly low (below the LOD for this method, 1.1 µg L-1). Other rationales are also
presented in section 6.4.3 of this chapter. However, this is a targeted study and does not contain
all known PAs and PANOs. The results were obtained via extraction with SPE clean-up which
has proven extremely effective in previous studies of honeys (Griffin et al., 2013 and 2014b) and
herbal products (Griffin et al., 2014a). A new application of QuEChERS was also investigated
by applying a modified method to these dairy samples. Although the mean recoveries of fortified
extracts (40 to 41%) are not within the acceptable range of 70-120%, the method could be
modified further to allow for greater recoveries and thus be used as part of a multi-residue testing
regime in conjunction with veterinary residues. “The biggest difficulty with QuEChERS arises
from its greatest strength; it is extremely flexible and rugged” and thus different modifications
will give rise to different results (Lehotay et al., 2010).
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Final Conclusions
& Recommendations
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Conclusions
Pyrrolizidine alkaloids (PAs) are a large group of natural toxins produced by plants, several of
which are known to be highly hepatotoxic and also have been shown to be carcinogenic. PAs
have been associated with a number of livestock diseases and cases of human poisoning
following contamination of staple foods, generally grain crops, or upon consumption of some
herbal remedies. Other possible food sources of exposure include honey, milk, offal and eggs,
which have all been found to contain PAs in some instances although cases of human poisoning
resulting from exposure through these sources have not been reported. It is unknown whether PA
residues are present in meat but the potential for exposure is thought to be slight due to the fast
metabolism and elimination of PAs from the bodies of animals. Veno-occlusive disease is the
most prominent hepatic lesion resulting from PA poisoning. Classical symptoms and signs are
abdominal pain and rapidly developing ascites. The effects of PAs can take time to develop and
might result from long term low level exposure. Cases of poisoning in humans and livestock,
combined with the results of studies in experimental animals indicate that there is variation
between species in susceptibility to PAs. Also, the metabolic pathways of PAs and PANOs are
yet to be fully elucidated.

The principal objective of this research was to investigate the presence of, and quantify, PAs and
PANOs in food using liquid chromatography-mass spectrometry. A range of food produce,
including honey, herbal teas, TCMs, milk and cheese, were investigated for PA-contamination.

Chapter 3 outlines the experimental approaches taken to achieve the research aims and illustrates
the improvements made upon previously published methods. A simple acidic extraction was
optimised for a range of food matrices (sample mass to acid volume ratio) before the extract was
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applied to a SCX polymeric SPE cartridge for clean-up. SCX-SPE provided superior clean-up of
both PA and PANO analytes. PAs interacted via a cation exchange mechanism whilst PANOs by
polar interactions with the active sites of the sorbent, thus mixed-mode. A study was conducted
of LC analytical columns in an effort to improve chromatographic performance and provide
superior elution of a range of PAs and PANOs over previously published methods. Both ion trap
MS and QqQ-MS analysers were used. Each method has its own benefits. The IT-MS method
allowed for accurate detection of PAs/PANOs via a spectral library, identification of
characteristic fragments and quantitation through established processing methods. The QqQ-MS
methods used both MRM and SRM modes for data acquisition. These methods are targeted but
allow for accurate detection of PAs and PANOs with high sensitivity and selectivity.

The experimental work contained within Chapter 4 provides quantitative data on the occurrence
of PAs at the point of consumption in Ireland for honeys. It was determined from a large scale
survey (369 honeys) that approximately 24% of honeys contain one or more PAs and/or PANOs.
The mean concentration for the total survey was 20 µg kg-1 (or 81 µg kg-1 based upon the
positives detected). All quantitation was performed using certified reference standards rather
than retronecine-type PA equivalents which have been used by some research groups. Using
equivalents will generally underestimate the PA-content as otonecine-type PAs are not accounted
for. It was also determined that imported honey from Australia and New Zealand, accounting for
approximately 20% of the honeys sold in the Irish market, contained higher concentrations (145
µg kg-1) of PA toxins in comparison with honeys originating from other regions of the world or
with indigenous honeys (no PAs/PANOs detected). It was for this reason a subsequent survey
was conducted on 59 Australian and New Zealand honeys which were purchased from Australian
supermarkets. In analysing these samples the first isocratic method for PAs and PANOs was
developed. The method was comparable to the previously developed method which employed a
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gradient elution. The isocratic method, while giving the same selectivity and sensitivity as the
validated gradient method, allows for fast identification of PA-positives. Isocratic elution is
particularly useful for quality testing laboratories or regulatory control agencies. This chapter
also includes findings from a risk exposure assessment which was conducted using data on PAconcentrations from the 369 honeys and dietary intake information from surveys conducted by
the IUNA (2012). Research colleagues at UCD utilised a modelling software package (Creme
software) to conduct both deterministic and probabilistic risk assessments. This highlighted that
PAs are an emerging risk to the food chain. From both assessments high consumers of honey
(and foods which contain honey as an ingredient), that is the 95th percentile, all exceed the
maximum recommended intake limit of 0.007 µg kg-1 bw day-1 as proposed by EFSA (2011).
Troublingly, the average or mean consumer of honey, particularly children, while not exceeding
the limit are extremely close to it (0.004 µg kg-1 bw day-1). It should be noted that these figures
are based solely on the consumption of honeys (or food where honey is listed as an ingredient).
If other foods which tested PA-positive, such as herbal teas reported in Chapter 5, were to be
incorporated into the risk assessment then this would increase the exposure of PAs to the section
of the Irish population who consumed same.

Chapter 5 contains the experimental work conducted on herbal teas and traditional Chinese
medicines (TCMs). The analytical methods developed, validated and described in Chapter 3, and
applied to the testing of honeys in Chapter 4, were used to test 18 herbal teas and 54 TCMs for
PAs (and their N-oxides). All samples were sourced within Ireland. The results were surprising
in that 50% of herbal teas and 78% of TCMs tested positive for one or more PAs and/or PANOs.
With regards to herbal products the term ‘Natural’ does not necessarily indicate that the product
is safe. The herbal teas and TCMs tested herein could potentially contain other hepatotoxic and
carcinogenic compounds, or other PAs and PANOs, which were not included in this targeted
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study and hence increase their toxicity further. Since this work was completed and published
further research has been conducted by other groups highlighting the presence of PAs in herbal
teas and products sourced within Germany and Switzerland. Similar findings were reported.
This has prompted the Food and Environmental Research Agency (FERA) in the UK to conduct
a large scale survey (> 250 samples) of herbal teas (2014).

Chapter 6 represents the initial experimental work conducted on commercial milk and cheese
samples. To date there are no publications on research of commercial milk products. Until now
research has focused on the carryover of PAs in milk from experimental feeding studies using
spiked/contaminated feed and fodder. There was no detectable level of PAs and PANOs in retail
milk (n = 48) or cheese (n = 72) products. The results were obtained via acidic extraction
followed by SPE clean-up which has proven extremely effective in previous studies of honeys
and herbal products. This indicates that even if some of the produce originated from an animal
that had grazed on PA containing plants the transfer into the retail produce tested here was
significantly low (below the LOD for the LC-MS/MS method). However, it may also show that
Good Agricultural Practices have been adopted within Ireland leading to effective pasture
management. Chapter 6 also investigated the new application of QuEChERS by applying this
technique to milk and cheese samples for the detection of PAs and PANOs. Although the mean
recoveries (41%) of fortified extracts were not within the acceptable range of 70-120%, the
method could be optimised to allow for greater recoveries and therefore be used as part of a
multi-residue testing regime in conjunction with veterinary residues. Since the completion of this
research a publication on PAs in animal feed utilised a similar modified QuEChERS technique
(Bolechova et al., 2015). The authors did not subject the sample extracts to dispersive SPE
(dSPE) clean-up, which is the second and final step of the QuEChERS technique. They reported
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mean recoveries of 88% for five retronecine-type PAs in animal feed. Thus, if the dSPE clean-up
was eliminated from the protocol detailed herein, it may improve recoveries.

Although measures exist within the food supply chain to improve both food safety and
traceability, there is still a distinct lack of same with regards to PA toxins and exposure. In
response, this research work is a significant contribution to the area of PA analysis, detection of
PAs within the food chain and the profiling of PAs.
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Recommendations / Future Work
o Further research needed to fully elucidate biosynthesis of PAs and the metabolism of PAs in
both humans and livestock.
o Investigations need to be conducted on the variation between species in susceptibility to PAs.
o Make additions to the work of Smith and Culvenor (1981), by identifying more PA-plants.
o Extend our knowledge on the PA-content of various plant species, between aerial parts and
roots and the environmental conditions which lend to differences in PA-concentration.
o Develop methods (such as preparative HPLC) to isolate and purify PAs (and their N-oxides)
as there is a significant dearth of commercially available reference standards.
o Develop other techniques such as colourimetric field tests, ELISA and NIR spectroscopy, the
latter being used as an in-process quality control measure (non-destructive technique).
o Apply the developed sample preparation and SCX-SPE protocol to a range of other food
matrices. It has proven effective for complex matrices such as honey, milk and cheese.
o Develop the QuEChERS protocol further, optimise the analyte recoveries, and investigate the
potential of using this technique for multi-analyte analysis.
o Consider the economic consequences for the presence of PAs within the food chain. For
example, honey blending is essential at EU level to meet consumer demands. The EU
currently imports over half of the honey it consumes (EFSA, 2011). Testing bulk honeys for
the presence of PAs before blending occurs would eliminate or significantly reduce PAcontamination (through dilution).
o Expand the survey of herbal teas, herbal products and dairy produce.
o Investigate if PA toxins accumulate in muscle tissues, offal and meat. During this work the
possibility of PAs binding or forming complexes with protein should be considered.
o Develop the spectral library further; include other PA reference standards which have become
available since the completion of this research and develop a multi-analyte platform..
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Appendix B
Copy of importers licence for honey samples received from Australia issued by the Department
of Agriculture, Food and the Marine.

267

268

